Emergent Capital (EMGC) 10-K 14 Mar 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 12, 2018	Jun. 30, 2017
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Trading Symbol	EMGC
Entity Registrant Name	Emergent Capital, Inc.
Entity Central Index Key	1,494,448
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		158,475,399
Entity Public Float			$ 9,577,209

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Assets
Cash and cash equivalents	$ 18,131	$ 2,246
Certificate of deposit	1,010	6,025
Prepaid expenses and other assets	617	1,112
Deposits - other	1,377	1,347
Life settlements, at estimated fair value	750	680
Fixed assets, net	145	232
Total assets	634,390	525,818
Liabilities
Accounts payable and accrued expenses	2,015	2,590
Other liabilities	451	359
Total liabilities	437,748	352,944
Commitments and Contingencies (Note 17)
Stockholders’ Equity
Common stock (par value $0.01 per share, 415,000,000 and 80,000,000 authorized at December 31, 2017 and December 31, 2016; 158,495,399 issued and 157,887,399 outstanding at December 31, 2017; 29,021,844 issued and 28,413,844 outstanding as of December 31, 2016	1,585	290
Preferred stock (par value $0.01 per share, 40,000,000 authorized; 0 issued and outstanding as of December 31, 2017 and 2016)	0	0
Treasury Stock, net of cost (608,000 shares as of December 31, 2017 and 2016)	(2,534)	(2,534)
Additional paid-in-capital	333,629	307,647
Accumulated deficit	(136,038)	(132,529)
Total stockholders’ equity	196,642	172,874
Total liabilities and stockholders’ equity	634,390	525,818
8.50% Senior Unsecured Convertible Notes Due 2019
Liabilities
Interest payable	46	2,272
Convertible Notes, net of discount and deferred debt costs	1,098	60,535
5.0% Senior Unsecured Convertible Notes Due 2023
Liabilities
Interest payable	1,432	0
Convertible Notes, net of discount and deferred debt costs	68,654	0
15.0% Senior Secured Notes
Liabilities
Interest payable	0	213
Senior Secured Notes, net of deferred debt costs	0	29,297
8.5% New Senior Secured Notes Due 2021
Liabilities
Interest payable	132	0
Senior Secured Notes, net of deferred debt costs	33,927	0
VIE
Assets
Cash and cash equivalents	13,136	9,072
Prepaid expenses and other assets	53	0
Life settlements, at estimated fair value	566,742	497,720
Receivable for maturity of life settlements (VIE)	30,045	5,000
Investment in affiliates (VIE)	2,384	2,384
Liabilities
Accounts payable and accrued expenses	753	593
VIE | White Eagle Revolving Credit Facility
Liabilities
White Eagle Revolving Credit Facility, at estimated fair value (VIE Note 3)	$ 329,240	$ 257,085

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Common stock, par value (usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	415,000,000	80,000,000
Common stock, shares issued (shares)	158,495,399	29,021,844
Common stock, shares outstanding (shares)	157,887,399	28,413,844
Preferred stock, par value (usd per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (shares)	40,000,000	40,000,000
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Treasury stock (shares)	608,000	608,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income
(Loss) gain on life settlements, net	$ 0	$ 0	$ (41)
Change in fair value of life settlements (Notes 7 & 15)	51,551	864	46,717
Other income	322	251	215
Total income	51,873	1,115	46,891
Expenses
Interest expense	32,797	29,439	27,286
Change in fair value of Revolving Credit Facilities (Notes 8, 9 & 15)	4,501	(1,898)	12,197
Loss on extinguishment of debt	2,018	554	8,782
Personnel costs	5,069	6,070	6,384
Legal fees	3,721	6,427	20,739
Professional fees	4,445	7,081	7,133
Insurance	783	835	1,275
Other selling, general and administrative expenses	1,777	2,036	2,194
Total expenses	55,111	50,544	85,990
(Loss) income from continuing operations before income taxes	(3,238)	(49,429)	(39,099)
(Benefit) provision for income taxes	0	0	(8,719)
Net (loss) income from continuing operations	(3,238)	(49,429)	(30,380)
Discontinued Operations:
(Loss) income from discontinued operations, net of income taxes	(271)	(260)	(644)
Income tax benefit	0	0	0
Net (loss) income from discontinued operations	(271)	(260)	(644)
Net (loss) income	$ (3,509)	$ (49,689)	$ (31,024)
Basic and diluted (loss) earnings per common share
Continuing operations (usd per share)	$ (0.04)	$ (1.79)	$ (1.22)
Discontinued operations (usd per share)	0	(0.01)	(0.03)
Net (loss) income (usd per share)	$ (0.04)	$ (1.80)	$ (1.25)
Weighted average shares outstanding:
Basic and diluted (in shares)	82,323,050	27,660,711	24,851,178

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2014		21,402,990	0
Beginning Balance at Dec. 31, 2014	$ 215,103	$ 214	$ 0	$ 266,705	$ (51,816)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(31,024)				(31,024)
Stock-based compensation (in shares)		41,259
Stock-based compensation	490			490
Purchase of treasury stock, net of costs (in shares)			608,000
Purchase of treasury stock, net of costs	(2,534)		$ (2,534)
Common stock issued for rights offering, net of costs (in shares)		6,688,433
Common stock issued for rights offering, net of costs	38,334	$ 67		38,267
Retirement of common stock (in shares)		(2,174)
Retirement of common stock	(12)			(12)
Ending Balance (in shares) at Dec. 31, 2015		28,130,508	608,000
Ending Balance at Dec. 31, 2015	220,357	$ 281	$ (2,534)	305,450	(82,840)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(49,689)				(49,689)
Stock-based compensation (in shares)		265,212
Stock-based compensation	411	$ 3		408
Common stock issued, net (in shares)		628,309
Common stock issued, net	1,803	$ 6		1,797
Retirement of common stock (in shares)		(2,185)
Retirement of common stock	(8)			(8)
Ending Balance (in shares) at Dec. 31, 2016		29,021,844	608,000
Ending Balance at Dec. 31, 2016	172,874	$ 290	$ (2,534)	307,647	(132,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(3,509)				(3,509)
Stock-based compensation (in shares)		1,991,132
Stock-based compensation	408	$ 20		388
Common stock issued, net (in shares)		127,500,000
Common stock issued, net	26,889	$ 1,275		25,614
Retirement of common stock (in shares)		(17,577)
Retirement of common stock	(20)			(20)
Ending Balance (in shares) at Dec. 31, 2017		158,495,399	608,000
Ending Balance at Dec. 31, 2017	$ 196,642	$ 1,585	$ (2,534)	$ 333,629	$ (136,038)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities
Net income (loss)	$ (3,509)	$ (49,689)	$ (31,024)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	102	108	113
Revolving Credit Facilities financing cost and fees withheld by lender	931	1,020	7,493
8.5% Convertible Notes debt modification costs	2,537	0	0
Stock-based compensation	388	403	490
Change in fair value of life settlements	(51,551)	(864)	(46,717)
Unrealized change in fair value of structured settlements	0	0	(20)
Change in fair value of Revolving Credit Facilities	4,501	(1,898)	12,197
Loss on life settlements	0	0	41
Interest income	(76)	(67)	(87)
Loss on extinguishment of debt	2,018	554	8,782
Interest Paid in Kind on Senior Unsecured Convertible Notes	6,288	0	0
Deferred tax liability	0	0	(8,729)
Change in assets and liabilities:
Deposits—other	(30)	0	(654)
Structured settlement receivables	0	0	1,065
Prepaid expenses and other assets	323	161	(74)
Accounts payable and accrued expenses	779	(287)	(3,105)
Other liabilities	116	34	(860)
Net cash used in operating activities	(34,847)	(45,555)	(54,348)
Cash flows from investing activities
Purchase of fixed assets, net of disposals	(4)	(9)	(69)
Certificate of deposit	5,025	(3,500)	(2,501)
Premiums paid on life settlements	(84,718)	(71,681)	(64,923)
Purchases of life settlements	0	(1,390)	(29,065)
Proceeds from sale of life settlements, net	0	0	2,150
Proceeds from maturity of life settlements	42,131	50,460	53,454
Net cash used in investing activities	(37,566)	(26,120)	(40,954)
Cash flows from financing activities
Proceeds from rights offering, net	0	0	38,334
Proceeds from issue of common stock, net	19,188	1,803	0
Purchase of treasury shares	0	0	(2,534)
Payment under finance lease obligations	(25)	(35)	(34)
Payment of Recapitalization Transaction closing cost	(1,287)	0	0
Secured Notes deferred debt costs	0	0	(5)
Net cash provided by financing activities	92,362	62,652	60,726
Net increase/(decrease) in cash and cash equivalents	19,949	(9,023)	(34,576)
Cash and cash equivalents, at beginning of the year	11,318	20,341	54,917
Cash and cash equivalents, at end of the year	31,267	11,318	20,341
Supplemental disclosures of cash flow information:
Cash paid for interest during the period	21,379	24,337	13,802
Supplemental disclosures of non-cash financing activities:
Interest Paid in Kind on 8.5% Senior Unsecured Convertible Notes	6,288	0	0
Interest payment and fees withheld from borrowings by lender	931	1,020	7,493
Issue of 8.5% Senior Secured Notes through Recapitalization Transaction	30,000	0	0
Recapitalization Transaction closing cost and other costs withheld from proceeds	4,338	0	0
Red Falcon Revolving Credit Facility origination cost paid to lender	0	0	2,200
Borrowings under Red Falcon Revolving Credit Facility	0	0	54,000
Red Falcon Revolving Credit Facility
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Debt origination costs	0	297	3,329
Cash flows from financing activities
Repayment of borrowings under credit facilities	0	(10,452)	(4,378)
Borrowings from lines of credit	0	19,673	5,741
Extinguishment of Secured Notes	0	(315)	0
Payments for debt origination costs	0	(150)	(483)
Supplemental disclosures of non-cash financing activities:
Repayment of line of credit	0	0	51,800
White Eagle Revolving Credit Facility
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Debt origination costs	0	388	0
Cash flows from financing activities
Repayment of borrowings under credit facilities	(19,633)	(34,799)	(43,241)
Borrowings from lines of credit	86,356	57,978	47,146
Supplemental disclosures of non-cash financing activities:
Repayment of line of credit	0	64,965	0
8.50% Senior Unsecured Convertible Notes Due 2019
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Amortization of discount and deferred debt costs	2,433	3,724	3,132
Change in assets and liabilities:
Interest payable	(2,226)	0	0
15.0% Senior Secured Notes
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Amortization of discount and deferred debt costs	184	348	0
Change in assets and liabilities:
Interest payable	(213)	213	0
Cash flows from financing activities
Borrowings from lines of credit	2,763	0	0
Proceeds from Secured Notes, net	0	30,000	0
Payments for debt origination costs	0	(1,051)	0
Supplemental disclosures of non-cash financing activities:
Repayment of Notes principal, interest and penalty through recapitalization transaction	31,675	0	0
12.875% Senior Secured Notes
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Amortization of discount and deferred debt costs	0	0	541
Change in assets and liabilities:
Interest payable	0	0	(261)
5.0% Senior Unsecured Convertible Notes Due 2023
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Amortization of discount and deferred debt costs	496	0	0
Change in assets and liabilities:
Interest payable	1,432	0	0
8.5% New Senior Secured Notes Due 2021
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Amortization of discount and deferred debt costs	98	0	0
Change in assets and liabilities:
Interest payable	132	0	0
Cash flows from financing activities
Proceeds from Secured Notes, net	5,000	0	0
Secured Notes
Cash flows from financing activities
Proceeds from Secured Notes, net	0	0	23,750
Extinguishment of Secured Notes	0	0	(3,570)
15.00% Promissory Note
Supplemental disclosures of non-cash financing activities:
Repayment of Notes principal, interest and penalty through recapitalization transaction	$ 2,799	$ 0	$ 0

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS ACTIVITIES	12 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS ACTIVITIES	ORGANIZATION AND DESCRIPTION OF BUSINESS ACTIVITIES Emergent Capital, Inc. was founded in December 2006 as a Florida limited liability company, Imperial Holdings, LLC, and converted into Imperial Holdings, Inc. on February 3, 2011 in connection with the Company’s initial public offering. Effective September 1, 2015, the name was changed to Emergent Capital, Inc. (with its subsidiary companies, the "Company" or "Emergent Capital"). Emergent Capital, through its subsidiary companies, owns a portfolio of 608 life insurance policies, also referred to as life settlements, with a fair value of $567.5 million and an aggregate death benefit of approximately $2.9 billion at December 31, 2017 . The Company primarily earns income on these policies from changes in their fair value and through death benefits. 606 of these policies, with an aggregate death benefit of approximately $2.9 billion and a fair value of 566.7 million at December 31, 2017 are pledged under a $370.0 million , revolving credit agreement (the "White Eagle Revolving Credit Facility") entered into by the Company’s indirect subsidiary, White Eagle Asset Portfolio, LP ("White Eagle"). At December 31, 2017 , two policies owned by the Company, with an aggregate death benefit of approximately $12.0 million and a fair value of $750,000 were not pledged as collateral under the White Eagle Revolving Credit Facility.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company, all of its wholly-owned subsidiary companies and its special purpose entities, with the exception of Imperial Settlements Financing 2010, LLC ("ISF 2010"), an unconsolidated special purpose entity which is accounted for using the cost method of accounting. The special purpose entity has been created to fulfill specific objectives. All significant intercompany balances and transactions have been eliminated in consolidation, including income from services performed by subsidiary companies in connection with the White Eagle Revolving Credit Facility. Notwithstanding consolidation, as referenced above, White Eagle is the owner of 606 policies, with an aggregate death benefit of approximately $2.9 billion and an estimated fair value of approximately $566.7 million . Going Concern Historically, the Company has incurred substantial losses and reported negative cash flows from operating activities of $34.8 million , $45.6 million and $54.3 million for the years ended December 31, 2017 , 2016 and 2015 , respectively. As of December 31, 2017 , we had approximately $31.3 million of cash and cash equivalents and certificates of deposit of $1.0 million ; of this amount, approximately $19.1 million is available to pay premiums on the 2 unencumbered policies and other overhead expenses, with approximately $13.1 million being restricted by the White Eagle Revolving Credit Facility. The Company’s ability to continue as a going concern is dependent on its ability to meet its liquidity needs through a combination of the receipt of death benefits from life insurance policy maturities, borrowings under the White Eagle Revolving Credit Facility, strategic capital market raises, policy sales (subject to certain asset sale restrictions) and cash on hand. During the year ended December 31, 2017 , the Company entered into certain agreements for the purpose of recapitalizing the Company, and on July 28, 2017 and August 11, 2017, the Company consummated the Transactions (as defined below). See Note 10, "8.5% Senior Unsecured Convertible Notes", Note 11 "5.0% Senior Unsecured Convertible Notes", Note 12, "15% Senior Secured Notes", Note 13, "8.5% Senior Secured Notes" and Note 18, "Stockholders' Equity" for further information. In considering the cash on hand at December 31, 2017 and management's projections for receipts of death benefits from policy maturities, we estimate that our liquidity and capital resources are sufficient for our current and projected financial needs for the next twelve months, at a minimum, from the date of filing this Form 10-K. The accompanying consolidated financial statements are prepared on a going concern basis and do not include any adjustments that might result from uncertainty about the Company’s ability to continue as a going concern. Discontinued Operations On October 25, 2013, the Company sold substantially all of the assets comprising its structured settlement business. As a result, the Company has discontinued segment reporting and classified its operating results of the structured settlement business, net of income taxes, as discontinued operations. The accompanying consolidated statements of operations for each of the three years in the period ended December 31, 2017 , 2016 and 2015 and the related notes to the consolidated financial statements reflect the classification of its structured settlement business operating results, net of tax, as discontinued operations. See Note 6, "Discontinued Operations," of the accompanying consolidated financial statements for further information. Unless otherwise noted, the following notes refer to the Company’s continuing operations. Ownership of Life Insurance Policies In the ordinary course of our legacy premium finance business, a large portion of our borrowers defaulted by not paying off their loans and relinquished ownership of their life insurance policies to us in exchange for our release of the obligation to pay amounts due. We also buy life insurance policies in the secondary and tertiary markets. We account for life insurance policies that we own as life settlements (life insurance policies) in accordance with ASC 325-30, Investments in Insurance Contracts , which requires us to either elect the investment method or the fair value method. The election is made on an instrument-by-instrument basis and is irrevocable. We have elected to account for these life insurance policies as investments using the fair value method. We initially record life settlements at the transaction price. For policies acquired upon relinquishment by our borrowers, we determined the transaction price based on fair value of the acquired policies at the date of relinquishment. The difference between the net carrying value of the loan and the transaction price is recorded as a gain (loss) on loan payoffs and settlement. For policies acquired for cash, the transaction price is the amount paid. Valuation of Insurance Policies Our valuation of insurance policies is a critical component of our estimate of the fair value of our life settlements (life insurance policies). We currently use a probabilistic method of valuing life insurance policies, which we believe to be the preferred valuation method in the industry. The most significant assumptions are the Company’s estimate of the life expectancy of the insured and the discount rate. See Note 15, "Fair Value Measurements" of the accompanying consolidated financial statements. Fair Value Measurement Guidance We follow ASC 820, Fair Value Measurements and Disclosures , which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Our investments in life insurance policies and debt under the Revolving Credit Facilities are considered Level 3 as there is currently no active market where we are able to observe quoted prices for identical assets/liabilities and our valuation model incorporates significant inputs that are not observable. See Note 15, "Fair Value Measurements" of the accompanying consolidated financial statements. Fair Value Option We have elected to account for life settlements using the fair value method. The fair value of the asset is the estimated amount that would be received to sell an asset in an orderly transaction between market participants at the measurement date. We calculate the fair value of the asset using a present value technique to estimate the fair value of the life settlements. The Company currently uses a probabilistic method of valuing life insurance policies, which the Company believes to be the preferred valuation method in the industry. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. See Note 7, "Life Settlements (Life Insurance Policies)" and Note 15, "Fair Value Measurements" of the accompanying consolidated financial statements. We have elected to account for the debt under the White Eagle Revolving Credit Facility, which includes the interests in policy proceeds to the lender, using the fair value method. The fair value of the debt is the estimated amount that would have to be paid to transfer the debt to a market participant in an orderly transaction. We calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, our estimates are not necessarily indicative of the amounts that we, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of assumptions and/or estimation methodologies could have a material effect on estimated fair values. Income Recognition from Continuing Operations Our primary sources of income from continuing operations are in the form of changes in fair value and gains on life settlements, net. Our income recognition policies for these sources of income are as follows: • Changes in Fair Value of Life Settlements —When the Company acquires certain life insurance policies, we initially record these investments at the transaction price, which is the fair value of the policy for those acquired upon relinquishment or the amount paid for policies acquired for cash. The fair value of the investment in insurance policies is evaluated at the end of each reporting period. Changes in the fair value of the investment are recorded as changes in fair value of life settlements in our consolidated statement of operations. The fair value is determined on a discounted cash flow basis that incorporates current life expectancy assumptions. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the policy would require. The Company recognizes income from life settlement maturities on the date we are in receipt of death notice or verified obituary of the insured. This income is the difference between the death benefit and fair value of the policy at the time of maturity. • Loss on Life Settlements, Net —The Company recognizes gains or losses from the sale of life settlement contracts that the Company owns upon the signed sale agreement and/or filing of ownership forms and funds transferred to escrow. Income Taxes In July 2013, the FASB issued ASU No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists ("ASU 2013-11"). ASU 2013-11 requires, unless certain conditions exists, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, similar tax loss, or a tax credit carryforward. The Company adopted ASU 2013-11 effective January 1, 2014 , which required the Company to reclassify a $6.3 million current liability for unrecognized tax benefits to deferred taxes. As of December 31, 2017 , the Company has determined that the deferred tax assets that gave rise to this reclassification are worthless due to effects of the ownership change and should be written off. As such, the $6.3 million deferred tax liability for unrecognized tax benefits has also been reversed during the current year. In November 2015, the FASB issued ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes, which requires that all deferred tax assets and liabilities, along with any related valuation allowances be classified as a net noncurrent asset or liability in the balance sheet based on a jurisdictional basis. The new guidance became effective for public business entities in fiscal years beginning after December 15, 2016, including interim periods within those years. The adoption of this guidance only affects the presentation of deferred taxes in the Company’s consolidated balance sheets. In March 2016, the FASB issued ASU No. 2016-09, "Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" as part of its Simplification Initiative. The guidance simplifies several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public business entities, these amendments became effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption was permitted including adoption in an interim period, as long as any adjustment is reflected as of the beginning of the fiscal year that includes the interim period. The Company adopted this guidance during the year ended December 31, 2017. The adoption of this ASU did not impact the consolidated financial statements or related disclosures. In October 2016, the FASB issued ASU No. 2016-16 Income Taxes (Topic 740): Intra-entity transfers of assets other than inventory ("ASU 2016-16"). Current GAAP prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. This prohibition on recognition is an exception to the principle of comprehensive recognition of current and deferred income taxes in GAAP. The Board decided that an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Consequently, the amendments in this Update eliminate the exception for an intra-entity transfer of an asset other than inventory. For public business entities, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2017, including interim reporting periods within those annual reporting periods. We are currently evaluating whether the adoption of this new guidance will have a significant impact on our consolidated financial statements and related disclosures. Cash and Cash Equivalents Cash and cash equivalents include cash on hand and all highly liquid instruments with an original maturity of three months or less, when purchased. The Company maintains the majority of its cash in several operating accounts with two commercial banks. Balances on deposit are insured by the Federal Deposit Insurance Corporation ("FDIC"). However, from time to time, the Company’s balances may exceed the FDIC insurable amount at its banks. Certificate of Deposit The Company maintains a portion of its operating funds in certificate of deposit. At December 31, 2017 and 2016, the carrying amount of the certificate of deposits was $1 million and $6.0 million , respectively, which approximates fair value. The certificate of deposit matures on September 22, 2018 and bears interest at a rate of 0.2% . Deferred Debt Costs Deferred debt costs include costs incurred in connection with acquiring and maintaining debt arrangements. These costs are directly deducted from the carrying amount of the liability in the consolidated balance sheets, are amortized over the life of the related debt using the effective interest method and are classified as interest expense in the accompanying consolidated statements of operations. These deferred costs are related to the Company's 8.5% Convertible Notes, 5% Convertible Notes and 8.5% Senior Secured Notes. The Company did not recognize any deferred debt costs on the White Eagle Revolving Credit Facility given all costs were expensed due to electing the fair value option in valuing the White Eagle Revolving Credit Facility. Treasury Stock The Company accounts for its treasury stock using the treasury stock method as set forth in ASC 505-30, Treasury Stock . Under the treasury stock method, the total amount paid to acquire the stock is recorded and no gain or loss is recognized at the time of purchase. Gains and losses are recognized at the time the treasury stock is reinstated or retired and are recorded in additional paid in capital or retained earnings. At December 31, 2017 and 2016, the Company owned 608,000 shares of treasury stock. Stock-Based Compensation We have adopted ASC 718, Compensation—Stock Compensation. ASC 718 addresses accounting for share-based awards, including stock options, restricted stock, performance shares and warrants, with compensation expense measured using fair value and recorded over the requisite service or performance period of the award. The fair value of equity instruments awarded will be determined based on a valuation using an option pricing model that takes into account various assumptions that are subjective. Key assumptions used in the valuation will include the expected term of the equity award taking into account both the contractual term of the award, the effects of expected exercise and post-vesting termination behavior, expected volatility, expected dividends and the risk-free interest rate for the expected term of the award. Compensation expense associated with performance shares is only recognized to the extent that it is probable the performance measurement will be met. Earnings Per Share The Company computes net income per share in accordance with ASC 260, Earnings Per Share . Under the provisions of ASC 260, basic net income per share is computed by dividing the net income available to common shareholders by the weighted average common shares outstanding during the period. Diluted net income per share adjusts basic net income per share for the effects of stock options, warrants, convertible notes and restricted stock awards only in periods in which such effect is dilutive. ASC 260 also requires the Company to present basic and diluted earnings per share information separately for each class of equity instruments that participate in any income distribution with primary equity instruments. Held-for-sale and discontinued operations We report a business as held-for-sale when management has approved or received approval to sell the business and is committed to a formal plan, the business is available for immediate sale, the business is being actively marketed, the sale is anticipated to occur during the ensuing year and certain other specified criteria are met. A business classified as held-for-sale is recorded at the lower of its carrying amount or estimated fair value less cost to sell. If the carrying amount of the business exceeds its estimated fair value, a loss is recognized. Depreciation is not recorded on assets of a business classified as held-for-sale. Assets and liabilities related to a business classified as held-for-sale are segregated in the Consolidated Balance Sheet and major classes are separately disclosed in the notes to the Consolidated Financial Statements commencing in the period in which the business is classified as held-for-sale. We report the results of operations of a business as discontinued operations if the business is classified as held-for-sale, the operations and cash flows of the business have been or will be eliminated from the ongoing operations of the Company as a result of a disposal transaction and we will not have any significant continuing involvement in the operations of the business after the disposal transaction. The results of discontinued operations are reported in Discontinued Operations in the Consolidated Statement of Operations for current and prior periods commencing in the period in which the business meets the criteria of a discontinued operation, and include any gain or loss recognized on closing or adjustment of the carrying amount to fair value less cost to sell. During the fourth quarter of 2013, we sold substantially all of our structured settlements business. As a result, we have classified our structured settlement operating results as discontinued operations. Foreign Currency We own certain foreign subsidiary companies formed under the laws of Ireland, Bahamas and Bermuda. These foreign subsidiary companies utilize the U.S. dollar as their functional currency. The foreign subsidiary companies' financial statements are denominated in U.S. dollars and therefore, there are no translation gains and losses resulting from converting the financial statements at exchange rates other than the functional currency. Any gains and losses resulting from foreign currency transactions (transactions denominated in a currency other than the subsidiary companies functional currency) are included in income. These gains and losses are immaterial to our financial statements. Use of Estimates The preparation of these consolidated financial statements, in conformity with generally accepted accounting principles in the United States of America ("GAAP"), requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results could differ from these estimates and such differences could be material. Significant estimates made by management include income taxes, the valuation of life settlements, the valuation of the debt owing under the White Eagle Revolving Credit Facility and the valuation of equity awards. Risks and Uncertainties In the normal course of business, the Company encounters economic, legal and longevity risk. There are two main components of economic risk that could potentially impact the Company: market risk and concentration of credit risk. Market risk for the Company includes interest rate risk. Market risk also reflects the risk of declines in valuation of the Company’s life settlements, including declines caused by the selection of increased discount rates associated with the Company’s fair value model for life settlements. It is reasonably possible that future changes to estimates involved in valuing life settlements could change and result in material effects to the future financial statements. Concentration of credit risk includes the risk that an insurance carrier who has issued life insurance policies held by the Company in its portfolio, does not remit the amount due under those policies due to the deteriorating financial condition of the carrier or otherwise. Legal risk includes the risk that statutes define or courts interpret insurable interest in a manner adverse to the Company’s ownership rights in its portfolio of life insurance policies and the risk that courts allow insurance carriers to retain premiums paid by the Company in respect of insurance policies that have been successfully rescinded or contested. Longevity risk refers to the risk that the Company does not experience the mortalities of insureds in its portfolio of life insurance policies that are anticipated to occur on an actuarial basis in a timely manner, which would result in the Company expending additional amounts for the payment of premiums. Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers," which converges the FASB and the International Accounting Standards Board ("IASB") standard on revenue recognition. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. In April 2015, the FASB voted to defer the effective date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In February 2016, the FASB issued ASU No. 2016-02, "Leases" (Topic 842). The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. All leases create an asset and a liability for the lessee in accordance with FASB Concepts Statement No. 6, Elements of Financial Statements , and, therefore, recognition of those lease assets and lease liabilities represents an improvement over previous GAAP, which did not require lease assets and lease liabilities to be recognized for most leases. This ASU is effective for annual periods beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In March 2016, the FASB issued ASU No. 2016-06, "Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments." Topic 815 requires that embedded derivatives be separated from the host contract and accounted for separately as derivatives if certain criteria are met. One of those criteria is that the economic characteristics and risks of the embedded derivatives are not clearly and closely related to the economic characteristics and risks of the host contract (the "clearly and closely related" criterion). The guidance in this ASU intends to resolve the diversity in practice resulting from the application of the existing four-step decision sequence defined in ASC 815-15-25-42 to call (put) options that can accelerate the repayment of principal on a debt instrument if they meet the clearly and closely related criterion by clarifying that an entity is required to perform only the four-step decision sequence. The entity does not have to separately assess whether the event that triggers its ability to exercise the contingent option is itself indexed only to interest rates or credit risk. This ASU is effective for annual periods beginning after December 15, 2017, and interim periods beginning after December 15, 2018. Early adoption is permitted including adoption in an interim period, as long as any adjustment is reflected as of the beginning of the fiscal year that includes the interim period. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments." This ASU provides specific guidance on eight cash flow classification issues that are either unclear or not included in current GAAP. These cash flow classification issues include debt prepayment or debt extinguishment costs, settlement of zero-coupon debt instruments, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, proceeds from the settlement of corporate-owned life insurance policies, distributions received from equity method investees, beneficial interests in securitization transactions, and separately identifiable cash flows and application of the predominance principle. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In January 2017, the FASB issued ASU 2017-01, "Business Combinations (Topic 805)," to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses by clarifying the definition of a business. The definition of a business affects many areas of accounting including acquisition, disposals, goodwill and consolidation. This amendment covers Phase 1 of a three phase project. The update is effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The amendments in this update should be applied prospectively on or after the effective date. We are currently evaluating the impact that the adoption of this ASU will have on our consolidated financial statements. In May 2017, the FASB issued ASU 2017-09, "Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting" to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under this new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. The guidance is effective prospectively for annual periods beginning on or after December 15, 2017. Early adoption was permitted. We do not anticipate the adoption of this guidance will have a material impact on our consolidated financial statements. In August 2017, the FASB issued Accounting Standards Update (ASU) No. 2017-12, "Derivatives and Hedging (Topic 815)," which simplifies and clarifies the accounting and disclosure for hedging activities by more closely aligning the results of cash flow and fair value hedge accounting with the risk management activities of an entity. The amendments in this update are effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2018, with early adoption permitted. We do not expect this standard to have an impact on our consolidated financial position, results of operations or cash flows. Adopted Accounting Pronouncements In August 2014, the FASB issued ASU No. 2014-15, "Disclosures of Uncertainties About an Entity’s Ability to Continue as a Going Concern." The standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. The Company adopted this guidance during the year ended December 31, 2017 . Management has performed a going concern analysis of the Company's liquidity needs and the appropriate disclosures have been incorporated in the accompanying consolidated financial statements for the year ended December 31, 2017 . In November 2015, the FASB issued ASU No. 2015-17, "Income Taxes (Topic 740): Balance Sheet Classifications of Deferred Taxes," which aligns the FASB and the IASB standard for financial statement presentation of deferred income taxes. To simplify the presentation of deferred income taxes, this standard requires that deferred tax assets and liabilities be presented as noncurrent on the balance sheet. This ASU is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption was permitted, including adoption in an interim period. The Company adopted this guidance during the year ended December 31, 2017 and it did not have any material impact on our financial position, results of operations or cash flows. In March 2016, the FASB issued ASU No. 2016-09, "Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" as part of its Simplification Initiative. The guidance simplifies several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public business entities, these amendments are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption was permitted including adoption in an interim period, as long as any adjustment is reflected as of the beginning of the fiscal year that includes the interim period. The adoption of this ASU did not impact the consolidated financial statements or related disclosures.

CONSOLIDATION OF VARIABLE INTER

CONSOLIDATION OF VARIABLE INTEREST ENTITIES	12 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
CONSOLIDATION OF VARIABLE INTEREST ENTITIES	CONSOLIDATION OF VARIABLE INTEREST ENTITIES The Company evaluates its interests in variable interest entities ("VIEs") on an ongoing basis and consolidates those VIEs in which it has a controlling financial interest and is thus deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be potentially significant to the VIE. The following table presents the consolidated assets and consolidated liabilities of VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated in the Company’s financial statements as of December 31, 2017 and 2016 , as well as non-consolidated VIEs for which the Company has determined it is not the primary beneficiary (in thousands): Primary Beneficiary Not Primary Beneficiary Consolidated VIEs Non-consolidated VIEs Assets Liabilities Total Assets Maximum Exposure To Loss December 31, 2017 $ 609,976 $ 329,993 $ 2,384 $ 2,384 December 31, 2016 $ 511,792 $ 257,678 $ 2,384 $ 2,384 As of December 31, 2017 , 606 life insurance policies owned by White Eagle with an aggregate death benefit of approximately $2.9 billion and an estimated fair value of approximately $566.7 million were pledged as collateral under the White Eagle Revolving Credit Facility. In accordance with ASC 810, Consolidation , the Company consolidated White Eagle in its financial statements for the years ended December 31, 2017 and 2016 . Imperial Settlements Financing 2010, LLC ("ISF 2010"), which was formed as an affiliate of the Company to serve as a special purpose financing entity to allow the Company to sell structured settlements and assignable annuities, is a non-consolidated special purpose financing entity, as well as a non-consolidated VIE for which the Company has determined it is not the primary beneficiary. Approximately $2.4 million is included in investment in affiliates in the accompanying balance sheet as of December 31, 2017 and December 31, 2016 , respectively.

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2017
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE As of December 31, 2017 , 2016 and 2015 , there were 158,495,399 , 29,021,844 and 28,130,508 shares of common stock issued, respectively, and 157,887,399 , 28,413,844 , and 27,522,508 of shares of common stock outstanding, respectively. Outstanding shares as of December 31, 2017 , 2016 and 2015 have been adjusted to reflect 608,000 treasury shares. Basic net income per share is computed by dividing the net earnings attributable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income attributable to common shareholders by the weighted average number of common shares outstanding, increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued. Conversion or exercise of the potential common shares is not reflected in diluted earnings per share unless the effect is dilutive. The dilutive effect, if any, of outstanding common share equivalents is reflected in diluted earnings per share by application of the treasury stock method and if-converted method, as applicable. The following tables reconcile actual basic and diluted earnings per share for the years ended December 31, 2017 , 2016 and 2015 (in thousands except per share data). 2017 2016 2015 (1) (2) (3) Loss per share: Numerator: Net (loss) income from continuing operations $ (3,238 ) $ (49,429 ) $ (30,380 ) Net (loss) income from discontinued operations (271 ) (260 ) (644 ) Net (loss) income $ (3,509 ) $ (49,689 ) $ (31,024 ) Basic and diluted (loss) income per common share: Basic and diluted (loss) income per share from continuing operations $ (0.04 ) $ (1.79 ) $ (1.22 ) Basic and diluted (loss) income per share from discontinued operations $ — $ (0.01 ) $ (0.03 ) Basic and diluted (loss) income per share available to common shareholders $ (0.04 ) $ (1.80 ) $ (1.25 ) Denominator: Basic and diluted 82,323,050 27,660,711 24,851,178 (1) The computation of diluted EPS does not include 542,102 options, 48,740,521 warrants, 2,102,522 shares of restricted stock, and up to 37,918,483 shares of underlying common stock issuable upon conversion of the 5% Convertible Notes (as defined below) and up to 181,249 shares of underlying common stock issuable upon conversion of the 8.5% Convertible Notes (as defined below) for the year ended December 31, 2017 , as the effect of their inclusion would have been anti-dilutive. (2) The computation of diluted EPS did not include 763,594 options, 6,240,521 warrants, 265,212 shares of restricted stock and up to 10,738,165 shares of underlying common stock issuable upon conversion of the Convertible Notes for the year ended December 31, 2016 , as the effect of their inclusion would have been anti-dilutive. (3) The computation of diluted EPS did not include 774,394 options and 6,240,521 warrants, 41,259 shares of restricted stock, up to 10,738,165 shares of underlying common stock issuable upon conversion of the Convertible Notes, and 319,500 performance shares for the year ended December 31, 2015 , as the effect of their inclusion would have been anti-dilutive.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION On June 27, 2017, the shareholders of the Company voted to amend, and the Company amended, the Amended and Restated 2010 Omnibus Incentive Plan (as amended, the "Omnibus Plan") to increase the number of shares authorized for issuance thereunder by 9,900,000 shares. Awards under the Omnibus Plan may consist of incentive awards, stock options, stock appreciation rights, performance shares, performance units, and shares of common stock, restricted stock, restricted stock units or other stock-based awards as determined by the compensation committee of the Company's board of directors. The Omnibus Plan has an aggregate of 12,600,000 shares of common stock authorized for issuance thereunder, subject to adjustment as provided therein. Options As of December 31, 2017 , all options to purchase shares of common stock issued by the Company were fully vested. There was no stock-based compensation expense relating to stock options granted under the Omnibus Plan during years ended December 31, 2017 and 2016 . The Company recognized approximately $238,000 in stock-based compensation expense relating to stock options granted under the Omnibus Plan during the year ended December 31, 2015 . As of December 31, 2017 , options to purchase 542,102 shares of common stock were outstanding under the Omnibus Plan at a weighted average exercise price of $8.75 per share. The following table presents the activity of the Company’s outstanding stock options of common stock for the year ended December 31, 2017 : Common Stock Options Number of Shares Weighted Average Price per Share Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Options outstanding, January 1, 2017 763,594 $ 8.52 2.47 $ — Options granted — — — Options exercised — — — Options forfeited (221,492 ) 9.01 — Options expired — — — Options outstanding, December 31, 2017 542,102 $ 8.75 1.33 $ — Exercisable at December 31, 2017 542,102 8.75 1.33 Unvested at December 31, 2017 — $ — — $ — As of December 31, 2017 , all outstanding stock options had an exercise price above the fair market value of the common stock on that date. There are no remaining unamortized amounts to be recognized on these options. Restricted Stock The Company incurred additional stock-based compensation expense of approximately $388,000 , $411,000 , and $252,000 relating to restricted stock granted to its board of directors and certain employees during the years ended December 31, 2017 , 2016 , and 2015 , respectively. Under the Omnibus Plan, 41,259 shares of restricted stock granted to the Company's directors during 2015 vested during the year ended December 31, 2016 . The fair value of the restricted stock was valued at $255,000 based on the closing price of the Company’s shares on the day prior to the grant date. The Company incurred stock-based compensation expense of approximately $0 , $103,000 and $144,000 related to these 41,259 shares of restricted stock during the years ended December 31, 2017 , 2016 and 2015 , respectively. During the year ended December 31, 2016 , the Company granted 65,212 shares of restricted stock to its directors under the Omnibus Plan, which are subject to a one year vesting period that commenced on the date of grant. The fair value of the restricted stock was valued at approximately $255,000 based on the closing price of the Company’s shares on the date prior to the grant date. The Company incurred stock-based compensation expense related to these 65,212 shares of restricted stock of approximately $106,000 and $141,000 during the years ended December 31, 2017 and 2016 , respectively. The 65,212 shares of restricted stock vested during the year ended December 31, 2017 . During the year ended December 31, 2016 , the Company granted 200,000 shares of restricted stock units to certain employees under the Omnibus Plan, which are subject to a two year vesting period that commenced on the date of grant. The fair value of the unvested restricted stock was valued at approximately $674,000 based on the closing price of the Company's shares on the day prior to the grant date. The Company incurred stock-based compensation expense of approximately $215,000 and $168,000 related to these 200,000 shares of restricted stock during the years ended December 31, 2017 and 2016 , respectively. Approximately 46,000 and 60,000 shares of restricted stock were vested and forfeited, respectively, during the year ended December 31, 2017 , with 94,000 remaining unvested at December 31, 2017 . During the year ended December 31, 2017 , the Company granted 51,132 shares of restricted stock to its directors under the Omnibus Plan, which are subject to a one year vesting period that commenced on the date of grant. The fair value of the unvested restricted stock was valued at approximately $17,000 based on the closing price of the Company’s shares on the date prior to the grant date. The Company incurred stock-based compensation expense related to these 51,132 shares of restricted stock of approximately $17,000 during year ended December 31, 2017 . Approximately 42,610 shares of restricted stock vested during the year ended December 31, 2017 with 8,522 remaining unvested at December 31, 2017 . During the year ended December 31, 2017 , the Company granted 2,000,000 shares of restricted stock units to certain employees under the Omnibus Plan, which are subject to a two year vesting period that commenced on the date of grant. The fair value of the unvested restricted stock was valued at approximately $745,000 based on the closing price of the Company's shares on the day prior to the grant date. The Company incurred stock-based compensation expense of approximately $51,000 related to these 2,000,000 shares of restricted stock during the year ended December 31, 2017 . The following table presents the activity of the Company’s unvested restricted stock for the year ended December 31, 2017 : Common Unvested Shares Number of Shares Outstanding January 1, 2017 265,212 Granted 2,051,132 Vested (153,822 ) Forfeited (60,000 ) Outstanding December 31, 2017 2,102,522 The aggregate intrinsic value of the awards of 8,522 , 94,000 and 2,000,000 shares is $3,000 , $28,200 and $600,000 , respectively, and the remaining weighted average life of these awards is 0.57 years, 0.24 years and 0.92 years, respectively, as of December 31, 2017 . As of December 31, 2017 , a total of $783,000 in stock based compensation remained unrecognized. Performance Shares During 2014, the Company awarded 323,500 target performance shares for restricted common stock to its directors and certain employees, of which 150,000 shares were subject to shareholder approval of the Omnibus Plan, which was obtained at the Company’s 2015 annual meeting on May 28, 2015. The issuance of the performance shares was contingent on the Company’s financial performance, as well as the performance of the Company’s common stock through June 30, 2016, with the actual shares to be issued ranging between 0 – 150% of the target performance shares. Given that the Company's financial performance goal was not achieved during the year ended December 31, 2017 , the remaining performance shares have been forfeited. At December 31, 2016 , the Company determined that it was not probable that the performance conditions would be achieved and no related expense was recognized for the year then ended. Warrants On February 11, 2011, three shareholders received warrants that may be exercised for up to a total of 4,240,521 shares of the Company’s common stock at a weighted average exercise price of $14.51 per share. The warrants will expire seven years after the date of issuance. At December 31, 2017 , all 4,240,521 warrants remained outstanding and are exercisable as they are fully vested. In connection with a settlement of class action litigation arising in connection with the investigation by the U.S. Attorney's Office for District of New Hampshire ("USAO") into the Company's now legacy premium finance business (the "USAO Investigation"), the Company issued warrants to purchase 2,000,000 shares of the Company’s stock into an escrow account in April of 2014. The estimated fair value as of the measurement date of such warrants was $5.4 million , which is included in stockholders’ equity. The warrants were distributed in October 2014 and have a five -year term from the date they were distributed to the class participants with an exercise price of $10.75 . The Company is obligated to file a registration statement to register the shares underlying the warrants with the SEC if shares of the Company’s common stock have an average daily trading closing price of at least $8.50 per share for a 45 day period. The warrants will be exercisable upon effectiveness of the registration statement. On July 28, 2017, in connection with the recapitalization transaction, the Company issued common stock warrants to certain investors to purchase up to an aggregate of 42,500,000 shares of the Company’s common stock at an exercise price of $0.20 per share (the "Warrant Shares"). The warrants shall vest and become exercisable as follows: (i) with respect to 17,500,000 Warrant Shares, immediately upon the issuance of the warrants, and (ii) with respect to the remaining 25,000,000 Warrant Shares, at later times tied to the conversion of the Convertible Notes and New Convertible Notes (each as defined below) outstanding on July 28, 2017 into shares of the Company’s common stock or, if earlier, upon the date that all Convertible Notes or New Convertible Notes are no longer outstanding. The warrants have an eight year term. The number of Warrant Shares is subject to anti-dilution adjustment provisions.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Dec. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS	DISCONTINUED OPERATIONS On October 25, 2013, the Company sold substantially all of the operating assets comprising its structured settlement business to Majestic Opco LLC pursuant to an Asset Purchase Agreement. No structured settlement receivables were sold and no on-balance sheet liabilities were transferred in connection with the sale. On August 18, 2015, the Company sold its remaining structured settlement receivables asset for $920,000 to the buyer of its operating assets. As a result of the sale of its structured settlements business, the Company reclassified its structured settlement business operating results as discontinued operations in the accompanying Consolidated Statements of Operations for all periods presented. Operating results related to the Company’s discontinued structured settlement business are as follows: Year Ended December 31, 2017 2016 2015 (in thousands) Total income $ 33 $ 12 $ 81 Total expenses 304 272 725 Income (loss) before income taxes (271 ) (260 ) (644 ) Income tax benefit — — — Income (loss) from discontinued operations, net of income taxes $ (271 ) $ (260 ) $ (644 )

LIFE SETTLEMENTS (LIFE INSURANC

LIFE SETTLEMENTS (LIFE INSURANCE POLICIES)	12 Months Ended
	Dec. 31, 2017
Investments, All Other Investments [Abstract]
LIFE SETTLEMENTS (LIFE INSURANCE POLICIES)	LIFE SETTLEMENTS (LIFE INSURANCE POLICIES) The Company accounts for policies it acquires using the fair value method in accordance with ASC 325-30-50 Investments—Other—Investment in Insurance Contracts . Under the fair value method, the Company recognizes the initial investment at the purchase price. For policies that were relinquished in satisfaction of premium finance loans at maturity, the initial investment is the loan carrying value. For policies purchased in the secondary or tertiary markets, the initial investment is the amount of cash outlay at the time of purchase. At each reporting period, the Company re-measures the investment at fair value in its entirety and recognizes changes in the Statements of Operations in the periods in which the changes occur. As of December 31, 2017 and 2016 , the Company owned 608 and 621 policies, respectively, with an aggregate estimated fair value of life settlements of $567.5 million and $498.4 million , respectively. The weighted average life expectancy calculated based on death benefit of insureds in the policies owned by the Company at December 31, 2017 was 8.3 years . The following table describes the Company’s life settlements as of December 31, 2017 (dollars in thousands): Remaining Life Expectancy (In Years)* Number of Life Settlement Contracts Fair Value Face Value 0-1 9 $ 29,520 $ 36,474 1-2 13 30,362 42,718 2-3 25 46,609 92,780 3-4 32 68,439 168,946 4-5 60 98,516 281,865 Thereafter 469 294,046 2,257,704 Total 608 $ 567,492 $ 2,880,487 *Based on remaining life expectancy at December 31, 2017 , as derived from reports of third party life expectancy providers, and does not indicate the timing of expected death benefits. See "Life Settlements," in Note 15, "Fair Value Measurements," of the accompanying consolidated financial statements. The weighted average life expectancy calculated based on death benefit of insureds in the policies owned by the Company at December 31, 2016 was 9.0 years . The following table describes the Company’s life settlements as of December 31, 2016 (dollars in thousands) Remaining Life Expectancy (In Years)* Number of Life Settlement Contracts Fair Value Face Value 0-1 4 $ 16,280 $ 19,497 1-2 14 35,019 52,093 2-3 14 31,300 57,274 3-4 31 44,096 114,449 4-5 40 57,792 172,157 Thereafter 518 313,913 2,531,041 Total 621 $ 498,400 $ 2,946,511 *Based on remaining life expectancy at December 31, 2016 , as derived from reports of third party life expectancy providers, and does not indicate the timing of expected death benefits. See "Life Settlements," in Note 15, "Fair Value Measurements," of the accompanying consolidated financial statements. Estimated premiums to be paid for each of the five succeeding fiscal years and thereafter to keep the life insurance policies in force as of December 31, 2017 , are as follows (in thousands): 2018 $ 89,963 2019 97,420 2020 100,343 2021 100,015 2022 96,541 Thereafter 784,442 $ 1,268,724 The amount of $1.27 billion noted above represents the estimated total future premium payments required to keep the life insurance policies in force during the life expectancies of all the underlying insured lives and does not give effect to projected receipt of death benefits. The estimated total future premium payments could increase or decrease significantly to the extent that insurance carriers increase the cost of insurance on their issued policies or that actual mortalities of insureds differs from the estimated life expectancies.

WHITE EAGLE REVOLVING CREDIT FA

WHITE EAGLE REVOLVING CREDIT FACILITY	12 Months Ended
	Dec. 31, 2017
Debt Instrument [Line Items]
CREDIT FACILITY	15.0% PROMISSORY NOTE On May 15, 2017, the Company entered into a $1.5 million Promissory Note with PJC Investments, LLC (the "Bridge Note"), to provide financing to fund the Company's continued operations with a maturity date of July 3, 2017. The Bridge Note was amended on June 28, 2017 (the "Amended and Restated Bridge Note") to (i) increase the principal amount under the Bridge Note to $3.3 million and (ii) extend the maturity date from July 3, 2017 to the earlier of (a) July 28, 2017 or (b) the date on which the Master Transaction Agreements are consummated. Under the Amended and Restated Bridge Note, the Company may request an advance of funds, and PJC shall make an advance to the Company, provided that (i) the aggregate amount of outstanding advances shall not exceed $3.3 million and (ii) the Company’s proposed budgeted use of proceeds for such advance is reasonably acceptable to PJC. Advances under the Amended and Restated Bridge Note bear interest at an annual rate of 15% . The Amended and Restated Bridge Note includes certain default provisions customary to bridge financing facilities of this type which are subject to customary grace periods, including, among others, (i) defaults related to payment failures; (ii) failure to comply with covenants; (iii) any material misrepresentation of fact made or deemed made by or on behalf of the Company; (iv) failure by the Company to comply with any of its obligations under any Master Transaction Agreement; (v) defaults in payment of any indebtedness of the Company that continues after the applicable grace or cure period; (vi) bankruptcy and related events and; (vii) change of control without the prior written consent of PJC. Default interest accrues at an annual rate of 17% . The Amended and Restated Bridge Note contains certain affirmative and negative covenants customary for bridge financing facilities of this type. In consideration for the Bridge Note and pursuant to a fee letter agreement by and between the Company and PJC dated May 15, 2017, the Company agreed to pay an additional termination fee equal to $1.5 million in the event that the Company becomes obligated to pay certain termination fees pursuant to certain termination provisions under the Master Transaction Agreements. The Company drew approximately $2.8 million on the Amended and Restated Bridge Note and recorded interest expense of approximately $36,000 during the year ended December 31, 2017 . All outstanding principal and interest amounts due under the Amended and Restated Bridge Note were repaid on July 28, 2017 in connection with the Transaction Closing.
White Eagle Revolving Credit Facility
Debt Instrument [Line Items]
CREDIT FACILITY	65% N/A 100% —% —% 50-65% N/A 70% 16.5% 13.5% 35-50% N/A 55% 24.8% 20.3% 0-35% N/A 45% 30.3% 24.8% Provided that (i) if (a) the Company failed to maintain a cash interest coverage ratio of at least 2.0 :1 at any time during the immediately preceding calendar quarter or (b) the Company fails to take steps to improve its solvency in a manner acceptable to the required lenders (as determined in their sole and absolute discretion), then the cash flow sweep percentage to the lenders shall equal one-hundred percent ( 100% ) and (ii) if such distribution date occurs on or after December 29, 2025, then the cash flow sweep percentage shall equal one-hundred percent ( 100% ). As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1 and the loan to value ratio was 63% , as calculated using the lenders' valuation. The cash interest coverage ratio is the ratio of (i) consolidated cash and cash equivalents maintained by the Company to (ii) the aggregate interest amounts that will be due and payable in cash on (x) the $35.0 million 8.5 % Senior Secured Notes due July 15, 2021 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), the $75.8 million 5.0% Convertible Notes due February 15, 2023 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), and the $1.2 million 8.50% Convertible Notes due February 15, 2019 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes) and (y) any additional indebtedness issued by the Company after December 29, 2016, in each case, during the twelve month period following such date of determination. See Note 10, " 8.50% Senior Unsecured Convertible Notes", Note 11, " 5.0% Senior Unsecured Convertible Notes" and Note 13, " 8.5 % Senior Secured Notes", to the accompanying consolidated financial statements for further information. With respect to approximately 25% of the face amount of policies pledged as collateral under the White Eagle Revolving Credit Facility, White Eagle has agreed that if policy proceeds that are otherwise due are not paid by an insurance carrier, the foregoing distributions will be altered such that the lenders will receive any "catch-up" payments with respect to amounts that they would have received in the waterfall prior to distributions being made to White Eagle. During the continuance of events of default or unmatured events of default, the amounts from collections of policy proceeds that might otherwise be paid to White Eagle will instead be held in a designated account controlled by the lenders and may be applied to fund operating and third party expenses, interest and principal, "catch-up" payments or percentage payments that would go to the lenders as described above. Assuming no event of default, funds on account from policy proceeds shall be distributed in specified stages of priority. For the year ended December 31, 2017 , approximately $37.1 million of proceeds received from the maturity of policies pledged under the White Eagle Revolving Credit Facility, were distributed through the waterfall in the following stages of priority (in thousands): December 31, 2017 December 31, 2016 Clause Amount Use of Proceeds First: $ 313 $ 239 Custodian and Securities Intermediary Second: — — White Eagle - Ongoing Maintenance Cost Reimbursable Third: — — Administrative Agent - Protective Advances Fourth: 39 53 Administrative Agent - Administrative Agent Fee and Legal Expense Reimbursement Fifth: 16,037 10,932 Administrative Agent - Accrued and Unpaid Interest Sixth: 19,633 34,799 Administrative Agent - Required Amortization Seventh: — — Administrative Agent - Amortization Shortfall Eighth: 467 — Administrative Agent - Participation Interest Ninth: — — Reserved Tenth: — — Administrative Agent Aggregate Unpaid Participation Interest Eleventh: — — Administrative Agent - Remaining Available Amount After Clause First to Tenth Twelfth: — — Wilmington Trust - Custodian and Securities Intermediary - Unpaid Fees Thirteenth: 570 — Borrower - Any Remaining Available Amount After Clause First to Twelfth Total Distributions $ 37,059 $ 46,023 Approximately $2.5 million of the amount distributed during the year ended December 31, 2017 was from maturity proceeds collected during the year ended December 31, 2016 . The below is a reconciliation of proceeds collected by the White Eagle Revolving Credit Facility and distributed through the waterfall as shown above (in thousands): Face value collected in 2016 and distributed in 2017 $ 2,480 Face value collected in 2017 and distributed in 2017 34,372 Face value collected in 2017 and distributed in 2018 7,759 Other collections* 247 Total collection in 2017 44,858 Less: Total waterfall distribution in 2017 (37,059 ) Total to be distributed in 2018 $ 7,799 *Includes refund of premiums and interest earned on maturity proceeds Use of Proceeds. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral and to pay the fees of service providers. Effective with the White Eagle Amendment on November 9, 2015, ongoing advances may no longer be used to pay interest, which will now be paid by White Eagle if there is not otherwise sufficient amounts available from policy proceeds to be distributed to pay interest expense pursuant to the waterfall described above in "Amortization and Distributions." Subsequent advances and the use of proceeds from those advances are at the discretion of the lenders. During the years ended December 31, 2017 and 2016 , advances for premium payments and fees to service providers amounted to (in thousands): December 31, 2017 2016 Amount drawn for premium payments $ 84,889 $ 51,342 Amount drawn in fees to service providers 2,398 1,721 Amount drawn for Red Falcon policies purchase — 71,079 Total amount drawn $ 87,287 $ 124,142 Interest. Borrowings under the White Eagle Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.50% , which was increased from 4.00% pursuant to the November 9, 2015 amendment, and subject to a rate floor component equal to the greater of LIBOR (or the applicable rate) and 1.5% . The base rate under the White Eagle Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5% . Based on the loan agreement, the LIBOR portion of the interest rate will re-adjust annually, once the floor has exceeded 1.5% . The applicable rate will be dependent on the rate at the last business day of the preceding calendar year. On December 29, 2017 , the LIBOR floor increased from 1.69% to 2.11% . The effective rate at December 31, 2017 was 6.61% compared to 6.19% at December 31, 2016 . Interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the White Eagle Revolving Credit Facility debt. The below table shows the composition of interest for the year ended December 31, 2017 and December 31, 2016 (in thousands): December 31, 2017 2016 Interest paid through waterfall $ 16,037 $ 10,932 Interest paid by White Eagle 782 103 Debt issuance cost — 388 Participation interest paid through waterfall 467 — Total interest expense $ 17,286 $ 11,423 Maturity. Effective with the White Eagle Second Amendment, the term of the White Eagle Revolving Credit Facility expires December 31, 2031 , which is also the scheduled commitment termination date (though the lenders’ commitments to fund borrowings may terminate earlier in an event of default). The lenders’ interests in and rights to a portion of the proceeds of the policies does not terminate with the repayment of the principal borrowed and interest accrued thereon, the termination of the White Eagle Revolving Credit Facility or expiration of the lenders’ commitments. Covenants/Events of Defaults . The White Eagle Revolving Credit Facility contains covenants and events of default that are customary for asset-based credit agreements of this type, but also include cross defaults under the servicing, account control, contribution and pledge agreements entered into in connection with the White Eagle Revolving Credit Facility (including in relation to breaches by third parties thereunder), certain changes in law, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, White Eagle and third parties. Effective with the White Eagle Second Amendment, and as described above in "Amortization and Distributions", the White Eagle Revolving Credit Facility contains a financial covenant requiring White Eagle to maintain a cash interest coverage ratio of at least 1.75 :1 commencing after June 30, 2019. Failure to maintain this ratio for 60 consecutive days after June 30, 2019 constitutes an event of default. There is no cash interest coverage ratio requirement that would result in an event of default prior to this date; however, any failure to maintain a cash interest coverage ratio of at least 2.0 :1 does impact the cash flow sweep percentage for proceeds distributed through the waterfall. As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1. The White Eagle Revolving Credit Facility also contains certain tests relating to asset maintenance, performance and valuation, the satisfaction of which will be determined by the lenders with a high degree of discretion. Remedies. The White Eagle Revolving Credit Facility and ancillary transaction documents afford the lenders a high degree of discretion in their selection and implementation of remedies, including strict foreclosure, in relation to any event of default, including a high degree of discretion in determining whether to foreclose upon and liquidate all or any pledged policies, the interests in White Eagle, and the manner of any such liquidation. White Eagle has limited ability to cure events of default through the sale of policies or the procurement of replacement financing. The Company elected to account for the debt under the White Eagle Revolving Credit Facility in accordance with ASC 820, which includes the 45% interest in policy proceeds to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. At December 31, 2017 , the fair value of the outstanding debt was $329.2 million and the borrowing base was approximately $333.2 million , which includes $329.0 million of outstanding principal. Approximately $4.1 million was available to borrow under the White Eagle Revolving Credit Facility. There are no scheduled repayments of principal prior to maturity although payments are due upon the next distribution date following the receipt of death benefits and distributed pursuant to the waterfall as described above. At December 31, 2017 , approximately $7.8 million included in restricted cash was on account with White Eagle awaiting distribution through the waterfall." id="sjs-B7">WHITE EAGLE REVOLVING CREDIT FACILITY Effective April 29, 2013 , White Eagle entered into a 15 -year revolving credit agreement with LNV Corporation, as initial lender, Imperial Finance & Trading, LLC, as servicer and portfolio manager and CLMG Corp., as administrative agent. Proceeds from the initial advance under the facility were used, in part, to retire a bridge facility and to fund a payment to the lender protection insurance provider to release subrogation rights in certain of the policies pledged as collateral for the White Eagle Revolving Credit Facility. On May 16, 2014, White Eagle Asset Portfolio, LLC converted from a Delaware limited liability company to White Eagle Asset Portfolio, LP, a Delaware limited partnership (the “Conversion”) and all of its ownership interests were transferred to an indirect, wholly-owned Irish subsidiary of the Company. In connection with the Conversion, the White Eagle Revolving Credit Facility was amended and restated among White Eagle, as borrower, Imperial Finance and Trading, LLC, as the initial servicer, the initial portfolio manager and guarantor, Lamington Road Bermuda Ltd., as portfolio manager, LNV Corporation, as initial lender, the other financial institutions party thereto as lenders, and CLMG Corp., as administrative agent for the lenders. The White Eagle Revolving Credit Facility was amended on November 9, 2015. As amended, the White Eagle Revolving Credit Facility may provide earlier participation in the portfolio cash flows if certain loan to value ("LTV") ratios are achieved. Additionally, the maximum facility limit was reduced from $300.0 million to $250.0 million , and the interest rate under the facility was increased by 50 basis points . On December 29, 2016, White Eagle entered into a Second Amendment to the Amended and Restated Loan and Security Agreement ("White Eagle Second Amendment") and on January 31, 2017, as required by the terms of the White Eagle Amendment, White Eagle executed the Second Amended and Restated Loan and Security Agreement, dated January 31, 2017, which consolidated into a single document the amendments evidenced by the White Eagle Amendment and all previous amendments. As amended, the White Eagle Revolving Credit Facility adjusted the loan-to-value ("LTV") ratios which directed cash flow participation and became subjected to achieving certain financial metrics, as more fully described below under "Amortization & Distributions." Pursuant to the White Eagle Second Amendment, 190 life settlement policies purchased from wholly owned subsidiaries of the Company were pledged as additional collateral under the facility for an additional policy advance of approximately $71.1 million . The maximum facility limit was increased to $370.0 million and the term of the facility was extended to December 31, 2031 . Additional loan terms and amendment changes are more fully described in the sections that follow. On October 4, 2017, White Eagle entered into an amendment to the Second Amended and Restated Loan and Security Agreement. The amendment changed the provisions over how participation of the proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. The amendment included an exclusion from the cash interest coverage ratio of at least 2.0 :1 for the period of July 1, 2017 through July 28, 2017. As a result of the amendment, the Company was able to participate in the waterfall distribution scheduled during October 2017. General & Security . The White Eagle Revolving Credit Facility provides for an asset-based revolving credit facility backed by White Eagle’s portfolio of life insurance policies with an aggregate lender commitment of up to $370.0 million , subject to borrowing base availability. 606 life insurance policies with an aggregate death benefit of approximately $2.9 billion and an estimated fair value of approximately $566.7 million are pledged as collateral under the White Eagle Revolving Credit Facility at December 31, 2017 . In addition, the equity interests in White Eagle have been pledged under the White Eagle Revolving Credit Facility. Borrowing Base. Borrowing availability under the White Eagle Revolving Credit Facility is subject to a borrowing base, which at any time is equal to the lesser of (A) the sum of all of the following amounts that have been funded or are to be funded through the next distribution date (i) the initial advance and all additional advances to acquire additional pledged policies that are not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, plus (iii) 100% of fees and expense deposits and other fees and expenses funded and to be funded as approved by the required lenders, less (iv) any required payments of principal and interest previously distributed and to be distributed through the next distribution date; (B) 75% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 50% of the aggregate face amount of the policies pledged as collateral (excluding certain specified life insurance policies); and (D) the then applicable facility limit. At December 31, 2017 , $41.0 million was undrawn and $4.1 million was available to borrow under the White Eagle Revolving Credit Facility. The amount available to borrow is calculated based on and limited to the premium payments and expenses if any, that are due as of the calculation date. In essence, what is available, is what is required to pay expenses and keep the policies in force as of the calculation date. Amortization & Distributions. Proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. After distributions for premium payments, fees to service providers and payments of interest, a percentage of the collections from policy proceeds are to be paid to the Company, which will vary depending on the then LTV ratio as illustrated below where the valuation is determined by the lenders: LTV Premiums, Interest & Other Fees Principal Distribution to White Eagle - 55% Lender Participation - 45% N/A 100% —% —% —% >65% N/A 100% —% —% 50-65% N/A 70% 16.5% 13.5% 35-50% N/A 55% 24.8% 20.3% 0-35% N/A 45% 30.3% 24.8% Provided that (i) if (a) the Company failed to maintain a cash interest coverage ratio of at least 2.0 :1 at any time during the immediately preceding calendar quarter or (b) the Company fails to take steps to improve its solvency in a manner acceptable to the required lenders (as determined in their sole and absolute discretion), then the cash flow sweep percentage to the lenders shall equal one-hundred percent ( 100% ) and (ii) if such distribution date occurs on or after December 29, 2025, then the cash flow sweep percentage shall equal one-hundred percent ( 100% ). As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1 and the loan to value ratio was 63% , as calculated using the lenders' valuation. The cash interest coverage ratio is the ratio of (i) consolidated cash and cash equivalents maintained by the Company to (ii) the aggregate interest amounts that will be due and payable in cash on (x) the $35.0 million 8.5 % Senior Secured Notes due July 15, 2021 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), the $75.8 million 5.0% Convertible Notes due February 15, 2023 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), and the $1.2 million 8.50% Convertible Notes due February 15, 2019 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes) and (y) any additional indebtedness issued by the Company after December 29, 2016, in each case, during the twelve month period following such date of determination. See Note 10, " 8.50% Senior Unsecured Convertible Notes", Note 11, " 5.0% Senior Unsecured Convertible Notes" and Note 13, " 8.5 % Senior Secured Notes", to the accompanying consolidated financial statements for further information. With respect to approximately 25% of the face amount of policies pledged as collateral under the White Eagle Revolving Credit Facility, White Eagle has agreed that if policy proceeds that are otherwise due are not paid by an insurance carrier, the foregoing distributions will be altered such that the lenders will receive any "catch-up" payments with respect to amounts that they would have received in the waterfall prior to distributions being made to White Eagle. During the continuance of events of default or unmatured events of default, the amounts from collections of policy proceeds that might otherwise be paid to White Eagle will instead be held in a designated account controlled by the lenders and may be applied to fund operating and third party expenses, interest and principal, "catch-up" payments or percentage payments that would go to the lenders as described above. Assuming no event of default, funds on account from policy proceeds shall be distributed in specified stages of priority. For the year ended December 31, 2017 , approximately $37.1 million of proceeds received from the maturity of policies pledged under the White Eagle Revolving Credit Facility, were distributed through the waterfall in the following stages of priority (in thousands): December 31, 2017 December 31, 2016 Clause Amount Use of Proceeds First: $ 313 $ 239 Custodian and Securities Intermediary Second: — — White Eagle - Ongoing Maintenance Cost Reimbursable Third: — — Administrative Agent - Protective Advances Fourth: 39 53 Administrative Agent - Administrative Agent Fee and Legal Expense Reimbursement Fifth: 16,037 10,932 Administrative Agent - Accrued and Unpaid Interest Sixth: 19,633 34,799 Administrative Agent - Required Amortization Seventh: — — Administrative Agent - Amortization Shortfall Eighth: 467 — Administrative Agent - Participation Interest Ninth: — — Reserved Tenth: — — Administrative Agent Aggregate Unpaid Participation Interest Eleventh: — — Administrative Agent - Remaining Available Amount After Clause First to Tenth Twelfth: — — Wilmington Trust - Custodian and Securities Intermediary - Unpaid Fees Thirteenth: 570 — Borrower - Any Remaining Available Amount After Clause First to Twelfth Total Distributions $ 37,059 $ 46,023 Approximately $2.5 million of the amount distributed during the year ended December 31, 2017 was from maturity proceeds collected during the year ended December 31, 2016 . The below is a reconciliation of proceeds collected by the White Eagle Revolving Credit Facility and distributed through the waterfall as shown above (in thousands): Face value collected in 2016 and distributed in 2017 $ 2,480 Face value collected in 2017 and distributed in 2017 34,372 Face value collected in 2017 and distributed in 2018 7,759 Other collections* 247 Total collection in 2017 44,858 Less: Total waterfall distribution in 2017 (37,059 ) Total to be distributed in 2018 $ 7,799 *Includes refund of premiums and interest earned on maturity proceeds Use of Proceeds. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral and to pay the fees of service providers. Effective with the White Eagle Amendment on November 9, 2015, ongoing advances may no longer be used to pay interest, which will now be paid by White Eagle if there is not otherwise sufficient amounts available from policy proceeds to be distributed to pay interest expense pursuant to the waterfall described above in "Amortization and Distributions." Subsequent advances and the use of proceeds from those advances are at the discretion of the lenders. During the years ended December 31, 2017 and 2016 , advances for premium payments and fees to service providers amounted to (in thousands): December 31, 2017 2016 Amount drawn for premium payments $ 84,889 $ 51,342 Amount drawn in fees to service providers 2,398 1,721 Amount drawn for Red Falcon policies purchase — 71,079 Total amount drawn $ 87,287 $ 124,142 Interest. Borrowings under the White Eagle Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.50% , which was increased from 4.00% pursuant to the November 9, 2015 amendment, and subject to a rate floor component equal to the greater of LIBOR (or the applicable rate) and 1.5% . The base rate under the White Eagle Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5% . Based on the loan agreement, the LIBOR portion of the interest rate will re-adjust annually, once the floor has exceeded 1.5% . The applicable rate will be dependent on the rate at the last business day of the preceding calendar year. On December 29, 2017 , the LIBOR floor increased from 1.69% to 2.11% . The effective rate at December 31, 2017 was 6.61% compared to 6.19% at December 31, 2016 . Interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the White Eagle Revolving Credit Facility debt. The below table shows the composition of interest for the year ended December 31, 2017 and December 31, 2016 (in thousands): December 31, 2017 2016 Interest paid through waterfall $ 16,037 $ 10,932 Interest paid by White Eagle 782 103 Debt issuance cost — 388 Participation interest paid through waterfall 467 — Total interest expense $ 17,286 $ 11,423 Maturity. Effective with the White Eagle Second Amendment, the term of the White Eagle Revolving Credit Facility expires December 31, 2031 , which is also the scheduled commitment termination date (though the lenders’ commitments to fund borrowings may terminate earlier in an event of default). The lenders’ interests in and rights to a portion of the proceeds of the policies does not terminate with the repayment of the principal borrowed and interest accrued thereon, the termination of the White Eagle Revolving Credit Facility or expiration of the lenders’ commitments. Covenants/Events of Defaults . The White Eagle Revolving Credit Facility contains covenants and events of default that are customary for asset-based credit agreements of this type, but also include cross defaults under the servicing, account control, contribution and pledge agreements entered into in connection with the White Eagle Revolving Credit Facility (including in relation to breaches by third parties thereunder), certain changes in law, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, White Eagle and third parties. Effective with the White Eagle Second Amendment, and as described above in "Amortization and Distributions", the White Eagle Revolving Credit Facility contains a financial covenant requiring White Eagle to maintain a cash interest coverage ratio of at least 1.75 :1 commencing after June 30, 2019. Failure to maintain this ratio for 60 consecutive days after June 30, 2019 constitutes an event of default. There is no cash interest coverage ratio requirement that would result in an event of default prior to this date; however, any failure to maintain a cash interest coverage ratio of at least 2.0 :1 does impact the cash flow sweep percentage for proceeds distributed through the waterfall. As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1. The White Eagle Revolving Credit Facility also contains certain tests relating to asset maintenance, performance and valuation, the satisfaction of which will be determined by the lenders with a high degree of discretion. Remedies. The White Eagle Revolving Credit Facility and ancillary transaction documents afford the lenders a high degree of discretion in their selection and implementation of remedies, including strict foreclosure, in relation to any event of default, including a high degree of discretion in determining whether to foreclose upon and liquidate all or any pledged policies, the interests in White Eagle, and the manner of any such liquidation. White Eagle has limited ability to cure events of default through the sale of policies or the procurement of replacement financing. The Company elected to account for the debt under the White Eagle Revolving Credit Facility in accordance with ASC 820, which includes the 45% interest in policy proceeds to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. At December 31, 2017 , the fair value of the outstanding debt was $329.2 million and the borrowing base was approximately $333.2 million , which includes $329.0 million of outstanding principal. Approximately $4.1 million was available to borrow under the White Eagle Revolving Credit Facility. There are no scheduled repayments of principal prior to maturity although payments are due upon the next distribution date following the receipt of death benefits and distributed pursuant to the waterfall as described above. At December 31, 2017 , approximately $7.8 million included in restricted cash was on account with White Eagle awaiting distribution through the waterfall.

RED FALCON REVOLVING CREDIT FAC

RED FALCON REVOLVING CREDIT FACILITY	12 Months Ended
	Dec. 31, 2017
Debt Instrument [Line Items]
CREDIT FACILITY	15.0% PROMISSORY NOTE On May 15, 2017, the Company entered into a $1.5 million Promissory Note with PJC Investments, LLC (the "Bridge Note"), to provide financing to fund the Company's continued operations with a maturity date of July 3, 2017. The Bridge Note was amended on June 28, 2017 (the "Amended and Restated Bridge Note") to (i) increase the principal amount under the Bridge Note to $3.3 million and (ii) extend the maturity date from July 3, 2017 to the earlier of (a) July 28, 2017 or (b) the date on which the Master Transaction Agreements are consummated. Under the Amended and Restated Bridge Note, the Company may request an advance of funds, and PJC shall make an advance to the Company, provided that (i) the aggregate amount of outstanding advances shall not exceed $3.3 million and (ii) the Company’s proposed budgeted use of proceeds for such advance is reasonably acceptable to PJC. Advances under the Amended and Restated Bridge Note bear interest at an annual rate of 15% . The Amended and Restated Bridge Note includes certain default provisions customary to bridge financing facilities of this type which are subject to customary grace periods, including, among others, (i) defaults related to payment failures; (ii) failure to comply with covenants; (iii) any material misrepresentation of fact made or deemed made by or on behalf of the Company; (iv) failure by the Company to comply with any of its obligations under any Master Transaction Agreement; (v) defaults in payment of any indebtedness of the Company that continues after the applicable grace or cure period; (vi) bankruptcy and related events and; (vii) change of control without the prior written consent of PJC. Default interest accrues at an annual rate of 17% . The Amended and Restated Bridge Note contains certain affirmative and negative covenants customary for bridge financing facilities of this type. In consideration for the Bridge Note and pursuant to a fee letter agreement by and between the Company and PJC dated May 15, 2017, the Company agreed to pay an additional termination fee equal to $1.5 million in the event that the Company becomes obligated to pay certain termination fees pursuant to certain termination provisions under the Master Transaction Agreements. The Company drew approximately $2.8 million on the Amended and Restated Bridge Note and recorded interest expense of approximately $36,000 during the year ended December 31, 2017 . All outstanding principal and interest amounts due under the Amended and Restated Bridge Note were repaid on July 28, 2017 in connection with the Transaction Closing.
Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
CREDIT FACILITY	65% N/A 100% —% —% 50-65% N/A 70% 16.5% 13.5% 35-50% N/A 55% 24.8% 20.3% 0-35% N/A 45% 30.3% 24.8% Provided that (i) if (a) the Company failed to maintain a cash interest coverage ratio of at least 2.0 :1 at any time during the immediately preceding calendar quarter or (b) the Company fails to take steps to improve its solvency in a manner acceptable to the required lenders (as determined in their sole and absolute discretion), then the cash flow sweep percentage to the lenders shall equal one-hundred percent ( 100% ) and (ii) if such distribution date occurs on or after December 29, 2025, then the cash flow sweep percentage shall equal one-hundred percent ( 100% ). As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1 and the loan to value ratio was 63% , as calculated using the lenders' valuation. The cash interest coverage ratio is the ratio of (i) consolidated cash and cash equivalents maintained by the Company to (ii) the aggregate interest amounts that will be due and payable in cash on (x) the $35.0 million 8.5 % Senior Secured Notes due July 15, 2021 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), the $75.8 million 5.0% Convertible Notes due February 15, 2023 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), and the $1.2 million 8.50% Convertible Notes due February 15, 2019 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes) and (y) any additional indebtedness issued by the Company after December 29, 2016, in each case, during the twelve month period following such date of determination. See Note 10, " 8.50% Senior Unsecured Convertible Notes", Note 11, " 5.0% Senior Unsecured Convertible Notes" and Note 13, " 8.5 % Senior Secured Notes", to the accompanying consolidated financial statements for further information. With respect to approximately 25% of the face amount of policies pledged as collateral under the White Eagle Revolving Credit Facility, White Eagle has agreed that if policy proceeds that are otherwise due are not paid by an insurance carrier, the foregoing distributions will be altered such that the lenders will receive any "catch-up" payments with respect to amounts that they would have received in the waterfall prior to distributions being made to White Eagle. During the continuance of events of default or unmatured events of default, the amounts from collections of policy proceeds that might otherwise be paid to White Eagle will instead be held in a designated account controlled by the lenders and may be applied to fund operating and third party expenses, interest and principal, "catch-up" payments or percentage payments that would go to the lenders as described above. Assuming no event of default, funds on account from policy proceeds shall be distributed in specified stages of priority. For the year ended December 31, 2017 , approximately $37.1 million of proceeds received from the maturity of policies pledged under the White Eagle Revolving Credit Facility, were distributed through the waterfall in the following stages of priority (in thousands): December 31, 2017 December 31, 2016 Clause Amount Use of Proceeds First: $ 313 $ 239 Custodian and Securities Intermediary Second: — — White Eagle - Ongoing Maintenance Cost Reimbursable Third: — — Administrative Agent - Protective Advances Fourth: 39 53 Administrative Agent - Administrative Agent Fee and Legal Expense Reimbursement Fifth: 16,037 10,932 Administrative Agent - Accrued and Unpaid Interest Sixth: 19,633 34,799 Administrative Agent - Required Amortization Seventh: — — Administrative Agent - Amortization Shortfall Eighth: 467 — Administrative Agent - Participation Interest Ninth: — — Reserved Tenth: — — Administrative Agent Aggregate Unpaid Participation Interest Eleventh: — — Administrative Agent - Remaining Available Amount After Clause First to Tenth Twelfth: — — Wilmington Trust - Custodian and Securities Intermediary - Unpaid Fees Thirteenth: 570 — Borrower - Any Remaining Available Amount After Clause First to Twelfth Total Distributions $ 37,059 $ 46,023 Approximately $2.5 million of the amount distributed during the year ended December 31, 2017 was from maturity proceeds collected during the year ended December 31, 2016 . The below is a reconciliation of proceeds collected by the White Eagle Revolving Credit Facility and distributed through the waterfall as shown above (in thousands): Face value collected in 2016 and distributed in 2017 $ 2,480 Face value collected in 2017 and distributed in 2017 34,372 Face value collected in 2017 and distributed in 2018 7,759 Other collections* 247 Total collection in 2017 44,858 Less: Total waterfall distribution in 2017 (37,059 ) Total to be distributed in 2018 $ 7,799 *Includes refund of premiums and interest earned on maturity proceeds Use of Proceeds. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral and to pay the fees of service providers. Effective with the White Eagle Amendment on November 9, 2015, ongoing advances may no longer be used to pay interest, which will now be paid by White Eagle if there is not otherwise sufficient amounts available from policy proceeds to be distributed to pay interest expense pursuant to the waterfall described above in "Amortization and Distributions." Subsequent advances and the use of proceeds from those advances are at the discretion of the lenders. During the years ended December 31, 2017 and 2016 , advances for premium payments and fees to service providers amounted to (in thousands): December 31, 2017 2016 Amount drawn for premium payments $ 84,889 $ 51,342 Amount drawn in fees to service providers 2,398 1,721 Amount drawn for Red Falcon policies purchase — 71,079 Total amount drawn $ 87,287 $ 124,142 Interest. Borrowings under the White Eagle Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.50% , which was increased from 4.00% pursuant to the November 9, 2015 amendment, and subject to a rate floor component equal to the greater of LIBOR (or the applicable rate) and 1.5% . The base rate under the White Eagle Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5% . Based on the loan agreement, the LIBOR portion of the interest rate will re-adjust annually, once the floor has exceeded 1.5% . The applicable rate will be dependent on the rate at the last business day of the preceding calendar year. On December 29, 2017 , the LIBOR floor increased from 1.69% to 2.11% . The effective rate at December 31, 2017 was 6.61% compared to 6.19% at December 31, 2016 . Interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the White Eagle Revolving Credit Facility debt. The below table shows the composition of interest for the year ended December 31, 2017 and December 31, 2016 (in thousands): December 31, 2017 2016 Interest paid through waterfall $ 16,037 $ 10,932 Interest paid by White Eagle 782 103 Debt issuance cost — 388 Participation interest paid through waterfall 467 — Total interest expense $ 17,286 $ 11,423 Maturity. Effective with the White Eagle Second Amendment, the term of the White Eagle Revolving Credit Facility expires December 31, 2031 , which is also the scheduled commitment termination date (though the lenders’ commitments to fund borrowings may terminate earlier in an event of default). The lenders’ interests in and rights to a portion of the proceeds of the policies does not terminate with the repayment of the principal borrowed and interest accrued thereon, the termination of the White Eagle Revolving Credit Facility or expiration of the lenders’ commitments. Covenants/Events of Defaults . The White Eagle Revolving Credit Facility contains covenants and events of default that are customary for asset-based credit agreements of this type, but also include cross defaults under the servicing, account control, contribution and pledge agreements entered into in connection with the White Eagle Revolving Credit Facility (including in relation to breaches by third parties thereunder), certain changes in law, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, White Eagle and third parties. Effective with the White Eagle Second Amendment, and as described above in "Amortization and Distributions", the White Eagle Revolving Credit Facility contains a financial covenant requiring White Eagle to maintain a cash interest coverage ratio of at least 1.75 :1 commencing after June 30, 2019. Failure to maintain this ratio for 60 consecutive days after June 30, 2019 constitutes an event of default. There is no cash interest coverage ratio requirement that would result in an event of default prior to this date; however, any failure to maintain a cash interest coverage ratio of at least 2.0 :1 does impact the cash flow sweep percentage for proceeds distributed through the waterfall. As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1. The White Eagle Revolving Credit Facility also contains certain tests relating to asset maintenance, performance and valuation, the satisfaction of which will be determined by the lenders with a high degree of discretion. Remedies. The White Eagle Revolving Credit Facility and ancillary transaction documents afford the lenders a high degree of discretion in their selection and implementation of remedies, including strict foreclosure, in relation to any event of default, including a high degree of discretion in determining whether to foreclose upon and liquidate all or any pledged policies, the interests in White Eagle, and the manner of any such liquidation. White Eagle has limited ability to cure events of default through the sale of policies or the procurement of replacement financing. The Company elected to account for the debt under the White Eagle Revolving Credit Facility in accordance with ASC 820, which includes the 45% interest in policy proceeds to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. At December 31, 2017 , the fair value of the outstanding debt was $329.2 million and the borrowing base was approximately $333.2 million , which includes $329.0 million of outstanding principal. Approximately $4.1 million was available to borrow under the White Eagle Revolving Credit Facility. There are no scheduled repayments of principal prior to maturity although payments are due upon the next distribution date following the receipt of death benefits and distributed pursuant to the waterfall as described above. At December 31, 2017 , approximately $7.8 million included in restricted cash was on account with White Eagle awaiting distribution through the waterfall." id="sjs-B7">WHITE EAGLE REVOLVING CREDIT FACILITY Effective April 29, 2013 , White Eagle entered into a 15 -year revolving credit agreement with LNV Corporation, as initial lender, Imperial Finance & Trading, LLC, as servicer and portfolio manager and CLMG Corp., as administrative agent. Proceeds from the initial advance under the facility were used, in part, to retire a bridge facility and to fund a payment to the lender protection insurance provider to release subrogation rights in certain of the policies pledged as collateral for the White Eagle Revolving Credit Facility. On May 16, 2014, White Eagle Asset Portfolio, LLC converted from a Delaware limited liability company to White Eagle Asset Portfolio, LP, a Delaware limited partnership (the “Conversion”) and all of its ownership interests were transferred to an indirect, wholly-owned Irish subsidiary of the Company. In connection with the Conversion, the White Eagle Revolving Credit Facility was amended and restated among White Eagle, as borrower, Imperial Finance and Trading, LLC, as the initial servicer, the initial portfolio manager and guarantor, Lamington Road Bermuda Ltd., as portfolio manager, LNV Corporation, as initial lender, the other financial institutions party thereto as lenders, and CLMG Corp., as administrative agent for the lenders. The White Eagle Revolving Credit Facility was amended on November 9, 2015. As amended, the White Eagle Revolving Credit Facility may provide earlier participation in the portfolio cash flows if certain loan to value ("LTV") ratios are achieved. Additionally, the maximum facility limit was reduced from $300.0 million to $250.0 million , and the interest rate under the facility was increased by 50 basis points . On December 29, 2016, White Eagle entered into a Second Amendment to the Amended and Restated Loan and Security Agreement ("White Eagle Second Amendment") and on January 31, 2017, as required by the terms of the White Eagle Amendment, White Eagle executed the Second Amended and Restated Loan and Security Agreement, dated January 31, 2017, which consolidated into a single document the amendments evidenced by the White Eagle Amendment and all previous amendments. As amended, the White Eagle Revolving Credit Facility adjusted the loan-to-value ("LTV") ratios which directed cash flow participation and became subjected to achieving certain financial metrics, as more fully described below under "Amortization & Distributions." Pursuant to the White Eagle Second Amendment, 190 life settlement policies purchased from wholly owned subsidiaries of the Company were pledged as additional collateral under the facility for an additional policy advance of approximately $71.1 million . The maximum facility limit was increased to $370.0 million and the term of the facility was extended to December 31, 2031 . Additional loan terms and amendment changes are more fully described in the sections that follow. On October 4, 2017, White Eagle entered into an amendment to the Second Amended and Restated Loan and Security Agreement. The amendment changed the provisions over how participation of the proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. The amendment included an exclusion from the cash interest coverage ratio of at least 2.0 :1 for the period of July 1, 2017 through July 28, 2017. As a result of the amendment, the Company was able to participate in the waterfall distribution scheduled during October 2017. General & Security . The White Eagle Revolving Credit Facility provides for an asset-based revolving credit facility backed by White Eagle’s portfolio of life insurance policies with an aggregate lender commitment of up to $370.0 million , subject to borrowing base availability. 606 life insurance policies with an aggregate death benefit of approximately $2.9 billion and an estimated fair value of approximately $566.7 million are pledged as collateral under the White Eagle Revolving Credit Facility at December 31, 2017 . In addition, the equity interests in White Eagle have been pledged under the White Eagle Revolving Credit Facility. Borrowing Base. Borrowing availability under the White Eagle Revolving Credit Facility is subject to a borrowing base, which at any time is equal to the lesser of (A) the sum of all of the following amounts that have been funded or are to be funded through the next distribution date (i) the initial advance and all additional advances to acquire additional pledged policies that are not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, plus (iii) 100% of fees and expense deposits and other fees and expenses funded and to be funded as approved by the required lenders, less (iv) any required payments of principal and interest previously distributed and to be distributed through the next distribution date; (B) 75% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 50% of the aggregate face amount of the policies pledged as collateral (excluding certain specified life insurance policies); and (D) the then applicable facility limit. At December 31, 2017 , $41.0 million was undrawn and $4.1 million was available to borrow under the White Eagle Revolving Credit Facility. The amount available to borrow is calculated based on and limited to the premium payments and expenses if any, that are due as of the calculation date. In essence, what is available, is what is required to pay expenses and keep the policies in force as of the calculation date. Amortization & Distributions. Proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. After distributions for premium payments, fees to service providers and payments of interest, a percentage of the collections from policy proceeds are to be paid to the Company, which will vary depending on the then LTV ratio as illustrated below where the valuation is determined by the lenders: LTV Premiums, Interest & Other Fees Principal Distribution to White Eagle - 55% Lender Participation - 45% N/A 100% —% —% —% >65% N/A 100% —% —% 50-65% N/A 70% 16.5% 13.5% 35-50% N/A 55% 24.8% 20.3% 0-35% N/A 45% 30.3% 24.8% Provided that (i) if (a) the Company failed to maintain a cash interest coverage ratio of at least 2.0 :1 at any time during the immediately preceding calendar quarter or (b) the Company fails to take steps to improve its solvency in a manner acceptable to the required lenders (as determined in their sole and absolute discretion), then the cash flow sweep percentage to the lenders shall equal one-hundred percent ( 100% ) and (ii) if such distribution date occurs on or after December 29, 2025, then the cash flow sweep percentage shall equal one-hundred percent ( 100% ). As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1 and the loan to value ratio was 63% , as calculated using the lenders' valuation. The cash interest coverage ratio is the ratio of (i) consolidated cash and cash equivalents maintained by the Company to (ii) the aggregate interest amounts that will be due and payable in cash on (x) the $35.0 million 8.5 % Senior Secured Notes due July 15, 2021 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), the $75.8 million 5.0% Convertible Notes due February 15, 2023 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes), and the $1.2 million 8.50% Convertible Notes due February 15, 2019 (and any notes issued by the Company or any of its Affiliates in connection with refinancing, replacing, substituting or any similar action with respect to any such notes) and (y) any additional indebtedness issued by the Company after December 29, 2016, in each case, during the twelve month period following such date of determination. See Note 10, " 8.50% Senior Unsecured Convertible Notes", Note 11, " 5.0% Senior Unsecured Convertible Notes" and Note 13, " 8.5 % Senior Secured Notes", to the accompanying consolidated financial statements for further information. With respect to approximately 25% of the face amount of policies pledged as collateral under the White Eagle Revolving Credit Facility, White Eagle has agreed that if policy proceeds that are otherwise due are not paid by an insurance carrier, the foregoing distributions will be altered such that the lenders will receive any "catch-up" payments with respect to amounts that they would have received in the waterfall prior to distributions being made to White Eagle. During the continuance of events of default or unmatured events of default, the amounts from collections of policy proceeds that might otherwise be paid to White Eagle will instead be held in a designated account controlled by the lenders and may be applied to fund operating and third party expenses, interest and principal, "catch-up" payments or percentage payments that would go to the lenders as described above. Assuming no event of default, funds on account from policy proceeds shall be distributed in specified stages of priority. For the year ended December 31, 2017 , approximately $37.1 million of proceeds received from the maturity of policies pledged under the White Eagle Revolving Credit Facility, were distributed through the waterfall in the following stages of priority (in thousands): December 31, 2017 December 31, 2016 Clause Amount Use of Proceeds First: $ 313 $ 239 Custodian and Securities Intermediary Second: — — White Eagle - Ongoing Maintenance Cost Reimbursable Third: — — Administrative Agent - Protective Advances Fourth: 39 53 Administrative Agent - Administrative Agent Fee and Legal Expense Reimbursement Fifth: 16,037 10,932 Administrative Agent - Accrued and Unpaid Interest Sixth: 19,633 34,799 Administrative Agent - Required Amortization Seventh: — — Administrative Agent - Amortization Shortfall Eighth: 467 — Administrative Agent - Participation Interest Ninth: — — Reserved Tenth: — — Administrative Agent Aggregate Unpaid Participation Interest Eleventh: — — Administrative Agent - Remaining Available Amount After Clause First to Tenth Twelfth: — — Wilmington Trust - Custodian and Securities Intermediary - Unpaid Fees Thirteenth: 570 — Borrower - Any Remaining Available Amount After Clause First to Twelfth Total Distributions $ 37,059 $ 46,023 Approximately $2.5 million of the amount distributed during the year ended December 31, 2017 was from maturity proceeds collected during the year ended December 31, 2016 . The below is a reconciliation of proceeds collected by the White Eagle Revolving Credit Facility and distributed through the waterfall as shown above (in thousands): Face value collected in 2016 and distributed in 2017 $ 2,480 Face value collected in 2017 and distributed in 2017 34,372 Face value collected in 2017 and distributed in 2018 7,759 Other collections* 247 Total collection in 2017 44,858 Less: Total waterfall distribution in 2017 (37,059 ) Total to be distributed in 2018 $ 7,799 *Includes refund of premiums and interest earned on maturity proceeds Use of Proceeds. Generally, ongoing advances may be made for paying premiums on the life insurance policies pledged as collateral and to pay the fees of service providers. Effective with the White Eagle Amendment on November 9, 2015, ongoing advances may no longer be used to pay interest, which will now be paid by White Eagle if there is not otherwise sufficient amounts available from policy proceeds to be distributed to pay interest expense pursuant to the waterfall described above in "Amortization and Distributions." Subsequent advances and the use of proceeds from those advances are at the discretion of the lenders. During the years ended December 31, 2017 and 2016 , advances for premium payments and fees to service providers amounted to (in thousands): December 31, 2017 2016 Amount drawn for premium payments $ 84,889 $ 51,342 Amount drawn in fees to service providers 2,398 1,721 Amount drawn for Red Falcon policies purchase — 71,079 Total amount drawn $ 87,287 $ 124,142 Interest. Borrowings under the White Eagle Revolving Credit Facility bear interest at a rate equal to LIBOR or, if LIBOR is unavailable, the base rate, in each case plus an applicable margin of 4.50% , which was increased from 4.00% pursuant to the November 9, 2015 amendment, and subject to a rate floor component equal to the greater of LIBOR (or the applicable rate) and 1.5% . The base rate under the White Eagle Revolving Credit Facility equals the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5% . Based on the loan agreement, the LIBOR portion of the interest rate will re-adjust annually, once the floor has exceeded 1.5% . The applicable rate will be dependent on the rate at the last business day of the preceding calendar year. On December 29, 2017 , the LIBOR floor increased from 1.69% to 2.11% . The effective rate at December 31, 2017 was 6.61% compared to 6.19% at December 31, 2016 . Interest paid during the period is recorded in the Company’s consolidated financial statements. Accrued interest is reflected as a component of the estimated fair value of the White Eagle Revolving Credit Facility debt. The below table shows the composition of interest for the year ended December 31, 2017 and December 31, 2016 (in thousands): December 31, 2017 2016 Interest paid through waterfall $ 16,037 $ 10,932 Interest paid by White Eagle 782 103 Debt issuance cost — 388 Participation interest paid through waterfall 467 — Total interest expense $ 17,286 $ 11,423 Maturity. Effective with the White Eagle Second Amendment, the term of the White Eagle Revolving Credit Facility expires December 31, 2031 , which is also the scheduled commitment termination date (though the lenders’ commitments to fund borrowings may terminate earlier in an event of default). The lenders’ interests in and rights to a portion of the proceeds of the policies does not terminate with the repayment of the principal borrowed and interest accrued thereon, the termination of the White Eagle Revolving Credit Facility or expiration of the lenders’ commitments. Covenants/Events of Defaults . The White Eagle Revolving Credit Facility contains covenants and events of default that are customary for asset-based credit agreements of this type, but also include cross defaults under the servicing, account control, contribution and pledge agreements entered into in connection with the White Eagle Revolving Credit Facility (including in relation to breaches by third parties thereunder), certain changes in law, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, White Eagle and third parties. Effective with the White Eagle Second Amendment, and as described above in "Amortization and Distributions", the White Eagle Revolving Credit Facility contains a financial covenant requiring White Eagle to maintain a cash interest coverage ratio of at least 1.75 :1 commencing after June 30, 2019. Failure to maintain this ratio for 60 consecutive days after June 30, 2019 constitutes an event of default. There is no cash interest coverage ratio requirement that would result in an event of default prior to this date; however, any failure to maintain a cash interest coverage ratio of at least 2.0 :1 does impact the cash flow sweep percentage for proceeds distributed through the waterfall. As of December 31, 2017 , the cash interest coverage ratio was 3.52 :1. The White Eagle Revolving Credit Facility also contains certain tests relating to asset maintenance, performance and valuation, the satisfaction of which will be determined by the lenders with a high degree of discretion. Remedies. The White Eagle Revolving Credit Facility and ancillary transaction documents afford the lenders a high degree of discretion in their selection and implementation of remedies, including strict foreclosure, in relation to any event of default, including a high degree of discretion in determining whether to foreclose upon and liquidate all or any pledged policies, the interests in White Eagle, and the manner of any such liquidation. White Eagle has limited ability to cure events of default through the sale of policies or the procurement of replacement financing. The Company elected to account for the debt under the White Eagle Revolving Credit Facility in accordance with ASC 820, which includes the 45% interest in policy proceeds to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. At December 31, 2017 , the fair value of the outstanding debt was $329.2 million and the borrowing base was approximately $333.2 million , which includes $329.0 million of outstanding principal. Approximately $4.1 million was available to borrow under the White Eagle Revolving Credit Facility. There are no scheduled repayments of principal prior to maturity although payments are due upon the next distribution date following the receipt of death benefits and distributed pursuant to the waterfall as described above. At December 31, 2017 , approximately $7.8 million included in restricted cash was on account with White Eagle awaiting distribution through the waterfall.
Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
CREDIT FACILITY	RED FALCON REVOLVING CREDIT FACILITY Effective July 16, 2015 , Red Falcon Trust ("Red Falcon"), a Delaware statutory trust formed by Blue Heron Designated Activity Company ("Blue Heron"), a wholly-owned Irish subsidiary of the Company, entered into a revolving loan and security agreement (together with its ancillary documents, the "Red Falcon Revolving Credit Facility," and together with the White Eagle Revolving Credit Facility, the "Revolving Credit Facilities") with LNV Corporation, as initial lender, the other lenders party thereto from time to time, Imperial Finance & Trading, LLC, as guarantor, Blue Heron as portfolio administrator and CLMG Corp., as administrative agent. On July 15, 2016, the Company amended its Red Falcon Revolving Credit Facility (the "Red Falcon Amendment"). Pursuant to the amendment, six additional policies and additional portions of 20 policies that were previously pledged in part as collateral under the initial credit agreement were pledged for an additional policy advance. Amounts advanced to Red Falcon following effectiveness of the amendment to the credit agreement were approximately $3.0 million. On December 29, 2016 , the Red Falcon Revolving Credit Facility was terminated (the "Facility Termination"). The policies pledged under the Red Falcon Revolving Credit Facility were sold to White Eagle, a subsidiary of the Company, in exchange for a distribution of cash totaling $65.1 million , which was used to repay all outstanding principal and interest due under the Red Falcon Revolving Credit Facility. The significant terms in effect through the termination date are included below. General & Security . The Red Falcon Revolving Credit Facility provided for a revolving credit facility backed by Red Falcon’s portfolio of life insurance policies with an initial aggregate lender commitment of up to $110.0 million , subject to borrowing base availability. As of December 31, 2017 , all life insurance policies previously owned by Red Falcon and pledged as collateral under the Red Falcon Revolving Credit Facility were sold to White Eagle, an affiliate of the Company. See Note 8, "White Eagle Revolving Credit Facility," to the accompanying consolidated financial statements for further information regarding the Company's portfolio subsequent to the Facility Termination. Borrowing Base & Availability . Revolving credit borrowings were permitted for a five -year period with the loans under the Red Falcon Revolving Credit Facility maturing on July 15, 2022. Borrowing availability under the Red Falcon Revolving Credit Facility was subject to a borrowing base, which at any time was equal to the lesser of (A) the sum of all of the following amounts that were funded or were to be funded through the next distribution date (i) the initial advance and all additional advances in respect of newly pledged policies that were not for ongoing maintenance advances, plus (ii) 100% of the sum of the ongoing maintenance costs, less (iii) any required amortization payments previously distributed and which were to be distributed through the next distribution date; (B) 60% of the valuation of the policies pledged as collateral as determined by the lenders; (C) 45% of the aggregate face amount of the policies pledged as collateral; and (D) $110 million . All outstanding principal and interest was repaid in connection with the Facility Termination as of December 31, 2016 Amortization & Distributions. Proceeds from the policies pledged as collateral under the Red Falcon Revolving Credit Facility were distributed pursuant to a waterfall with, subject to yield maintenance provisions, 5% of policy proceeds directed to the lenders. Thereafter proceeds were directed to pay fees to service providers and premiums with any remaining proceeds directed to pay outstanding interest and required amortization of 8% per annum on the greater of the then outstanding balance of the loan or the initial advance. Generally, after payment of interest and required amortization, a percentage of the collections from policy proceeds were to be paid to the lenders, which will varied depending on the then LTV as follows: (1) if the LTV was equal to or greater than 50% , all remaining proceeds were to be directed to the lenders to repay the then outstanding principal balance; (2) if the LTV was less than 50% but greater than or equal to 25% , 65% of the remaining proceeds were to be directed to the lenders to repay the then outstanding principal balance; or (3) if the LTV was less than 25% , 35% of the remaining proceeds were to be directed to the lenders to repay the then outstanding principal balance, in each case, with remaining proceeds directed to Red Falcon. To the extent there were not sufficient remaining proceeds in the waterfall to satisfy the amount of required interest and amortization then due, Red Falcon would have had to pay any such shortfall amount. Assuming no event of default, funds on account from policy proceeds shall be distributed in specified stages of priority. For the year ended December 31, 2016 , approximately $7.6 million of proceeds received from the maturity of policies which were pledged under the Red Falcon Revolving Credit Facility were distributed through the waterfall in the following stages of priority (in thousands): Clause Amount Distribution of Proceeds First: $ 378 Administrative Agent - 5% Contingent Interest Second: 37 Servicer, Custodian and Securities Intermediary Fees Third: 15 Portfolio Manager Fees Fourth: — Administrative Agent - Protective Advances Fifth: 47 Administrative Agent Fees Sixth: 537 Accrued and Unpaid Interest Seventh: 756 Lender - Repayment of Principal - 0.5% of Proceeds Eighth: 5,787 Lender - Repayment of Principal - LTV over 50% Ninth: — Unpaid Servicer, Custodian and Securities Fees Tenth: — Red Falcon Total Distributions $ 7,557 Initial Advance and Use of Proceeds. Amounts advanced to Red Falcon following effectiveness of the Red Falcon Revolving Credit Facility were approximately $54.0 million with certain of the proceeds used to pay transaction expenses and to purchase the policies pledged as collateral under the Red Falcon Revolving Credit Facility from certain affiliates of the Company, who then made a distribution to the Company which was used to redeem the Company's 12.875% Secured Notes. Generally, ongoing advances may have been made for paying premiums on the life insurance policies pledged as collateral, and to pay the fees of service providers. Subsequent advances in respect of newly pledged policies are at the discretion of the lenders. Interest. Borrowings under the Red Falcon Revolving Credit Facility bore interest at a rate equal to LIBOR or, if LIBOR was unavailable, the base rate, in each case plus an applicable margin of 4.50% and subject to a rate floor of 1.0% . The base rate under the Red Falcon Revolving Credit Facility equaled the sum of (i) the weighted average of the interest rates on overnight federal funds transactions or, if unavailable, the average of three federal funds quotations received by the Agent plus 0.75% and (ii) 0.5% . Based on the loan agreement, the LIBOR portion of the interest rate readjusted monthly, once the floor had exceeded 1.0% . The applicable rate was dependent on the rate at the last business day of the immediately preceding calendar month. During the year ended December 31, 2016 , the LIBOR floor increased from 1.0% to 1.64% prior to the Facility Termination. Interest expense paid during the period is recorded in the Company’s consolidated financial statements. Interest expense on the facility was $4.3 million and included $297,000 in debt issuance cost which was not capitalized as a result of electing the fair value option for valuing this debt and $4.0 million relating to interest payments paid by Red Falcon for the year ended December 31, 2016 . Maturity and Early Extinguishment. The original term of the Red Falcon Revolving Credit Facility expired July 15, 2022 . On December 29, 2016 Red Falcon terminated the facility and repaid all outstanding principal and interest in the amount of $65.1 million . Approximately $554,000 was recorded as a loss on extinguishment of debt related to the early repayment of the facility. This includes the debt valuation allowance of $239,000 and costs incurred related to the facility termination of $315,000 at December 31, 2016 . Covenants/Events of Defaults . The Red Falcon Revolving Credit Facility contained covenants and events of default, including those that are customary for asset-based credit facilities of this type and including cross defaults under the servicing, portfolio management and sales agreements entered into in connection with the Red Falcon Revolving Credit Facility, changes in control of or insolvency or bankruptcy of the Company and relevant subsidiary companies and performance of certain obligations by certain relevant subsidiary companies, Red Falcon and third parties. The Red Falcon Revolving Credit Facility did not contain any financial covenants, but did contain certain tests relating to asset maintenance, performance and valuation with determinations as to the satisfaction of such tests involving determinations made by the lenders with a high degree of discretion. The Company elected to account for the debt under the Red Falcon Revolving Credit Facility using the fair value method in accordance with ASC 820. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, the Company’s estimates are not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have had a material effect on the estimated fair values. At December 31, 2017 , there was no outstanding principal and interest as the Red Falcon Revolving Credit Facility had been fully repaid on December 29, 2016 .

8.50% SENIOR UNSECURED CONVERTI

8.50% SENIOR UNSECURED CONVERTIBLE NOTES	12 Months Ended
	Dec. 31, 2017
Debt Instrument [Line Items]
SENIOR NOTES	15.0% PROMISSORY NOTE On May 15, 2017, the Company entered into a $1.5 million Promissory Note with PJC Investments, LLC (the "Bridge Note"), to provide financing to fund the Company's continued operations with a maturity date of July 3, 2017. The Bridge Note was amended on June 28, 2017 (the "Amended and Restated Bridge Note") to (i) increase the principal amount under the Bridge Note to $3.3 million and (ii) extend the maturity date from July 3, 2017 to the earlier of (a) July 28, 2017 or (b) the date on which the Master Transaction Agreements are consummated. Under the Amended and Restated Bridge Note, the Company may request an advance of funds, and PJC shall make an advance to the Company, provided that (i) the aggregate amount of outstanding advances shall not exceed $3.3 million and (ii) the Company’s proposed budgeted use of proceeds for such advance is reasonably acceptable to PJC. Advances under the Amended and Restated Bridge Note bear interest at an annual rate of 15% . The Amended and Restated Bridge Note includes certain default provisions customary to bridge financing facilities of this type which are subject to customary grace periods, including, among others, (i) defaults related to payment failures; (ii) failure to comply with covenants; (iii) any material misrepresentation of fact made or deemed made by or on behalf of the Company; (iv) failure by the Company to comply with any of its obligations under any Master Transaction Agreement; (v) defaults in payment of any indebtedness of the Company that continues after the applicable grace or cure period; (vi) bankruptcy and related events and; (vii) change of control without the prior written consent of PJC. Default interest accrues at an annual rate of 17% . The Amended and Restated Bridge Note contains certain affirmative and negative covenants customary for bridge financing facilities of this type. In consideration for the Bridge Note and pursuant to a fee letter agreement by and between the Company and PJC dated May 15, 2017, the Company agreed to pay an additional termination fee equal to $1.5 million in the event that the Company becomes obligated to pay certain termination fees pursuant to certain termination provisions under the Master Transaction Agreements. The Company drew approximately $2.8 million on the Amended and Restated Bridge Note and recorded interest expense of approximately $36,000 during the year ended December 31, 2017 . All outstanding principal and interest amounts due under the Amended and Restated Bridge Note were repaid on July 28, 2017 in connection with the Transaction Closing.
8.50% Senior Unsecured Convertible Notes Due 2019
Debt Instrument [Line Items]
SENIOR NOTES	8.50% SENIOR UNSECURED CONVERTIBLE NOTES In February 2014, the Company issued $70.7 million in an aggregate principal amount of 8.50% senior unsecured convertible notes due 2019 (the "Convertible Notes" or "8.5% Convertible Notes"). The Convertible Notes were issued pursuant to an indenture dated February 21, 2014 , between the Company and U.S. Bank National Association, as trustee (the "Convertible Note Indenture"). The Convertible Notes are general senior unsecured obligations and rank equally in right of payment with all of the Company's other existing and future senior unsecured indebtedness. The Convertible Notes are effectively subordinate to all of the Company's secured indebtedness to the extent of the value of the assets collateralizing such indebtedness. The Convertible Notes are not guaranteed by the Company's subsidiaries. The maturity date of the Convertible Notes is February 15, 2019 . The Convertible Notes accrue interest at the rate of 8.50% per annum on the principal amount of the Convertible Notes, payable semi-annually in arrears on August 15 and February 15 of each year . The Convertible Notes are convertible into shares of common stock at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. Initially, the Convertible Notes were convertible into shares of common stock at a conversion rate of 147.9290 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to a conversion price of $6.76 per share of common stock). In the second quarter of 2015, the conversion rate was adjusted to 151.7912 shares of common stock per $1,000 principal amount of Convertible Notes (equivalent to a conversion price of $6.59 per share of common stock) in connection with an anti-dilution adjustment triggered by a rights offering that resulted in the issuance of 6,688,433 shares of the Company’s common stock. On and after February 15, 2017 and prior to the maturity date, the Company may redeem for cash all, but not less than all, of the Convertible Notes if the last reported sale price of the Company’s common stock equals or exceeds 130% of the applicable conversion price for at least 20 trading days during the 30 consecutive trading day period ending on the trading day immediately prior to the date the Company delivers notice of the redemption. The redemption price will be equal to 100% of the principal amount of the Convertible Notes, plus any accrued and unpaid interest to, but excluding, the redemption date. In addition, a make-whole fundamental change occurs prior to the maturity date, and a holder elects to convert its Convertible Notes in connection therewith, the Company will, in certain circumstances, increase the conversion rate by a number of additional shares of common stock for holders who convert their notes prior to the redemption date. The Company determined that an embedded conversion option existed in the Convertible Notes that was required to be separately accounted for as a derivative under ASC 815 which required the Company to bifurcate the embedded conversion option, record it as a liability at fair value and record a debt discount by an equal amount. Upon receipt of shareholder approval to issue shares of common stock upon conversion of the Convertible Notes in an amount that exceeded applicable New York Stock Exchange limits for issuances without shareholder approval, the Company reclassified the embedded conversion derivative liability to equity. The Convertible Notes are recorded at accreted value and will continue to be accreted up to the par value of the Convertible Notes at maturity. On February 14, 2017, the Company solicited consents (the "Consent Solicitation") to issue additional 8.50% Convertible Notes (the "Additional Convertible Notes") in lieu of a cash payment of interest on February 15, 2017 (the "2017 Interest Payment Date") to holders of the Convertible Notes. On March 14, 2017, the Company issued Additional Convertible Notes for an aggregate principal amount of $3.5 million following the Company’s receipt of the requisite consents of the holders of approximately 98% of the aggregate principal amount of Convertible Notes (the "Consenting Holders"), pursuant to the Consent Solicitation, whereby each Consenting Holder agreed to accept Additional Convertible Notes in lieu of a cash payment of interest on the Convertible Notes due on the 2017 Interest Payment Date. All Additional Convertible Notes issued by the Company to Consenting Holders were issued under the Convertible Note Indenture and such Additional Convertible Notes have identical terms to the existing Convertible Notes. Interest on the Additional Convertible Notes will accrue from February 15, 2017. On March 15, 2017 and May 12, 2017, the Company entered into a series of separate Master Transaction Agreements (the "Master Transaction Agreements") by and among the Company, PJC Investments, LLC, a Texas limited liability company ("PJC") and each such Consenting Convertible Note Holder that is a party to such Master Transaction Agreement regarding a series of integrated transactions with the intent to effect a recapitalization of the Company (the "Transaction") which included, among other transactions, a Convertible Note Exchange Offer and a New Convertible Note Indenture providing for the issuance of New Convertible Notes to be delivered in connection with the Transaction (each as defined in the Master Transaction Agreements). As part of the Transaction, on April 18, 2017, the Company launched an exchange offer (the "Convertible Note Exchange Offer") to the existing holders of its outstanding Convertible Notes for 5.0% Senior Unsecured Convertible Notes due 2023 (the "New Convertible Notes" or "5% Convertible Notes"). At least 98% of the holders of the Convertible Notes were required to tender in the Convertible Note Exchange Offer as a condition to closing the Transaction. On July 26, 2017, the Company’s offer to exchange its outstanding $74.2 million aggregate principal amount of Convertible Notes for its New Convertible Notes expired. Holders of at least 98% of the Convertible Notes tendered in the Convertible Note Exchange Offer. On July 28, 2017, the Company consummated a series of integrated transactions to effect a recapitalization of the Company (the "Transaction Closing") pursuant to the Master Transaction Agreements, which transactions included the consummation of the Convertible Note Exchange Offer. The amount exchanged included approximately $73.0 million of principal outstanding prior to the exchange and approximately $2.8 million of interest paid in kind at the exchange date. The outstanding principal amount of the Convertible Notes remaining after the exchange was approximately $1.2 million . In connection with the Transaction Closing, the Company entered into a supplemental indenture (the "Supplemental Convertible Note Indenture") to the Convertible Note Indenture governing the Convertible Notes. The purpose of the Supplemental Convertible Note Indenture was to eliminate substantially all of the restrictive covenants, eliminate certain events of default, eliminate the covenant restricting mergers and consolidations and modify certain provisions relating to defeasance contained in the Convertible Note Indenture and the Convertible Notes (collectively, the "Proposed Amendments") promptly after the receipt of the requisite consents for the Proposed Amendments. The Company performed an assessment of the modification of the Convertible Notes under ASC 470, Debt , and determined the transaction is a troubled debt restructuring. The Company did not recognize any gain as a result of the restructuring, therefore, approximately $7.7 million was reclassified to the New Convertible Notes, including $6.7 million and $1.0 million related to debt discount and origination cost, respectively. Additionally, approximately $2.5 million was expensed as a onetime debt modification cost. See Note 11 "5.0% Senior Unsecured Convertible Notes" for a description of the changes in terms of the note. As of December 31, 2017 , the carrying value of the Convertible Notes was $1.1 million , net of unamortized debt discounts and deferred debt costs of $84,000 and $12,000 , respectively. These are being amortized over the remaining life of the Convertible Notes using the effective interest method. The Company recorded $9.2 million of interest expense on the Convertible Notes, including $4.2 million , $2.5 million , $2.1 million and $314,000 from interest, one time debt modification cost, amortizing debt discounts and originations costs, respectively, during the year ended December 31, 2017 . Interest for the year ended December 31, 2017 included approximately $522,000 of additional interest paid in kind to note holders. For the year ended December 31, 2016 , the Company recorded $9.7 million of interest expense on the Convertible Notes, including $6.0 million , $3.2 million and $480,000 from interest, amortizing debt discounts and origination costs, respectively.

5.0% SENIOR UNSECURED CONVERTIB

5.0% SENIOR UNSECURED CONVERTIBLE NOTES	12 Months Ended
	Dec. 31, 2017
Debt Instrument [Line Items]
SENIOR NOTES	15.0% PROMISSORY NOTE On May 15, 2017, the Company entered into a $1.5 million Promissory Note with PJC Investments, LLC (the "Bridge Note"), to provide financing to fund the Company's continued operations with a maturity date of July 3, 2017. The Bridge Note was amended on June 28, 2017 (the "Amended and Restated Bridge Note") to (i) increase the principal amount under the Bridge Note to $3.3 million and (ii) extend the maturity date from July 3, 2017 to the earlier of (a) July 28, 2017 or (b) the date on which the Master Transaction Agreements are consummated. Under the Amended and Restated Bridge Note, the Company may request an advance of funds, and PJC shall make an advance to the Company, provided that (i) the aggregate amount of outstanding advances shall not exceed $3.3 million and (ii) the Company’s proposed budgeted use of proceeds for such advance is reasonably acceptable to PJC. Advances under the Amended and Restated Bridge Note bear interest at an annual rate of 15% . The Amended and Restated Bridge Note includes certain default provisions customary to bridge financing facilities of this type which are subject to customary grace periods, including, among others, (i) defaults related to payment failures; (ii) failure to comply with covenants; (iii) any material misrepresentation of fact made or deemed made by or on behalf of the Company; (iv) failure by the Company to comply with any of its obligations under any Master Transaction Agreement; (v) defaults in payment of any indebtedness of the Company that continues after the applicable grace or cure period; (vi) bankruptcy and related events and; (vii) change of control without the prior written consent of PJC. Default interest accrues at an annual rate of 17% . The Amended and Restated Bridge Note contains certain affirmative and negative covenants customary for bridge financing facilities of this type. In consideration for the Bridge Note and pursuant to a fee letter agreement by and between the Company and PJC dated May 15, 2017, the Company agreed to pay an additional termination fee equal to $1.5 million in the event that the Company becomes obligated to pay certain termination fees pursuant to certain termination provisions under the Master Transaction Agreements. The Company drew approximately $2.8 million on the Amended and Restated Bridge Note and recorded interest expense of approximately $36,000 during the year ended December 31, 2017 . All outstanding principal and interest amounts due under the Amended and Restated Bridge Note were repaid on July 28, 2017 in connection with the Transaction Closing.
5.0% Senior Unsecured Convertible Notes Due 2023
Debt Instrument [Line Items]
SENIOR NOTES	5.0% SENIOR UNSECURED CONVERTIBLE NOTES On July 26, 2017, the Company’s Convertible Note Exchange Offer expired. Holders of at least 98% of the Convertible Notes tendered in the Convertible Note Exchange Offer. In connection with the Transaction Closing, the Company caused to be issued the New Convertible Notes in an aggregate amount of approximately $75.8 million pursuant to an Indenture (the "New Convertible Note Indenture") between the Company and U.S. Bank, National Association, as indenture trustee. The terms of the New Convertible Notes are governed by the New Convertible Note Indenture, which provide, among other things, that the New Convertible Notes are unsecured senior obligations of the Company and will mature on February 15, 2023 . The New Convertible Notes bear interest at a rate of 5% per annum from the issue date, payable semi-annually on August 15 and February 15 of each year, beginning on August 15, 2017. Holders of New Convertible Notes may convert their New Convertible Notes at their option on any day prior to the close of business on the second scheduled trading day immediately preceding February 15, 2023 . Upon conversion, the Company will deliver shares of Common Stock, together with any cash payment for any fractional share of Common Stock. The initial conversion rate for the New Convertible Notes denominated in $1,000 increments will be 500 shares of Common Stock per $1,000 principal amount of New Convertible Notes, which corresponds to an initial conversion price of approximately $2.00 per share of Common Stock. The initial conversion rate for the New Convertible Notes denominated in $1.00 increments will be 0.5 shares of Common Stock per $1.00 principal amount of New Convertible Notes, which corresponds to an initial conversion price of approximately $2.00 per share of Common Stock. The conversion rate will be subject to adjustment in certain circumstances. The Company may redeem, in whole but not in part, the New Convertible Notes at a redemption price of 100% of the principal amount of the New Convertible Notes to be redeemed, plus accrued and unpaid interest and additional interest, if any, if and only if the last reported sale price of the Common Stock equals or exceeds 120% of the conversion price for at least 15 trading days in any period of 30 consecutive trading days. The Company may, at its election, pay or deliver as the case may be, to all Holders of the New Convertible Notes, either (a) solely cash, (b) solely shares of Common Stock, or (c) a combination of cash and shares of Common Stock. The provisions of the New Convertible Note Indenture include a make-whole provision to compensate the Company’s debt holders for the lost option time value and forgone interest payments upon the Company experiencing a Fundamental Change (as defined in the New Convertible Note Indenture). These Fundamental Changes revolve around change in beneficial ownership, the consummation of specified transactions which result in the conversion of common stock into other assets or the sale, transfer or lease of all or substantially all of the Company’s assets, a majority change in the composition of the Company’s Board of Directors, the Company’s stockholders approval of any plan for liquidation of dissolution of the Company, and the Common Stock ceasing to be listed or quoted on a Trading Market . The number of incremental additional shares to be issued as a result of a Fundamental Change is based on a table which calculates the adjustment based on the inputs of time and share value. The New Convertible Note Indenture provides for customary events of default, which include (subject in certain cases to customary grace and cure periods), among others: nonpayment of principal or interest; breach of covenants or other agreements in the New Convertible Note Indenture; defaults or failure to pay certain other indebtedness; and certain events of bankruptcy or insolvency. Generally, if an event of default occurs and is continuing under the New Convertible Note Indenture, the trustee or the holders of at least 25% in aggregate principal amount of the New Convertible Notes then outstanding may declare all unpaid principal plus accrued interest on the New Convertible Notes immediately due and payable, subject to certain conditions set forth in the New Convertible Note Indenture. In addition, holders of the New Convertible Notes may require the Company to repurchase the New Convertible Notes upon the occurrence of certain designated events at a repurchase price of 100% of the principal amount of the New Convertible Notes, plus accrued and unpaid interest. The New Convertible Note Indenture, among other things includes provisions such as the Company’s failure to timely file any document or report that is required to be filed with the SEC, as well as a registration statement covering the re-sale by holders of the New Convertible Notes not being declared effective by the SEC; the Company’s failure to cure such a default within 14 days after the occurrence will result in the Company being required to pay additional interest in cash. Additional interest on the New Convertible Notes will accrue with respect to the first 90-day period (or portion thereof) following the restricted transfer triggering date, which is 120 days after the last date on which any securities are originally issued under the New Convertible Note Indenture or a registration statement regarding the resale by the holders of the securities or holders of any shares of common stock issuable upon conversion. For each day that a restricted transfer default is continuing at a rate equal to 0.25% per annum of the principal amount of New Convertible Notes, which rate will increase by an additional 0.25% per annum of the principal amount of the New Convertible Notes for each subsequent 90 - day period (or portion thereof) while a restricted transfer default is continuing until all restricted transfer defaults have been cured, up to a maximum of 0.5% of the principal amount of the securities. Following the cure of all restricted transfer defaults, the accrual of additional interest arising from restricted transfer defaults will cease. The New Convertible Note Indenture states that the sole remedy for an event of default relating to the failure by the Company to comply with the provisions of the New Convertible Note Indenture requiring timely reporting by the Company and for any failure to comply with Section 314(a)(1) of the Trust Indenture Act shall, for the first 365 days after the occurrence of such an Event of Default, consist exclusively of the right to receive special interest on the New Convertible Notes at an annual rate equal to 0.5% of the principal amount of the New Convertible Notes. As of December 31, 2017 , the carrying value of the New Convertible Notes was $68.7 million , net of unamortized debt discounts and origination costs of $6.3 million and $927,000 , respectively. These are being amortized over the remaining life of the New Convertible Notes using the effective interest method. During the year ended December 31, 2017 , the Company recorded $2.1 million of interest expense on the New Convertible Notes, including $1.6 million , $432,000 and $64,000 from interest, amortization of debt discount and origination costs, respectively.

15% SENIOR SECURED NOTES

15% SENIOR SECURED NOTES	12 Months Ended
	Dec. 31, 2017
Debt Instrument [Line Items]
SENIOR NOTES	15.0% PROMISSORY NOTE On May 15, 2017, the Company entered into a $1.5 million Promissory Note with PJC Investments, LLC (the "Bridge Note"), to provide financing to fund the Company's continued operations with a maturity date of July 3, 2017. The Bridge Note was amended on June 28, 2017 (the "Amended and Restated Bridge Note") to (i) increase the principal amount under the Bridge Note to $3.3 million and (ii) extend the maturity date from July 3, 2017 to the earlier of (a) July 28, 2017 or (b) the date on which the Master Transaction Agreements are consummated. Under the Amended and Restated Bridge Note, the Company may request an advance of funds, and PJC shall make an advance to the Company, provided that (i) the aggregate amount of outstanding advances shall not exceed $3.3 million and (ii) the Company’s proposed budgeted use of proceeds for such advance is reasonably acceptable to PJC. Advances under the Amended and Restated Bridge Note bear interest at an annual rate of 15% . The Amended and Restated Bridge Note includes certain default provisions customary to bridge financing facilities of this type which are subject to customary grace periods, including, among others, (i) defaults related to payment failures; (ii) failure to comply with covenants; (iii) any material misrepresentation of fact made or deemed made by or on behalf of the Company; (iv) failure by the Company to comply with any of its obligations under any Master Transaction Agreement; (v) defaults in payment of any indebtedness of the Company that continues after the applicable grace or cure period; (vi) bankruptcy and related events and; (vii) change of control without the prior written consent of PJC. Default interest accrues at an annual rate of 17% . The Amended and Restated Bridge Note contains certain affirmative and negative covenants customary for bridge financing facilities of this type. In consideration for the Bridge Note and pursuant to a fee letter agreement by and between the Company and PJC dated May 15, 2017, the Company agreed to pay an additional termination fee equal to $1.5 million in the event that the Company becomes obligated to pay certain termination fees pursuant to certain termination provisions under the Master Transaction Agreements. The Company drew approximately $2.8 million on the Amended and Restated Bridge Note and recorded interest expense of approximately $36,000 during the year ended December 31, 2017 . All outstanding principal and interest amounts due under the Amended and Restated Bridge Note were repaid on July 28, 2017 in connection with the Transaction Closing.
Senior Notes
Debt Instrument [Line Items]
SENIOR NOTES	15% SENIOR SECURED NOTES On March 11, 2016, the Company, as issuer, entered into an indenture with Wilmington Trust Company, as indenture trustee (the "Senior Secured Indenture"). The Senior Secured Indenture provides for the issuance of up to $30.0 million in senior secured notes (the "Senior Secured Notes"), of which approximately $21.2 million were issued on the Initial Closing Date with an additional $8.8 million issued on March 24, 2016. The 15% Senior Secured Notes were purchased in private transactions exempt from the registration requirements of the Securities Act of 1933, as amended, under the note purchase agreements with certain accredited investors and/or non U.S. persons, including certain members of the Company's board of directors, management and their affiliates, who purchased approximately $3.3 million of the 15% Senior Secured Notes issued on the Initial Closing Date. During the year ended December 31, 2017 , the Company entered into three supplemental indentures with the Senior Secured Note Trustee as follows: On February 21, 2017, the first supplemental indenture amended and restated the Senior Secured Indenture to: (i) amend the definition of "Permitted Indebtedness" to include all Additional Convertible Notes issued by the Company after February 14, 2017, in lieu of a cash payment of interest due to the holders of the Convertible Notes, and (ii) add Section 4.07(e) to restrict the Company from increasing the interest rate payable on the Convertible Notes. On May 15, 2017, the second supplemental indenture amended and restated the Senior Secured Indenture to amend the definition of "Permitted Indebtedness" to include the Bridge Note (as defined below) in the original principal amount of $1.5 million , made by the Company in favor of PJC Investments, LLC. On June 28, 2017, the third supplemental indenture amended and restated the Senior Secured Indenture to: (i) modify the definition of "Permitted Indebtedness" to include the increased principal amount of $3.3 million pursuant to the Amended and Restated Bridge Note (as defined below) and (ii) amend the definition of "Payment Date," so that beginning with and including July 14, 2017, the interest payment date occurs monthly, as opposed to quarterly. Interest on the 15% Senior Secured Notes accrues at 15.0% per annum payable quarterly and all 15% Senior Secured Notes will mature on September 14, 2018 (the "Maturity Date"). The 15% Senior Secured Notes may be optionally redeemed in full at any time and must be redeemed in full upon additional issuances of debt by Emergent Capital, Inc., in each case, at a price equal to 100% of the principal amount redeemed plus (i) accrued and unpaid interest on the 15% Senior Secured Notes redeemed up to the date of redemption, and (ii) the present value, as of the date of redemption of all remaining interest payments to the Maturity Date using a discount rate equal to the yield to maturity at the time of computation on the US treasury security with a constant maturity most nearly equal to the period from the redemption date to the Maturity Date plus 50 basis points. Upon a change of control, the Company will be required to make an offer to holders of the Senior Secured Notes to repurchase the Senior Secured Notes at a price equal to 107.5% of their principal amount. The 15% Senior Secured Notes contain negative covenants restricting additional debt incurred by Emergent Capital, Inc., creation of liens on the collateral securing the 15% Senior Secured Notes, and restrictions on dividends and stock repurchases. The 15% Senior Secured Notes are secured by settlement proceeds, if any, received from certain litigation involving the Company, certain notes issued to the Company and a pledge of 65% of the equity interests in Blue Heron Designated Activity Company, OLIPP IV, LLC and Red Reef Alternative Investments, LLC. On or about April 7, 2017, the Company entered into an Exchange Participation Agreement (the "Participation Agreement") with holders (the "Consenting Senior Note Holders") representing 100% of the aggregate outstanding principal amount of the Company's 15.0% Senior Secured Notes. Pursuant to the Participation Agreement, each Consenting Senior Note Holder agreed to enter into a Senior Note purchase agreement with PJC or its designee to sell 100% of the aggregate principal amount of the New Senior Notes that are to be issued to such Consenting Senior Note Holder at a price equal to 100% of the face amount of each New Senior Note purchased. In connection with the Transaction Closing, the Company agreed to pay each Consenting Senior Note Holder 5.0% of the face amount of the 15.0% Senior Secured Notes held by such Consenting Senior Note Holder, plus all accrued but unpaid interest under such 15.0% Senior Secured Notes through the date of the Transaction Closing. On June 15, 2017, the Company did not make an interest payment of $1.2 million (the "Interest Payment") due June 15, 2017 (the "Interest Payment Date") on the Company’s 15.0% Senior Secured Notes, of which $30.0 million principal amount was outstanding on that date. On June 21, 2017, the Company, the Consenting Senior Note Holders and the Senior Secured Note Trustee, entered into a Consent and Forbearance Agreement (the "Forbearance Agreement") relating to Senior Secured Indenture between the Company and the Senior Secured Note Trustee. Pursuant to the Forbearance Agreement, the Consenting Senior Note Holders agreed to: (i) extend the Interest Payment that would otherwise be due and payable on the Interest Payment Date to June 30, 2017 and (ii) forbear from exercising their rights and remedies against the Company solely with respect to a certain event of default under the Senior Secured Indenture (the "Specified Default") during the period commencing on June 15, 2017 and ending on the date that is the earlier of (a) July 1, 2017 and (b) the date on which any other breach of any Transaction Documents (as defined in the Senior Secured Indenture) by the Company occurs (the "Termination Date"); provided that if the Company made the Interest Payment in full in accordance with the Senior Secured Indenture prior to the Termination Date, the Specified Default shall be waived. On June 29, 2017, the Company made the Interest Payment in full and the Specified Default was deemed waived. In connection with the Transaction Closing, PJC, certain investors jointly designated by PJC and Triax (the "Note Purchase Investors") and holders (the "Senior Secured Note Holders") representing 100% of the aggregate outstanding principal amount of the Company’s 15.0% Senior Secured Notes entered into a Note Purchase Agreement (the "Note Purchase Agreement"). Pursuant to the Note Purchase Agreement, the Note Purchase Investors purchased 100% of the 15.0% Senior Secured Notes held by each Senior Secured Note Holder for an aggregate purchase price equal to the face amount of such purchased 15.0% Senior Secured Notes. The Note Purchase Agreement contained customary representations, warranties, and covenants. In connection with the Transaction Closing, the Company paid each Senior Secured Note Holder 5% of the face amount of the 15.0% Senior Secured Notes held by such Senior Secured Note Holder as of immediately prior to the Transaction Closing, plus all accrued but unpaid interest of such 15.0% Senior Secured Notes through the date of the Transaction Closing, pursuant to the Exchange Participation Agreement. All outstanding principal and interest amounts due under the 15.0% Senior Secured Note were repaid on July 28, 2017 in connection with the consummation of the Transaction Closing. As a result of the Transaction Closing, approximately $2.0 million was expensed as extinguishment related to early repayment of the facility, including $1.5 million and $518,000 related to prepayment penalty and write off of origination cost, respectively. The Company recorded approximately $2.8 million of interest expense on the 15% Senior Secured Notes, which includes $2.6 million of interest and $184,000 of amortizing debt issuance costs, during the year ended December 31, 2017 . The Company recorded approximately $4.0 million of interest expense on the 15% Senior Secured Notes, which includes $3.7 million of interest and $356,000 of amortizing debt issuance costs, during the year ended December 31, 2016 .

8.5% SENIOR SECURED NOTES

8.5% SENIOR SECURED NOTES	12 Months Ended
	Dec. 31, 2017
Debt Instrument [Line Items]
SENIOR NOTES	15.0% PROMISSORY NOTE On May 15, 2017, the Company entered into a $1.5 million Promissory Note with PJC Investments, LLC (the "Bridge Note"), to provide financing to fund the Company's continued operations with a maturity date of July 3, 2017. The Bridge Note was amended on June 28, 2017 (the "Amended and Restated Bridge Note") to (i) increase the principal amount under the Bridge Note to $3.3 million and (ii) extend the maturity date from July 3, 2017 to the earlier of (a) July 28, 2017 or (b) the date on which the Master Transaction Agreements are consummated. Under the Amended and Restated Bridge Note, the Company may request an advance of funds, and PJC shall make an advance to the Company, provided that (i) the aggregate amount of outstanding advances shall not exceed $3.3 million and (ii) the Company’s proposed budgeted use of proceeds for such advance is reasonably acceptable to PJC. Advances under the Amended and Restated Bridge Note bear interest at an annual rate of 15% . The Amended and Restated Bridge Note includes certain default provisions customary to bridge financing facilities of this type which are subject to customary grace periods, including, among others, (i) defaults related to payment failures; (ii) failure to comply with covenants; (iii) any material misrepresentation of fact made or deemed made by or on behalf of the Company; (iv) failure by the Company to comply with any of its obligations under any Master Transaction Agreement; (v) defaults in payment of any indebtedness of the Company that continues after the applicable grace or cure period; (vi) bankruptcy and related events and; (vii) change of control without the prior written consent of PJC. Default interest accrues at an annual rate of 17% . The Amended and Restated Bridge Note contains certain affirmative and negative covenants customary for bridge financing facilities of this type. In consideration for the Bridge Note and pursuant to a fee letter agreement by and between the Company and PJC dated May 15, 2017, the Company agreed to pay an additional termination fee equal to $1.5 million in the event that the Company becomes obligated to pay certain termination fees pursuant to certain termination provisions under the Master Transaction Agreements. The Company drew approximately $2.8 million on the Amended and Restated Bridge Note and recorded interest expense of approximately $36,000 during the year ended December 31, 2017 . All outstanding principal and interest amounts due under the Amended and Restated Bridge Note were repaid on July 28, 2017 in connection with the Transaction Closing.
8.5% New Senior Secured Notes Due 2021
Debt Instrument [Line Items]
SENIOR NOTES	8.5% SENIOR SECURED NOTES In connection with the Transaction Closing, the Company and the Senior Secured Note Trustee entered into an Amended and Restated Senior Secured Note Indenture (the "Amended and Restated Senior Secured Indenture") to amend and restate the Senior Secured Indenture between the Company and the Senior Secured Note Trustee following the Company’s receipt of requisite consents of the holders of the 15% Senior Secured Notes. Pursuant to the terms of the Amended and Restated Senior Secured Indenture, the Company caused the cancellation of all outstanding 15% Senior Secured Notes and the issuance of 8.5% Senior Secured Notes due 2021 (the "8.5% Senior Secured Notes") in an aggregate amount of $30.0 million . The Amended and Restated Senior Secured Indenture provides, among other things, that the 8.5% Senior Secured Notes will be secured senior obligations of the Company and will mature on July 15, 2021. The 8.5% Senior Secured Notes will bear interest at a rate of 8.5% per annum, payable quarterly on March 15, June 15, September 15 and December 15 of each year, beginning on September 15, 2017. Certain holders of the Company's securities that are party to Board Designation Agreements (as discussed below), purchased approximately $24.5 million of the 8.5% Senior Secured Notes that were issued in exchange for 15% Senior Secured Notes during the year ended December 31, 2017 . The Amended and Restated Senior Secured Indenture provides that the 8.5% Senior Secured Notes may be optionally redeemed in full by the Company at any time and must be redeemed in full upon additional issuances of debt by the Company in each case, at a price equal to 100% of the principal amount redeemed plus (i) accrued and unpaid interest on the 8.5% Senior Secured Notes redeemed up to the date of redemption, and (ii) the Applicable Premium, if any, as defined in the Amended and Restated Senior Secured Indenture. Upon a change of control, the Company will be required to make an offer to holders of the 8.5% Senior Secured Notes to repurchase the 8.5% Senior Secured Notes at a price equal to 107.5% of their principal amount, plus accrued and unpaid interest up to the date of redemption. The Amended and Restated Senior Secured Indenture contains negative covenants restricting additional debt incurred by the Company, creation of liens on the collateral securing the 8.5% Senior Secured Notes, and restrictions on dividends and stock repurchases, among other things. The 8.5% Senior Secured Notes are secured by settlement proceeds, if any, received from certain litigation involving the Company, certain notes issued to the Company, and pledges of 65% of the equity interests in Blue Heron Designated Activity Company, OLIPP IV, LLC and Red Reef Alternative Investments, LLC. The Amended and Restated Senior Secured Indenture provides for customary events of default which include (subject in certain cases to customary grace and cure periods), among others: nonpayment of principal or interest; breach of covenants or other agreements in the Amended and Restated Senior Secured Indenture; defaults in failure to pay certain other indebtedness; and certain events of bankruptcy or insolvency. Generally, if an event of default occurs and is continuing under the Amended and Restated Senior Secured Indenture, the trustee or the holders of at least 25% in aggregate principal amount of the 8.5% Senior Secured Notes then outstanding may declare the principal of and accrued but unpaid interest, plus a premium, if any, on all the 8.5% Senior Secured Notes immediately due and payable, subject to certain conditions set forth in the Amended and Restated Senior Secured Indenture. On August 11, 2017, the Company entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") by and between the Company and Brennan Opportunities Fund I LP ("Brennan"). Pursuant to the Securities Purchase Agreement, Brennan purchased from the Company (i) 12,500,000 shares (the "Brennan Shares") of Common Stock at a price of $0.40 per share for an aggregate purchase price of $5.0 million and (ii) $5.0 million principal amount of the Company’s 8.5% Senior Secured Notes (the "Brennan Notes," and together with the Brennan Shares, the "Brennan Securities"). The Securities Purchase Agreement contained customary representations, warranties, and covenants. The sale of the Brennan Securities was consummated on August 11, 2017, as to 8,750,000 shares of Common Stock and $3.5 million principal amount of 8.5% Senior Secured Notes, and on August 14, 2017, as to 3,750,000 shares of Common Stock and $1.5 million principal amount of 8.5% Senior Secured Notes. At December 31, 2017 , the outstanding principal of the 8.5% Senior Secured Notes is $35.0 million with a carrying value of $33.9 million , net of unamortized debt issuance cost of $1.1 million . During the year ended December 31, 2017 , the Company recorded approximately $1.4 million of interest expense on the 8.5% Senior Secured Notes, which includes $1.3 million of interest and $98,000 of amortizing debt issuance costs.

15.0% PROMISSORY NOTE

15.0% PROMISSORY NOTE	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
CREDIT FACILITY	15.0% PROMISSORY NOTE On May 15, 2017, the Company entered into a $1.5 million Promissory Note with PJC Investments, LLC (the "Bridge Note"), to provide financing to fund the Company's continued operations with a maturity date of July 3, 2017. The Bridge Note was amended on June 28, 2017 (the "Amended and Restated Bridge Note") to (i) increase the principal amount under the Bridge Note to $3.3 million and (ii) extend the maturity date from July 3, 2017 to the earlier of (a) July 28, 2017 or (b) the date on which the Master Transaction Agreements are consummated. Under the Amended and Restated Bridge Note, the Company may request an advance of funds, and PJC shall make an advance to the Company, provided that (i) the aggregate amount of outstanding advances shall not exceed $3.3 million and (ii) the Company’s proposed budgeted use of proceeds for such advance is reasonably acceptable to PJC. Advances under the Amended and Restated Bridge Note bear interest at an annual rate of 15% . The Amended and Restated Bridge Note includes certain default provisions customary to bridge financing facilities of this type which are subject to customary grace periods, including, among others, (i) defaults related to payment failures; (ii) failure to comply with covenants; (iii) any material misrepresentation of fact made or deemed made by or on behalf of the Company; (iv) failure by the Company to comply with any of its obligations under any Master Transaction Agreement; (v) defaults in payment of any indebtedness of the Company that continues after the applicable grace or cure period; (vi) bankruptcy and related events and; (vii) change of control without the prior written consent of PJC. Default interest accrues at an annual rate of 17% . The Amended and Restated Bridge Note contains certain affirmative and negative covenants customary for bridge financing facilities of this type. In consideration for the Bridge Note and pursuant to a fee letter agreement by and between the Company and PJC dated May 15, 2017, the Company agreed to pay an additional termination fee equal to $1.5 million in the event that the Company becomes obligated to pay certain termination fees pursuant to certain termination provisions under the Master Transaction Agreements. The Company drew approximately $2.8 million on the Amended and Restated Bridge Note and recorded interest expense of approximately $36,000 during the year ended December 31, 2017 . All outstanding principal and interest amounts due under the Amended and Restated Bridge Note were repaid on July 28, 2017 in connection with the Transaction Closing.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The Company carries life settlements and debt under the Revolving Credit Facilities at fair value as shown in the consolidated balance sheets. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value measurements are classified based on the following fair value hierarchy: Level 1 —Valuation is based on unadjusted quoted prices in active markets for identical assets and liabilities that are accessible at the reporting date. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment. Level 2 —Valuation is determined from pricing inputs that are other than quoted prices in active markets that are either directly or indirectly observable as of the reporting date. Observable inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and interest rates and yield curves that are observable at commonly quoted intervals. Level 3—Valuation is based on inputs that are both significant to the fair value measurement and unobservable. Level 3 inputs include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value generally require significant management judgment or estimation. Assets and liabilities measured at fair value on a recurring basis The balances of the Company’s assets measured at fair value on a recurring basis as of December 31, 2017 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Assets: Investment in life settlements $ — $ — $ 567,492 $ 567,492 $ — $ — $ 567,492 $ 567,492 The balances of the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2017 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Liabilities: White Eagle Revolving Credit Facility $ — $ — $ 329,240 $ 329,240 $ — $ — $ 329,240 $ 329,240 The balances of the Company’s assets measured at fair value on a recurring basis as of December 31, 2016 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Assets: Investment in life settlements $ — $ — $ 498,400 $ 498,400 $ — $ — $ 498,400 $ 498,400 The balances of the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2016 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Liabilities: White Eagle Revolving Credit Facility $ — $ — $ 257,085 $ 257,085 $ — $ — $ 257,085 $ 257,085 The Company categorizes its investment in life settlement portfolio in two classes, non-premium financed and premium financed. In considering the categories, historically, it has generally believed that market participants would require a lower risk premium for policies that were non-premium financed, while a higher risk premium would be required for policies that were premium financed; the Company believes that this risk premium has been declining. ($ in thousands) Quantitative Information about Level 3 Fair Value Measurements Fair Value at 12/31/17 Aggregate death benefit 12/31/2017 Valuation Technique Unobservable Input Range (Weighted Average) Non-premium financed $ 101,591 $ 305,963 Discounted cash flow Discount rate 14.50% - 17.50% Life expectancy evaluation 5.3 years Premium financed $ 465,901 $ 2,574,524 Discounted cash flow Discount rate 15.50% - 21.00% Life expectancy evaluation 8.6 years Life settlements $ 567,492 $ 2,880,487 Discounted cash flow Discount rate 15.95% Life expectancy evaluation 8.3 years White Eagle Revolving Credit Facility $ 329,240 $ 2,868,487 Discounted cash flow Discount rate 18.57% Life expectancy evaluation 8.3 years Following is a description of the methodologies used to estimate the fair values of assets and liabilities measured at fair value on a recurring basis and within the fair value hierarchy. Life settlements —The Company has elected to account for the life settlement policies it acquires using the fair value method. The Company uses a present value technique to estimate the fair value of its life settlements, which is a Level 3 fair value measurement as the significant inputs are unobservable and require significant management judgment or estimation. The Company currently uses a probabilistic method of valuing life insurance policies, which the Company believes to be the preferred valuation method in the industry. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The Company provides medical records for each insured to LE providers. Each LE provider reviews and analyzes the medical records and identifies all medical conditions it feels are relevant to the life expectancy determination of the insured. Debits and credits are assigned by each LE provider to the individual’s health based on identified medical conditions which are derived from the experience of mortality attributed to relevant conditions in the portfolio of lives that the LE provider monitors. The health of the insured is summarized by the LE provider into a life assessment of the individual’s life expectancy expressed both in terms of months and in mortality factor. The mortality factor represents the degree to which the given life can be considered more or less impaired than a life having similar characteristics (e.g. gender, age, smoking, etc.). For example, a standard insured (the average life for the given mortality table) would carry a mortality rating of 100% . A similar but impaired life bearing a mortality rating of 200% would be considered to have twice the chance of dying earlier than the standard life relative to the LE provider’s population. Since each provider’s mortality factor is based on its own mortality table, the Company calculates its own factors to apply to the table selected by the Company. The Company calculates mortality factors so that when applied to the mortality table selected by the Company, the resulting LE equals the LE provided by each LE provider. The resulting mortality factors are then blended to determine a factor for each insured. A mortality curve is then generated based on the calculated mortality factors and the rates from the Company selected mortality table to generate the best estimated probabilistic cash flow stream. The net present value of the cash flows is then calculated to determine the policy value. If the insured dies earlier than expected, the return will be higher than if the insured dies when expected or later than expected. The calculation allows for the possibility that if the insured dies earlier than expected, the premiums needed to keep the policy in force will not have to be paid. Conversely, the calculation also considers the possibility that if the insured lives longer than expected, more premium payments will be necessary. Since the quarter ended September 30, 2012, and prior to June 30, 2016, the Company used the 2008 Valuation Basic tables, smoker distinct ("2008 VBT"), mortality tables developed by the U.S. Society of Actuaries (the "SOA"). The mortality tables are created based on the expected rates of death among different groups categorized by factors such as age and gender. During 2015, the SOA released new versions of the Valuation Basic Tables, (the "2015 VBT"). The 2015 VBT is based on a much larger dataset of insured lives, face amount of policies and more current information compared to the dataset underlying the 2008 Valuation Basic Table. The new 2015 VBT dataset includes 266 million policies compared to the 2008 VBT dataset of 75 million . The experience data in the 2015 VBT dataset includes 2.55 million claims on policies from 51 insurance carriers. Life experiences implied by the 2015 VBT are generally longer for male and female nonsmokers between the ages of 65 and 80, while smokers and insureds of both genders over the age of 85 have significantly lower life expectancies. During the year ended December 31, 2016, the Company changed its valuation technique and decided to adopt the 2015 VBT, smoker and gender distinct tables, to determine the value of the policies. The table shows lower mortality rates in the earlier select periods at most ages, so while the Company continues to fit the life expectancies from the LE providers to the 2015 VBT, the change in the mortality curve changes the timing of the Company’s expected cash flow streams. Future changes in the life expectancies could have a material adverse effect on the fair value of the Company’s life settlements, which could have a material adverse effect on its business, financial condition and results of operations. Life expectancy sensitivity analysis If all of the insured lives in the Company’s life settlement portfolio lived six months shorter or longer than the life expectancies provided by these third parties, the change in estimated fair value would be as follows (dollars in thousands): Life Expectancy Months Adjustment Value Change in Value +6 $ 479,016 $ (88,476 ) - $ 567,492 — -6 $ 660,720 $ 93,228 Discount rate The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the policy would require. The Company re-evaluates its discount rates at the end of every reporting period in order to reflect the estimated discount rates that could reasonably be used in a market transaction involving the Company’s portfolio of life settlements. In doing so, consideration is given to the various factors influencing the rates, including risk tolerance and market activity. The Company relies on management insight, engages third party consultants to corroborate its assessment, engages in discussions with other market participants and extrapolates the discount rate underlying actual sales of policies. In considering these factors, at December 2017 , the Company determined that the weighted average discount rate calculated based on death benefit was 15.95% , compared to 16.37% at December 31, 2016 . At one time, due to the Company’s association with the USAO Investigation and certain civil litigation involving the Company, the Company believed that, when given the choice to invest in a policy that was associated with the Company’s premium finance business and a similar policy without such an association, all else being equal, an investor would have generally opted to invest in the policy that was not associated with the Company’s premium finance business. However, since the Company entered into a non-prosecution agreement with the USAO, investors have required less of a risk premium to transact in policies associated with the Company’s legacy premium finance business. With passage of time, and resolution of litigations, the Company now believes investors no longer require a greater risk premium for policies associated with the Company's premium finance business than the risk premium otherwise required for policies that were premium financed. In general, the Company believes that the risk premium an investor would require to transact in a policy that has been premium financed versus a policy without premium financing is lessening in the current market environment and further expects that, with the passage of time, investors will continue to require less of a risk premium to transact in policies that had been premium financed. Credit exposure of insurance company The Company considers the financial standing of the issuer of each life insurance policy. Typically, we seek to hold policies issued by insurance companies that are rated investment grade by the top three credit rating agencies. At December 2017 , the Company had 19 life insurance policies issued by three carriers that were rated non-investment grade as of that date. In order to compensate a market participant for the perceived credit and challenge risks associated with these policies, the Company applied an additional 300 basis point risk premium. The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit and 10% of total fair value of the Company's life settlements as of December 31, 2017 : Carrier Percentage of Total Fair Value Percentage of Total Death Benefit Moody’s Rating S&P Rating Lincoln National Life Insurance Company 22.4 % 19.5 % A1 AA- Transamerica Life Insurance Company 18.4 % 20.8 % A1 AA- Estimated risk premium As of December 31, 2017 , the Company owned 608 policies with an estimated fair value of $567.5 million . Of these 608 policies, 530 were previously premium financed and are valued using discount rates that range from 15.50% to 21.00% . The remaining 78 policies, which are non-premium financed, are valued using discount rates that range from 14.50% to 17.50% . As of December 31, 2017 , the weighted average discount rate calculated based on death benefit used in valuing the policies in the Company's life settlement portfolio was 15.95% . The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the policy would require. The extent to which the fair value could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount rate on the death benefit used to estimate the fair value. If the weighted average discount rate was increased or decreased by 1/2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value would be as follows (dollars in thousands): Market interest rate sensitivity analysis Weighted Average Rate Calculated Based on Death Benefit Rate Adjustment Value Change in Value 15.45% -0.50 % $ 581,538 $ 14,046 15.95% — $ 567,492 $ — 16.45% 0.50 % $ 554,001 $ (13,491 ) Future changes in the discount rates we use to value life insurance policies could have a material effect on the Company's yield on life settlement transactions, which could have a material adverse effect on our business, financial condition and results of our operations. At the end of each reporting period we re-value the life insurance policies using our valuation model in order to update our estimate of fair value for investments in policies held on our balance sheet. This includes reviewing our assumptions for discount rates and life expectancies as well as incorporating current information for premium payments and the passage of time. White Eagle Revolving Credit Facility —As of December 31, 2017 , 606 policies are pledged by White Eagle to serve as collateral for its obligations under the White Eagle Revolving Credit Facility. Absent an event of default under the White Eagle Revolving Credit Facility, ongoing borrowings will be used to pay the premiums on these policies and certain approved third party expenses. As more fully described in Note 8, "White Eagle Revolving Credit Facility," proceeds from the maturity of the policies pledged as collateral under the White Eagle Revolving Credit Facility are distributed pursuant to a waterfall. After premium payments, fees to service providers and payments of interest, a percentage of the collections from policy proceeds are to be paid to the Company, which will vary depending on the then LTV ratio. The Company elected to account for the debt under the White Eagle Revolving Credit Facility in accordance with ASC 820, which includes the 45% interest in policy proceeds payable to the lender, using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. We calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the White Eagle Revolving Credit Facility and probabilistic cash flows from the pledged policies. Accordingly, our estimates are not necessarily indicative of the amounts that we, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. During the year ended December 31, 2016, the Company changed its valuation technique by adopting the 2015 VBT, smoker and gender distinct tables, to determine the value of the life insurance policies pledged as collateral in the facility. The table shows lower mortality rates in the earlier select periods at most ages, so while the Company continues to fit the life expectancies from the LE providers to the 2015 VBT, the change in the mortality curve changes the timing of the Company’s expected cash flow streams, which resulted in an increase in projected borrowings. Life expectancy sensitivity analysis of the White Eagle Revolving Credit Facility A considerable portion of the fair value of the White Eagle Revolving Credit Facility is determined by the timing of receipt of future policy proceeds. Should life expectancies lengthen such that policy proceeds are collected further into the future, the fair value of this debt will decline. Conversely, should life expectancies shorten, the fair value of this debt will increase. Considerable judgment is required in interpreting market data to develop the estimates of fair value. If all of the insured lives in the life settlement portfolio pledged under the White Eagle Revolving Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the White Eagle Revolving Credit Facility debt, the change in estimated fair value would be as follows (dollars in thousands): Life Expectancy Months Adjustment Fair Value of White Eagle Revolving Credit Facility Change in Value +6 $ 270,304 $ (58,936 ) - $ 329,240 — -6 $ 369,499 $ 40,259 Future changes in the life expectancies could have a material effect on the fair value of the White Eagle Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of operations. Discount rate of the White Eagle Revolving Credit Facility The discount rate incorporates current information about market interest rates, credit exposure to insurance companies and the Company’s estimate of the return a lender lending against the policies would require. Market interest rate sensitivity analysis of the White Eagle Revolving Credit Facility The extent to which the fair value of the White Eagle Revolving Credit Facility could vary in the near term has been quantified by evaluating the effect of changes in the weighted average discount. If the weighted average discount rate were increased or decreased by 1/2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the White Eagle Revolving Credit Facility as of December 31, 2017 would be as follows (dollars in thousands): Discount Rate Rate Adjustment Fair Value of White Eagle Revolving Credit Facility Change in Value 18.07% -0.50 % $ 336,708 $ 7,468 18.57% — $ 329,240 $ — 19.07% 0.50 % $ 322,045 $ (7,195 ) Future changes in the discount rates could have a material effect on the fair value of the White Eagle Revolving Credit Facility, which could have a material adverse effect on its business, financial condition and results of its operations. At December 31, 2017 , the fair value of the debt was $329.2 million and the outstanding principal was approximately $329.0 million . Red Falcon Revolving Credit Facility —During the year ended December 2016, the Company terminated the Red Falcon Revolving Credit Facility and repaid all outstanding principal and interest. At December 31, 2017 , all policies that were pledged by Red Falcon to serve as collateral for its obligations under the Red Falcon Revolving Credit Facility were sold to White Eagle. Prior to the Facility Termination, proceeds from the policies pledged as collateral under the Red Falcon Credit Facility were distributed pursuant to a waterfall with, subject to yield maintenance provisions, 5% of policy proceeds directed to the lenders. Thereafter proceeds were directed to pay fees to service providers and premiums with any remaining proceeds directed to pay outstanding interest and required amortization of 8% per annum on the loan. Generally, after payment of interest and required amortization, a percentage of the collections from policy proceeds were to be paid to the lenders to repay the then outstanding principal balance, which varied depending on the then loan to value ratio as more fully described in Note 9,"Red Falcon Revolving Credit Facility." The Company had elected to account for this long-term debt using the fair value method. The fair value of the debt is the amount the Company would have to pay to transfer the debt to a market participant in an orderly transaction. The Company calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the Red Falcon Revolving Credit Facility and probabilistic cash flows from the pledged policies. Accordingly, the Company’s estimates were not necessarily indicative of the amounts that the Company, or holders of the instruments, could realize in a current market exchange. The most significant assumptions were the estimates of life expectancy of the insured and the discount rate. The use of different assumptions and/or estimation methodologies could have a material effect on the estimated fair values. During the year ended December 31, 2016, the Company changed its valuation technique by adopting the 2015 VBT, smoker and gender distinct tables, to determine the value of the life insurance policies pledged as collateral in the facility. The table shows lower mortality rates in the earlier select periods at most ages, so while the Company continues to fit the life expectancies from the LE providers to the 2015 VBT, the change in the mortality curve changes the timing of the Company’s expected cash flow streams, which resulted in an increase in projected borrowings. 8.5% Convertible Notes —The Company determined that an embedded conversion option in the Convertible Notes was required to be separately accounted for as a derivative under Accounting Standards Codification 815, Derivatives and Hedging ("ASC 815") . ASC 815 required the Company to bifurcate the embedded conversion option and record it as a liability at fair value and reduce the debt liability by a corresponding discount of an equivalent amount. The Company used a Black Scholes pricing model that incorporates present valuation techniques and reflect both the time value and the intrinsic value of the embedded conversion option to approximate the fair value of the conversion derivative liability at the end of each reporting period. This model required assumptions as to expected volatility, dividends, terms, and risk free rates. In accordance with ASC 815, upon receipt of shareholder approval the Company reclassified the embedded derivative to stockholders’ equity along with unamortized transaction costs proportionate to the allocation of the initial debt discount and the principal amount of the Convertible Notes. The Convertible Notes continue to be recorded at accreted value up to the par value of the Convertible Notes at maturity. On July 26, 2017, the Company’s Convertible Note Exchange Offer to exchange its outstanding $74.2 million aggregate principal amount of Convertible Notes for its New Convertible Notes expired. Holders of at least 98% of the Convertible Notes tendered in the Convertible Note Exchange Offer. The amount of Convertible Notes exchanged included approximately $73.0 million of principal outstanding prior to the exchange and approximately $2.8 million of interest paid in kind at the exchange date. The outstanding principal of the Convertible Notes after the exchange was approximately $1.2 million . See Note 10, "8.50% Senior Unsecured Convertible Notes," of the accompanying consolidated financial statements for further information. Although the Company believes its valuation method is appropriate, the use of different methodologies or assumptions to determine the fair value could result in different fair values. Changes in Fair Value The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2017 , for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consists solely of life settlements (in thousands): Life Settlements: Balance, January 1, 2017 $ 498,400 Purchase of policies — Change in fair value 51,551 Matured/lapsed/sold polices (67,177 ) Premiums paid 84,718 Transfers into level 3 — Transfers out of level 3 — Balance, December 31, 2017 $ 567,492 Changes in fair value included in earnings for the period relating to assets held at December 31, 2017 $ 12,848 The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2017 , for the White Eagle Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands): White Eagle Revolving Credit Facility: Balance, January 1, 2017 $ 257,085 Draws under the White Eagle Revolving Credit Facility 87,287 Payments on White Eagle Revolving Credit Facility (19,633 ) Unrealized change in fair value 4,501 Transfers into level 3 — Transfer out of level 3 — Balance, December 31, 2017 $ 329,240 Changes in fair value included in earnings for the period relating to liabilities at December 31, 2017 $ 4,501 The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2016 , for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consists solely of life settlements (in thousands): Life Settlements: Balance, January 1, 2016 $ 461,925 Purchase of policies 16 Retained death benefits acquisitions 1,374 Change in fair value* 864 Matured/lapsed/sold polices (37,460 ) Premiums paid 71,681 Transfers into level 3 — Transfers out of level 3 — Balance, December 31, 2016 $ 498,400 Changes in fair value included in earnings for the period relating to assets held at December 31, 2016 $ (17,442 ) *Change in the mortality curve after adoption of the 2015 VBT resulted in approximately $17.6 million reduction in the fair value of life settlements. The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2016 , for the White Eagle Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands): White Eagle Revolving Credit Facility: Balance, January 1, 2016 $ 169,131 Draws under the White Eagle Revolving Credit Facility 124,142 Payments on White Eagle Revolving Credit Facility (34,799 ) Unrealized change in fair value (1,389 ) Transfers into level 3 — Transfer out of level 3 — Balance, December 31, 2016 $ 257,085 Changes in fair value included in earnings for the period relating to liabilities at December 31, 2016 $ (1,389 ) The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2016 , for the Red Falcon Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands): Red Falcon Revolving Credit Facility Balance, January 1, 2016 $ 55,658 Subsequent draws under the Red Falcon Revolving Credit Facility 20,029 Payments on Red Falcon Revolving Credit Facility (75,417 ) Unrealized change in fair value (509 ) Extinguishment 239 Transfers into level 3 — Transfer out of level 3 — Balance, December 31, 2016 $ — Changes in fair value included in earnings for the period relating to liabilities at December 31, 2016 $ — There were no transfers of financial assets or liabilities between levels of the fair value hierarchy during the years ended December 31, 2017 and 2016 . Other Fair Value Considerations — Carrying value of certificate of deposits, prepaid expenses and other assets, receivable for maturity of life settlements, investment in affiliates, Senior Secured Notes, accounts payable and accrued expenses approximate fair value due to their short-term maturities and/or low credit risk.

SEGMENT INFORMATION

SEGMENT INFORMATION	12 Months Ended
	Dec. 31, 2017
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION On October 25, 2013, the Company sold its structured settlement business, which was previously reported as an operating segment. The operating results related to the Company’s structured settlement business have been included in discontinued operations in the Company’s Consolidated Statements of Operations for all periods presented and the Company has discontinued segment reporting. See, Note 6 "Discontinued Operations" to the accompanying consolidated financial statements.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Lease Agreements The Company leases office space under a lease that commenced on October 1, 2014. The lease expires on September 30, 2020 . The annual base rent is $246,000 , with a provision for a 3% increase on each anniversary of the rent commencement date. Rent expense was approximately $407,000 , $412,000 and $423,000 for the years ended December 31, 2017 , 2016 and 2015 , respectively. Future minimum payments under operating leases for each of the three succeeding years subsequent to December 31, 2017 are as follows (in thousands): December 31, 2018 $ 248 2019 255 2020 196 $ 699 Employment Agreements The Company does not have any general policies regarding the use of employment agreements, but has and may, from time to time, enter into such a written agreement to reflect the terms and conditions of employment of a particular named executive officer, whether at the time of hire or thereafter. The Company has entered into employment agreements with certain of its officers, including during the year ended December 31, 2017 , with the former chief executive officer, whose agreement provided for substantial payments in the event that the executive terminated his employment with the Company due to a material change in the geographic location where the chief executive officer performs his duties or upon a material diminution of his base salary or responsibilities, with or without cause. These payments are equal to three times the sum of the chief executive officer’s base salary and the average of the preceding three years’ annual cash bonus. CEO Separation Agreement On August 10, 2017, Antony Mitchell, then the Chief Executive Officer of the Company and a member of the Company's board of directors, notified the Company of his intention to terminate his employment agreement with the Company, effective as of a date to be determined in accordance with the terms of such agreement. On September 15, 2017, the Company entered into a Mediation Agreement with Mr. Mitchell, pursuant to which Mr. Mitchell agreed, among other things, to negotiate and enter into a separation agreement providing for his resignation from the position of Chief Executive Officer and from the Company's board of directors, in each case of the Company and its subsidiaries, no later than September 22, 2017. On October 23, 2017, the Company entered into a Separation Agreement (the "CEO Separation Agreement") with Antony Mitchell, pursuant to which Mr. Mitchell resigned from the position of Chief Executive Officer and as a director of the Company and its subsidiaries effective October 23, 2017. The CEO Separation Agreement obligates the Company to indemnify Mr. Mitchell for his legal fees of $150,000 , which amount is recognized in the consolidated statement of operations for the year ended December 31, 2017 . Litigation In accordance with applicable accounting guidance, the Company establishes an accrued liability for litigation and regulatory matters when those matters present loss contingencies that are both probable and estimable. In such cases, there may be an exposure to loss in excess of any amounts accrued. When a loss contingency is not both probable and estimable, the Company does not establish an accrued liability. As a litigation or regulatory matter develops, the Company, in conjunction with any outside counsel handling the matter, evaluates on an ongoing basis whether such matter presents a loss contingency that is probable and estimable. If, at the time of evaluation, the loss contingency related to a litigation or regulatory matter is not both probable and estimable, the matter will continue to be monitored for further developments that would make such loss contingency both probable and estimable. When a loss contingency related to a litigation or regulatory matter is deemed to be both probable and estimable, the Company will establish an accrued liability with respect to such loss contingency and record a corresponding amount of litigation-related expense. The Company will then continue to monitor the matter for further developments that could affect the amount of any such accrued liability. SEC Investigation On February 17, 2012, the Company received an initial subpoena issued by the staff of the SEC seeking documents from 2007 through the date of the subpoena, generally related to the Company’s premium finance business and corresponding financial reporting (the "SEC Investigation"). The SEC was investigating whether any violations of federal securities laws had occurred and the Company fully cooperated with the SEC regarding the matter. On December 27, 2016, the Company received notification from the SEC that it had concluded its investigation as to the Company and did not intend to recommend an enforcement action against the Company. Sun Life On April 18, 2013, Sun Life Assurance Company of Canada ("Sun Life") filed a complaint against the Company and several of its affiliates in the United States District Court for the Southern District of Florida, entitled Sun Life Assurance Company of Canada v. Imperial Holdings, Inc., et al . (" Sun Life Case "), asserting, among other things, that at least 28 life insurance policies issued by Sun Life and owned by the Company through certain of its subsidiary companies were invalid. The Sun Life complaint, as amended, asserted the following claims: (1) violations of the federal Racketeer Influenced and Corrupt Organizations ("RICO") Act, (2) conspiracy to violate the RICO Act, (3) common law fraud, (4) aiding and abetting fraud, (5) civil conspiracy to commit fraud, (6) tortious interference with contractual obligations, and (7) a declaration that the policies issued were void. Following the filing of a motion by the Company to dismiss the Sun Life Case, on December 9, 2014, counts (2), (4), (5), (6) and (7) of the Sun Life Case were dismissed with prejudice. The Company then filed a motion for summary judgment on the remaining counts. On February 4, 2015, the Court issued an order (the "Order") granting the Company’s motion for summary judgment on counts (1) and (3), resulting in the Company prevailing on all counts in the Sun Life Case. On July 29, 2013, the Company filed a separate complaint against Sun Life in the United States District Court for the Southern District of Florida, captioned Imperial Premium Finance, LLC v. Sun Life Assurance Company of Canada ("Imperial Case"), which was subsequently consolidated with the Sun Life Case. The Imperial Case asserted claims against Sun Life for breach of contract, breach of the covenant of good faith and fair dealing, and fraud, and sought a judgment declaring that Sun Life is obligated to comply with the promises made by it in certain insurance policies. The Imperial complaint also sought compensatory damages amounting to at least $30 million and an award of punitive damages. On August 23, 2013, Sun Life moved to dismiss the complaint, but the Court denied Sun Life’s motion in early 2015. Subsequently, on February 26, 2015, Sun Life appealed the denial to the United States Court of Appeals for the Eleventh Circuit. The Company moved to dismiss Sun Life’s appeal and, on December 17, 2015, the Court of Appeals ruled in favor of the Company, dismissing Sun Life’s appeal. The Imperial Case therefore returned to the District Court. On September 22, 2016, however, the District Court granted summary judgment in favor of Sun Life on the entirety of the Imperial Case. Subsequently, on January 12, 2017, the Company appealed the District Court’s decision, and on January 24, 2017, Sun Life filed its own notice of appeal. As part of these two appeals, the Court of Appeals will review every dispositive order issued by the District Court throughout the consolidated case. Per the Court of Appeals, oral argument will be scheduled in the near future. In January 2018, oral argument was held in the Eleventh Circuit Court of Appeals and the decision is pending. Other Litigation Other litigation is defined as smaller claims or litigations that are neither individually nor collectively material. It does not include lawsuits that relate to collections. The Company is party to various other legal proceedings that arise in the ordinary course of business, separate from normal course accounts receivable collections matters. Due to the inherent difficulty of predicting the outcome of these litigations and other legal proceedings, the Company cannot predict the eventual outcome of these matters, and it is reasonably possible that some of them could be resolved unfavorably to the Company. As a result, it is possible that the Company’s results of operations or cash flows in a particular fiscal period could be materially affected by an unfavorable resolution of pending litigation or contingencies. However, the Company believes that the resolution of these other proceedings will not, based on information currently available, have a material adverse effect on the Company’s financial position or results of operations.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY During the second quarter of 2015, the Company issued 6,688,433 shares of common stock pursuant to a rights offering at a price of $5.75 per share. In connection with the settlement of class litigation, the Company issued warrants to purchase two million shares of the Company’s stock into an escrow account in April 2014 and were distributed in October 2014. The estimated fair value at the measurement date of such warrants was $5.4 million , which is included in stockholder’s equity. The warrants have a five -year term from the date of their distribution with an exercise price of $10.75 . The Company is obligated to file a registration statement to register the shares underlying the warrants with the SEC if shares of the Company’s common stock have an average daily trading closing price of at least $8.50 per share for a 45 day period. The warrants will be exercisable upon effectiveness of the registration statement. The Company has reserved an aggregate of 12,600,000 shares of common stock under its Omnibus Plan, of which 542,102 options to purchase shares of common stock granted to existing employees were outstanding as of December 31, 2017 , 233,215 shares of restricted stock had been granted to directors under the plan and 2,094,000 shares of restricted stock units had been granted to certain employees, with a total of 2,102,522 shares subject to vesting. There were 9,730,683 securities remaining for future issuance under the Omnibus Plan as of December 31, 2017 . On September 1, 2015, the Company announced that its Board of Directors authorized a $10.0 million share and note repurchase program. The program had a two -year expiration date, and authorized the Company to repurchase up to $10.0 million of its common stock and/or its Convertible Notes due 2019. During 2015, the Company purchased 608,000 shares for a total cost of approximately $2.5 million , which is an average cost of $4.17 per share, including transaction fees. As of December 31, 2017 , the repurchase program has terminated. On March 14, 2016, the Company filed a prospectus supplement with the SEC related to the offer and sale from time to time of the Company's common stock at an aggregate offering price of up to $50.0 million through FBR Capital Markets & Co. and MLV & Co. LLC, as distribution agents. Sales of shares of the Company's common stock under the prospectus supplement and the equity distribution agreement entered into with the distribution agents, if any, may be made in negotiated transactions or transactions that are deemed to be "at the market" offerings as defined in Rule 415 under the Securities Act of 1933. The Company has agreed to pay the distribution agents a commission rate of up to 3% of the gross proceeds from the sale of any shares of common stock sold through the equity distribution agreement. During the year ended December 31, 2016 , the Company sold 628,309 shares of common stock under this prospectus supplement at a weighted average price per share of $3.00 , receiving proceeds net of commissions totaling approximately $1.8 million . Approximately $56,600 in commissions were paid in connection with the sales of shares. Recapitalization Transactions On July 28, 2017, the Company consummated a series of integrated transactions to effect a recapitalization of the Company (the "Transaction Closing") pursuant to the Master Transaction Agreements. Common Stock Purchase Agreement In connection with the Transaction Closing, the Company entered into a Common Stock Purchase Agreement (the "Stock Purchase Agreement") by and among the Company, PJC, certain investors jointly designated by PJC and Triax Capital Advisors LLC, a New York limited liability company ("Triax"), to be party to the Stock Purchase Agreement (collectively, the "Common Stock Investors"), and certain Convertible Note Holders that were a party to the Stock Purchase Agreement (collectively, the "Convertible Note Holder Purchasers," and together with PJC and the Common Stock Investors, the "Purchasers"). Pursuant to the Stock Purchase Agreement, the Company issued and sold to the Purchasers 115,000,000 shares (the "Stock Purchase Agreement Shares") of the Company’s common stock, $0.01 par value, at a price of $0.2 per share for an aggregate purchase price of $23.0 million , of which PJC and the Common Stock Investors purchased 75,000,000 Stock Purchase Agreement Shares for an aggregate purchase price of $15.0 million and the Convertible Note Holder Purchasers, pursuant to the previously announced rights offering which expired on July 26, 2017, purchased 40,000,000 Stock Purchase Agreement Shares for an aggregate purchase price of $8.0 million , of which PJC purchased 19,320,038 shares in connection with the exercise of rights assigned to it by certain Convertible Note Holder Purchasers. The Stock Purchase Agreement contained customary representations, warranties, and covenants. Common Stock Purchase Warrants In connection with the Transaction Closing, the Company issued Common Stock Purchase Warrants (the "Warrants") to certain investors jointly designated by PJC and Triax (collectively, the "Warrant Investors") to purchase up to an aggregate of 42,500,000 shares of the Common Stock at an exercise price of $0.20 per share (the "Warrant Shares"). The Warrants shall vest and become exercisable as follows: (i) with respect to 17,500,000 Warrant Shares, immediately upon the issuance of the Warrants, and (ii) with respect to the remaining 25,000,000 Warrant Shares, at later times tied to the conversion of Convertible Notes (as defined below) and New Convertible Notes (as defined below) outstanding upon the Transaction Closing into shares of Common Stock or, if earlier, upon the date that all Convertible Notes or New Convertible Notes are no longer outstanding. The Warrants have an eight year term. The number of Warrant Shares is subject to anti-dilution adjustment provisions. Articles Amendment Effective on July 17, 2017, the Company filed an Articles of Amendment to Articles of Incorporation (the "Articles Amendment") to increase the authorized Common Stock from 80,000,000 shares to 415,000,000 shares. As previously disclosed, the Articles Amendment was approved by the Company’s shareholders at the Company’s 2017 Annual Meeting. The adoption of the Articles Amendment results in a greater number of shares of Common Stock available for issuance. Board Designation Agreements In connection with the Transaction Closing, the Company entered into a series of separate Board Designation Agreements (collectively, the "Board Designation Agreements") with each of (i) Evermore Global Advisors, LLC ("Evermore"), (ii) PJC and JSARCo, LLC (the "Board Rights Investors"), (iii) Opal Sheppard Opportunities Fund I LP ("Opal Sheppard"), (iv) Ironsides P Fund L.P. and Ironsides Partners Special Situations Master Fund II L.P. (together with Ironsides P Fund L.P., the "Ironsides Funds") and (v) Nantahala Capital Management, LLC ("Nantahala"). Pursuant to the Board Designation Agreement with Evermore (the "Evermore Designation Agreement"), subject to the terms and conditions set forth therein, Evermore shall have the right to designate one director to the Company’s Board of Directors (the "Board") whom the Board must add as a director of the Company contemporaneously with the Transaction Closing. At each meeting of the Company’s shareholders at which the election of directors is to be considered and Evermore holds the requisite Minimum Percentage (as defined in the Evermore Designation Agreement), Evermore shall have the right to designate one nominee whom the Board must nominate for election at such meeting. Pursuant to the Board Designation Agreement with the Board Rights Investors (the "Investor Designation Agreement"), subject to the terms and conditions set forth therein, the Board Rights Investors shall have the right to designate three directors to the Board whom the Board must add as directors of the Company contemporaneously with the Transaction Closing, one of which shall be designated pursuant to the Opal Sheppard Agreement. At each meeting of the Company’s shareholders at which the election of directors is to be considered and the Board Rights Investors hold the requisite Minimum Percentage (as defined in the Investor Designation Agreement), the Board Rights Investors shall have the right to designate three nominees whom the Board must nominate for election at such meeting, one of which shall be designated pursuant to the Opal Sheppard Agreement so long as the Opal Sheppard Agreement is in effect. Pursuant to the Board Designation Agreement with Opal Sheppard (the "Opal Sheppard Designation Agreement"), subject to the terms and conditions set forth therein, Opal Sheppard shall have the right to designate one director to the Company’s Board of Directors (the "Board") whom the Board must add as a director of the Company contemporaneously with the Transaction Closing. At each meeting of the Company’s shareholders at which the election of directors is to be considered, so long as the Board Rights Investors have the right to three designees and Opal Sheppard holds the requisite Minimum Percentage (as defined in the Opal Sheppard Designation Agreement), Opal Sheppard shall have the right to designate one nominee whom the Board must nominate for election at such meeting. Pursuant to the Board Designation Agreement with the Ironsides Funds (the "Ironsides Designation Agreement"), subject to the terms and conditions set forth therein, the Ironsides Funds shall have the right to designate one director to the Board whom the Board must add as a director of the Company contemporaneously with the Transaction Closing. At each meeting of the Company’s shareholders at which the election of directors is to be considered and the Ironsides Funds hold the requisite Specified Percentage (as defined in the Ironsides Designation Agreement), the Ironsides Funds shall have the right to designate one nominee whom the Board must nominate for election at such meeting. Pursuant to the Board Designation Agreement with Nantahala (the "Nantahala Designation Agreement"), subject to the terms and conditions set forth therein, upon the termination of the Ironsides Designation Agreement in accordance with the terms thereof, Nantahala shall have the right to designate one director to the Board and, at each meeting of the Company’s shareholders at which the election of directors is to be considered and Nantahala holds the requisite Specified Percentage (as defined in the Nantahala Designation Agreement), Nantahala shall have the right to designate one nominee whom the Board must nominate for election at such meeting. Change in Significant Holders As a result of the consummation of the Master Transaction Agreements, on the date of the Transaction Closing, a change in significant holders of the Company's common stock occurred. PJC and Triax, together with certain of their affiliates, acquired beneficial ownership of approximately 38.9% of the outstanding Common Stock, based on their aggregate acquisition of 39,320,038 shares of Common Stock and warrants to purchase 27,150,000 shares of Common Stock. Other investors designated by PJC and Triax acquired beneficial ownership of approximately 43.6% of the outstanding Common Stock, based on their aggregate acquisition of 55,000,000 shares of Common Stock and warrants to purchase 13,350,000 shares of Common Stock. Additionally, pursuant to the Board Designation Agreements, PJC and Triax designated two of seven directors to the Company’s Board, two other investors designated a third new director and a fourth new director, and a fifth new director was designated by a holder of New Convertible Notes, collectively resulting in a change in the majority of the Company’s Board. Securities Purchase Agreement On August 11, 2017, the Company entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") by and between the Company and Brennan Opportunities Fund I LP ("Brennan"). Pursuant to the Securities Purchase Agreement, Brennan purchased from the Company (i) 12,500,000 shares (the "Brennan Shares") of Common Stock at a price of $0.40 per share for an aggregate purchase price of $5.0 million and (ii) $5.0 million principal amount of the Company’s 8.5% Senior Secured Notes (the "Brennan Notes," and together with the Brennan Shares, the "Brennan Securities"). The Securities Purchase Agreement contained customary representations, warranties, and covenants. The sale of the Brennan Securities was consummated on August 11, 2017, as to 8,750,000 shares of Common Stock and $3.5 million principal amount of 8.5% Senior Secured Notes, and on August 14, 2017, as to 3,750,000 shares of Common Stock and $1.5 million principal amount of 8.5% Senior Secured Notes. Registration Rights Agreement In connection with the Transaction Closing, the Company entered into a Registration Rights Agreement (the "Registration Rights Agreement") with the Common Stock Investors, the Warrant Investors, the Convertible Note Holder Purchasers and each such holder of the Company’s New Convertible Notes that is a party to the Registration Rights Agreement (the "New Convertible Note Holders"). Pursuant to the Registration Rights Agreement, the Company is required to register the resale of the Stock Purchase Agreement Shares, Warrant Shares, the New Convertible Notes and the shares of Common Stock issued or issuable upon conversion of the New Convertible Notes in accordance with the terms of the New Convertible Note Indenture (collectively, the "Registrable Securities"). Under the Registration Rights Agreement, the Company will be required to prepare and file a shelf registration statement with the Securities and Exchange Commission (the "SEC") within 60 days of the Transaction Closing, and to use its best efforts to have the registration statement declared effective upon the earliest to occur of (i) the date that is 120 days after the Transaction Closing, (ii) the date that is two (2) business days after the date that the SEC communicates to the Company that it has no comments to the registration statement, and (iii) the date that is two (2) business days after the date that the SEC communicates to the Company that all comments with respect to the registration statement have been resolved. Pursuant to the Registration Rights Agreement, the Company must use all commercially reasonable efforts to keep the registration statement continuously effective until the date when all of the Registrable Securities covered by such registration statement have been sold. The Registration Rights Agreement also contains piggyback registration rights in favor of the Common Stock Investors, Convertible Note Holder Purchasers and the New Convertibles Note Holders and customary indemnification provisions. On August 11, 2017, the Company entered into a Registration Rights Agreement with Brennan (the "Brennan Registration Rights Agreement"), pursuant to which the Company is required to register the resale of the Brennan Shares. The Brennan Registration Rights Agreement is substantially similar to the Registration Rights Agreement entered into in connection with the Transaction Closing. In accordance with its obligations under the Registration Rights Agreement and New Convertible Note Indenture, on August 25, 2017 the Company filed a shelf registration statement on Form S-1 (the "Registration Statement") with the SEC to register for the re-sale by certain selling stockholders named therein of up to 207,918,483 shares of Common Stock and up to $75.8 million in aggregate principal amount of the New Convertible Notes. The SEC declared the Registration Statement effective on September 28, 2017.

EMPLOYEE BENEFIT PLAN

EMPLOYEE BENEFIT PLAN	12 Months Ended
	Dec. 31, 2017
Postemployment Benefits [Abstract]
EMPLOYEE BENEFIT PLAN	EMPLOYEE BENEFIT PLAN The Company has adopted a 401(k) plan that covers employees that have reached 18 years of age and completed three months of service. The plan provides for voluntary employee contributions through salary deductions, as well as discretionary employer contributions. For the years ended December 31, 2017 , 2016 and 2015 , there were no employer contributions made.

SUMMARY OF QUARTERLY FINANCIAL

SUMMARY OF QUARTERLY FINANCIAL DATA (UNAUDITED)	12 Months Ended
	Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]
SUMMARY OF QUARTERLY FINANCIAL DATA (UNAUDITED)	SUMMARY OF QUARTERLY FINANCIAL DATA (UNAUDITED) The following tables set forth our unaudited consolidated financial data regarding continuing operations for each quarter of fiscal 2017 and 2016 (in thousands). This information, in the opinion of management, includes all adjustments necessary, consisting only of normal and recurring adjustments, to state fairly the information set forth therein. Certain amounts previously reported have been reclassified to conform to the current presentation. These reclassifications had no net impact on the results of operations (in thousands). Fiscal 2017 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Total income 25,590 3,461 24,488 (1,666 ) (Loss)/income from continuing operations before taxes 1,884 (6,474 ) 4,217 (2,865 ) Net (loss)/income from continuing operations 1,884 (6,474 ) 4,217 (2,865 ) (Loss)/income per share from continuing operations: Basic $ 0.07 $ (0.23 ) $ 0.04 $ (0.02 ) Diluted $ 0.06 $ (0.23 ) $ 0.03 $ (0.02 ) (1) Fiscal 2016 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Total income 8,454 (15,786 ) 4,767 3,680 (Loss)/income from continuing operations before income taxes (7,445 ) (9,775 ) (8,543 ) (23,666 ) Net (loss)/income from continuing operations (7,445 ) (9,775 ) (8,543 ) (23,666 ) (Loss)/income per share from continuing operations: Basic and diluted $ (0.27 ) $ (0.36 ) $ (0.31 ) $ (0.84 ) (1) (1) The sum of the basic and diluted earnings per share amounts for each quarter in fiscal year 2017 and the basic and diluted for 2016 do not equal the amount presented in the statements of operations for the years ended December 31, 2017 and December 31, 2016 due to the Company having a net loss for the years ended December 31, 2017 and December 31, 2016 and therefore all common stock equivalents were antidilutive.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The provision (benefit) for income taxes from continuing operations consisted of (in thousands): December 31, 2017 December 31, 2016 December 31, 2015 Continuing operations $ — $ — $ (8,719 ) Discontinued operations — — — Provision (benefit) for income taxes $ — $ — $ (8,719 ) Current Federal $ — $ — $ 10 State — — — $ — $ — $ 10 Deferred Federal 14,109 (16,550 ) (9,149 ) State 2,931 (1,292 ) (3,846 ) 17,040 (17,842 ) (12,995 ) Valuation allowance increase (decrease) (17,040 ) 17,842 4,266 $ — $ — $ (8,729 ) Provision (benefit) for income taxes from continuing operations $ — $ — $ (8,729 ) U.S. and foreign components of income (loss) from continuing operations before income taxes were as follows (in thousands): December 31, 2017 December 31, 2016 December 31, 2015 U.S. $ (19,016 ) $ (23,405 ) $ (51,749 ) Foreign 15,778 (26,024 ) 12,650 $ (3,238 ) $ (49,429 ) $ (39,099 ) The Company’s actual provision (benefit) for income taxes from continuing operations differ from the federal expected income tax provision as follows (in thousands): 2017 2016 2015 Amount Rate Amount Rate Amount Rate Tax provision (benefit) at statutory rate $ (1,134 ) 35.00 % $ (17,300 ) 35.00 % $ (13,685 ) 35.00 % Increase (decrease) in taxes resulting from: State tax (net of federal benefit) (679 ) 20.98 (836 ) 1.72 (1,617 ) 4.14 Attribute reduction from ownership change 35,871 (1,107.45 ) — — — — Impact of rate changes — — 253 (0.50 ) 23 (0.06 ) Litigation settlement — — — — 2,275 (5.82 ) Other permanent items 2 (0.07 ) 4 (0.01 ) 18 (0.05 ) Tax Cuts and Job Act Enactment (17,199 ) 530.99 — — — — Prior year true-ups 50 (1.54 ) — — — — Other 129 (3.99 ) 37 (0.07 ) — — Valuation allowance (decrease) increase (17,040 ) 526.08 17,842 (36.14 ) 4,267 (10.91 ) Provision (benefit) for income taxes $ — — % $ — — % $ (8,719 ) 22.30 % The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and tax liabilities were (in thousands): December 31, 2017 December 31, 2016 Deferred tax assets: Federal and state net operating loss carryforward $ 1,537 $ 37,511 Unrealized gains on life settlements 4 — Revolving Credit Facilities — 7,024 Deferred gain 6,178 14,112 Other 1,281 1,930 Total gross deferred tax assets 9,000 60,577 Less valuation allowance (5,522 ) (22,457 ) Total deferred tax assets 3,478 38,120 Deferred tax liabilities: Unrealized gains on life and structured settlements — 20,321 Gain on structured settlements deferred for tax purposes 2,466 3,655 Convertible debt discount 1,012 3,430 Deferred income — 10,714 Total deferred tax liabilities 3,478 38,120 Total net deferred tax asset (liability) $ — $ — The Company evaluates its deferred tax assets to determine if valuation allowances are required. In its evaluation, management considers taxable loss carryback availability, expectations of sufficient future taxable income, trends in earnings, existence of taxable income in recent years, the future reversal of temporary differences, and available tax planning strategies that could be implemented, if required. Valuation allowances are established based on the consideration of all available evidence using a more likely than not standard. Based on the Company’s evaluation, a deferred tax valuation allowance was established against its net deferred tax assets as of December 31, 2017 . This valuation allowance was determined to be necessary as an offset to the full amount of the federal and state deferred tax asset. The federal and state net operating loss carryovers ("NOLs") generated by the Company since its conversion to a corporation and remaining as of December 31, 2017 are approximately $113.8 million for federal income tax purposes and $119.1 million for state income tax purposes and expire beginning in 2031 (the NOL amounts include $11.2 million that were assumed from a prior reorganization transaction that involved a corporate shareholder and that were subject to Section 382 limitations). However, on July 28, 2017 , as part of a series of integrated transactions to effectuate a recapitalization of the Company, the Company experienced an ownership change as described under Section 382 of the Internal Revenue Code. As a result of the ownership change, a significant portion of the Company’s cumulative U.S. federal and state NOLs of $97.5 million became unavailable to offset future taxable income. Management believes it is appropriate under the Company’s facts and circumstances to write off this amount, as well as the $11.2 million that had previously been subject to Section 382 limitations as the worthless portion of the deferred tax asset. The impact of the write-off will be offset by a decrease in the valuation allowance and should have no net impact on tax expense. On December 22, 2017 the United States enacted the Tax Cuts and Jobs Act ("TCJA"). Under ASC 740, Income Taxes , the effects of new legislation are recognized upon enactment. Accordingly, recognition of the tax effects of the TCJA is required in the reporting periods that include December 22, 2017 . Management has reviewed the legislation and addressed the provisions that are most relevant to its business, including the required accounting under ASC 740 for 2017. Due to the complexities inherent in the tax law changes, the SEC released Staff Accounting Bulletin (SAB) No. 118 on December 22, 2017 , to address the application of ASC 740 where a company does not have the requisite information available, prepared or analyzed in reasonable detail to properly account for items under the TCJA. The SAB has provided that where a company can make a reasonable estimate, it should record that estimate and make appropriate disclosures with updates during a measurement period of no more than a year from enactment. The Company has made its best estimate with respect to the estimated transition tax charge as of December 31, 2017 based on guidance available as of the date of this filing. Upon gathering all necessary data, interpreting any additional guidance from tax authorities, and completing the analysis, our provisional amount may be adjusted in the measurement period allowable in accordance with SAB 118. The key provisions of the TCJA that have factored into the determination of the Company’s tax position for the year ended December 31, 2017 are discussed below. Corporate Tax Rate The TCJA reduced the corporate tax rate from 35% to 21% generally effective for tax years beginning after December 31, 2017 . Consequently, management has remeasured its deferred tax inventory at December 31, 2017 using the new corporate tax rate. The Company estimates that this will result in a reduction in the value of its net deferred tax asset of approximately $3.3 million that will be fully offset by its valuation allowance. The Company did not remeasure its deferred tax items as of December 22, 2017 (the TCJA enactment date) and account for any changes thereon through the end of 2017 using the 35% rate versus the 21% rate as any effects would be immaterial to the financial statements. Transition Tax Under Section 965 as amended by the TCJA, a U.S. shareholder of a controlled foreign corporation ("CFC") must generally include in gross income as a deemed dividend, at the end of the CFC’s last tax year beginning before January 1, 2018, the U.S. shareholder’s share of certain undistributed and previously untaxed accumulated earnings and profits ("E&P"). The income inclusion can be offset by a deduction intended to result (in the case of a Corporation) in an effective U.S. federal income tax rate of either 15.5% or 8% of the gross income inclusion amount. The applicable rate of tax will depend on the CFC’s cash and non-cash positions at certain measurement dates. The Company’s Ireland-based foreign subsidiaries had untaxed accumulated E&P that was deemed distributed to the United States in accordance with the provisions of the Transition Tax. The aggregation of the net income inclusion under Section 465 with other operating losses resulted in a U.S. taxable loss for 2017 of $1.6 million . As such, the Transition Tax did not result in a federal cash tax liability for the Company. For state tax purposes, Florida law has historically not included actual or deemed dividends from foreign subsidiaries in its tax base. The Florida legislature has not yet convened to determine the extent to which it will conform to the provisions within the TCJA. The Company has assumed that Florida will continue this treatment, and the Company will monitor future legislative developments in this area and appropriately adjust its deferred taxes, if necessary. At this time, the Company has made a reasonable estimate of the impact the deemed repatriation transition tax will have for the year ended December 31, 2017 . The final impact of the TCJA may differ from estimates, due to, among other things, changes in our interpretations and assumptions from additional guidance that may be issued by the IRS. Management will continue to monitor future guidance during the measurement period provided for by SAB No. 118 and adjust if necessary. Global Intangible Low-Taxed Income ("GILTI") Beginning in 2018, under certain circumstances , Section 245A enacted by the TCJA eliminates U.S. federal income tax on dividends received from foreign subsidiaries of domestic corporations under a new participation exemption. However, the TCJA also creates a new tax on certain taxed foreign income under new Section 951A. Specifically, income earned in excess of a deemed return on tangible assets held by a CFC (such excess called "GILTI") must now generally be included as U.S. taxable income on a current basis by its U.S. shareholders. In general, the gross income inclusion can be offset by a deduction in an amount up to 50% of the inclusion (through the end of 2025, thereafter the deduction is reduced to 37.5% ) under certain circumstances. Based on the Company’s life settlement assets held within Ireland, management expects the net income generated from these activities to qualify entirely as GILTI. On January 10, 2018, the FASB provided guidance on how to account for deferred tax assets and liabilities expected to reverse in future years as GILTI. The FASB provided that a company may either (1) elect to treat taxes due on future U.S. inclusions of GILTI as a current-period expense when incurred or (2) factor such amounts into the Company’s measurement of its deferred taxes. For ASC 740 purposes, the Company intends to adopt an accounting policy to treat any future GILTI inclusion as a current-period expense instead of providing for U.S. deferred taxes on all temporary differences related to future GILTI items. The Company has historically maintained U.S. deferred income taxes to account for outside basis differences in is foreign subsidiaries since the earnings from such subsidiaries were not indefinitely reinvested outside the United States. To transition to the new accounting policy, the Company has reversed a net deferred tax liability of $11.8 million pertaining to outside basis differences in its foreign subsidiaries and recorded a corresponding deferred tax benefit for 2017 as part of continuing operations. Treatment of NOLs The TCJA makes changes to the treatment of NOLs arising in taxable years beginning after December 31, 2017 . Such NOLs may only offset up to 80% of current year taxable income. Furthermore, such losses may not be carried back to prior years, but can be carried forward indefinitely. The treatment of NOLs arising for the year ended December 31, 2017 will remain as under prior law. Based on the volatility in the Company’s earnings from year to year, the new NOL provisions could have an impact on the Company’s cash taxes in future years. Other Tax disclosures The Company recorded a deferred tax asset for the increase in tax basis associated with the transfer of assets to subsidiaries located in Ireland. The net deferred asset with respect to these transactions is $6.2 million and $14.1 million for the years ended December 31, 2017 and December 31, 2016 , respectively, which will serve as a tax benefit upon reversal as life settlements mature or are sold. Generally, the amount of tax expense or benefit allocated to continuing operations is determined without regard to the tax effects of other categories of income or loss, such as other comprehensive income. However, an exception to the general rule is provided when, in the presence of a valuation allowance against deferred tax assets, there is a pretax loss from continuing operations and pretax income from other categories. In such instances, income from other categories must offset the current loss from operations, the tax benefit of such offset being reflected in continuing operations. For the year ended December 31, 2013, we increased our deferred tax valuation allowance from continuing operations by $56,000 to reflect the taxable income associated with unrealized gains in accumulated other comprehensive income. Tax years prior to 2014 are no longer subject to IRS examination. Various state jurisdiction tax years remain open to examination. Unrecognized Tax Benefits The Company recognizes interest and penalties accrued related to unrecognized tax benefits in tax expense. A reconciliation of the total amounts of unrecognized benefits at the beginning and end of the period was as follows (in thousands): December 31, 2017 December 31, 2016 December 31, 2015 Balance as of beginning of period $ 6,295 $ 6,295 $ 6,295 Additions based on tax positions taken in the current year — — — Reductions of tax positions for prior years (6,295 ) — — Balance as of end of period $ — $ 6,295 $ 6,295 The unrecognized benefit is reflected as a reduction of the deferred tax asset related to the federal and state NOLs. Due to the Section 382 limitation that will impact the future utilization of NOLs attributable to pre-ownership change periods, the NOLs that gave rise to the unrecognized tax benefit will be entirely forfeited. As such, the Company has written off the deferred tax asset and eliminated the liability for unrecognized tax benefits. The impact of reversing the unrecognized tax benefit will be offset by an increase to the valuation allowance and have no net impact to tax expense. Repatriation of Foreign Income Effective May 16, 2014 Lamington Road Limited, an Irish section 110 limited company and an indirect subsidiary of the Company ("Lamington") issued a promissory note to Markley Asset Portfolio, LLC a Delaware limited liability company and an indirect subsidiary of the Company ("Markley"), in a principal amount of $59.3 million . The amount was used by the Lamington as the partial purchase price of Markley’s interest in White Eagle. The annual interest rate on the Promissory Note is 8.5% and is due to be paid at the end of each calendar year; provided that any interest accrued at the end of a calendar year which is not paid within seven business days thereafter shall be capitalized and added to the outstanding principal balance. As of December 31, 2017 , the outstanding principal balance was $80.1 million , which includes $20.8 million in capitalized interest expense. Effective July 28, 2017 , Lamington, issued a promissory note to Markley, in a principal amount of $57.0 million . The amount represents distributions of earnings from Lamington's share of profits of White Eagle, to satisfy the Profit Participation Note issued by Markley to Lamington Road (the "Special Dividend Note"). The Special Dividend Note matures on July 28, 2027 and bears interest at an annual rate of 5.0% , provided that any interest accrued at the end of a calendar year which is not paid within seven business days thereafter shall be capitalized and increased to the outstanding principal balance. For 2017 , the Special Dividend Note will be treated as a distribution of previously taxed income for U.S. tax purposes to the extent that the Company recognized a deemed dividend under the Transition Tax provisions. Management has estimated that the recognition of the taxable dividend will not result in any cash taxes for 2017 . Future principal repayments of the Special Dividend Note to the Company should not result in an additional U.S. tax liability. As of December 31, 2017 , the outstanding principal balance was $57.7 million , which includes $665,000 in capitalized interest expense. As of December 31, 2017 , the Company had the opportunity to repatriate funds of approximately $137.8 million through these promissory notes without a U.S. federal or state income tax liability. Both promissory notes are eliminated in consolidation.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS Stock Purchase Agreement On January 22, 2018, the Company entered into a stock purchase agreement (the "Agreement") with SB Holdings, Inc., a California corporation ("Holdings"), and Sherman, Clay & Co., an Indiana corporation and wholly-owned Subsidiary of Holdings ("Sherman, Clay") pursuant to which the Company agreed to purchase all of the issued and outstanding capital stock of Sherman, Clay from Holdings for an initial purchase price of 18,000,000 shares (the "Initial Shares") of the Company’s common stock of which 2,700,000 shares will be held back for up to 18 months from closing to offset potential indemnified claims. The initial purchase price is subject to increase pursuant to earn-outs based on financial performance during the first year after the acquisition closes (the "Additional Shares") and, together with the Initial Shares, the "Consideration Shares") as provided for in the Agreement. The Agreement contains standard representations and warranties related to each party, and may be terminated prior to the closing under certain circumstances. The closing of the purchase of Sherman, Clay under the Agreement (the "Purchase") is subject to a number of closing conditions, including certain regulatory approvals and obtaining financing for working capital and general corporate purposes, and is anticipated to occur no later than the second quarter of 2018. In connection with the consummation of the Purchase, the Company also agreed to, among other things, enter into a registration rights agreement pursuant to which it will register the resale of the Consideration Shares. 8.5% Senior Secured Notes Amendment On January 10, 2018, the Company dissolved Red Falcon Trust, an indirect subsidiary of the Company ("Red Falcon"). On the same date, the Company also commenced the process of appointing a liquidator to liquidate Blue Heron Designated Activity Company, a direct subsidiary of the Company ("Blue Heron"). The completion of liquidation formalities of Blue Heron under Irish law is expected to take several months. Both Red Falcon and Blue Heron were inactive subsidiaries of the Company. The Company had pledged 65% of the equity and certain other assets of Blue Heron in favor of the secured parties under the Amended and Restated Senior Secured Indenture. In connection with liquidation of Blue Heron, the Company and Wilmington Trust, National Association, as trustee under the Amended and Restated Senior Secured Indenture (the "Trustee"), entered into (i) the First Supplemental Indenture (the "First Supplemental Indenture"), dated as of January 10, 2018, to implement certain amendments to the Indenture and (ii) the Amendment to Pledge and Security Agreement ("Pledge and Security Amendment"), dated as of January 10, 2018, to implement certain amendments to the Pledge and Security Agreement ("Pledge and Security Agreement"), dated as of March 11, 2016, between the Company and Trustee. The First Supplemental Indenture and the Pledge and Security Amendment amend the Indenture and Pledge and Security Agreement, respectively, to: (i) remove from the assets pledged to the secured parties under the Amended and Restated Senior Secured Indenture, 65% of the equity and certain other assets of Blue Heron; and (ii) reflect the pledge by the Company, in favor of the secured parties under the Indenture, of the promissory note dated as of December 29, 2016 in the principal sum of $69.6 million issued by OLIPP IV, LLC to Blue Heron and subsequently assigned to the Company. Amendments to Bylaws On March 6, 2018, the Board of Directors of the Company approved an amendment to the Company’s bylaws, effective March 6, 2018, to require that, in order to be eligible to nominate or propose for nomination a candidate for election as a director, a shareholder must hold at least one percent ( 1% ) of the Company’s outstanding shares of common stock for no less than twelve ( 12 ) months. Employment Agreements On March 13, 2018 , Imperial Finance and Trading, Inc., a wholly-owned subsidiary of the Company ("Imperial"), entered into a new employment agreement with Miriam Martinez (the "Martinez Agreement"), pursuant to which Ms. Martinez will continue to serve as our Senior Vice President and Chief Financial Officer. The term of the Martinez Agreement commenced on March 13, 2018 and continues for one year, with automatic one -year extensions unless (x) either Ms. Martinez or Imperial gives written notice not to extend at least sixty ( 60 )days’ prior to the end of the then-current term or (y) Ms. Martinez’s employment is terminated in accordance with the terms of the Martinez Agreement. The Martinez Agreement supersedes the employment agreement between the Company and Ms. Martinez from 2014 . Pursuant to the Martinez Agreement, Ms. Martinez will receive an annual base salary of $275,000 subject to reviews and increases by the Board. Ms. Martinez may receive an annual bonus at the determination of the Board based on Company performance with goals to be established annually by the Board or as otherwise determined by the Board. The Martinez Agreement further provides that Ms. Martinez is entitled to participate in all benefit plans provided to executives of the Company. If the Company terminates Ms. Martinez’s employment without cause or she resigns with Good Reason (as defined in the Martinez Agreement), the Martinez Agreement provides that she will be entitled to receive her base salary or $352,229 , whichever is greater, through the twelve ( 12 ) months following such termination (the "Severance Period") as well as any bonus earned but not yet paid. If Ms. Martinez resigns for good reason, she will also be entitled to have the Company continue to pay its portion of healthcare premiums for plans in which she is participating immediately prior to the termination through the Severance Period. If such termination or resignation occurs within two years after a change in control (as defined in the Martinez Agreement), then in lieu of receiving his base salary as described above, Ms. Martinez would be entitled to receive (i) accrued vacation days, (ii) a lump sum payment equal to the sum of two times her then base salary, (iii) a portion of her bonus prorated through the termination date that would be due to her when bonus payments are otherwise made for the year in which the termination occurs, (iv) any unpaid portion of a bonus for the year preceding the termination, and (v) reimbursement of COBRA healthcare costs for up to 12 months. On March 13, 2018 , the Company entered into an employment agreement with Jack Simony (the "Simony Agreement"), pursuant to which Mr. Simony will continue to serve as Vice President and Chief Investment Officer of the Company. The term of the Simony Agreement commenced on March 13, 2018 and continues for one year, with automatic one -year extensions unless (x) either Mr. Simony or the Company gives written notice not to extend at least sixty ( 60 ) days’ prior to the end of the then-current term or (y) Mr. Simony’s employment is terminated in accordance with the terms of the Simony Agreement. Pursuant to the Simony Agreement, Mr. Simony will receive an annual base salary of $275,000 . The Simony Agreement further provides that Mr. Simony is entitled to participate in all benefit plans provided to executives of the Company. If the Company terminates Mr. Simony’s employment without cause or he resigns with Good Reason (as defined in the Simony Agreement), the Simony Agreement provides that he will be entitled to receive his base salary through the six ( 6 ) months following such termination (the "Severance Period") as well as any incentive bonus that has been declared or awarded to him for a prior fiscal year but has not yet been paid. If Mr. Simony resigns for good reason, he will also be entitled to have the Company continue to pay its portion of healthcare premiums for plans in which he is participating immediately prior to the termination through the Severance Period. On March 13, 2018 , the Company entered into an employment agreement with Harvey Werblowsky (the "Werblowsky Agreement"), pursuant to which Mr. Werblowsky will continue to serve as Vice President, Chief Legal Officer and General Counsel of the Company. The term of the Simony Agreement commenced on March 13, 2018 and continues for one year, with automatic one -year extensions unless (x) either Mr. Werblowsky or the Company gives written notice not to extend at least sixty ( 60 ) days’ prior to the end of the then-current term or (y) Mr. Werblowsky’s employment is terminated in accordance with the terms of the Werblowsky Agreement. Pursuant to the Werblowsky Agreement, Mr. Werblowsky will receive an annual base salary of $ 250,000 . The Werblowsky Agreement further provides that Mr. Werblowsky is entitled to participate in all benefit plans provided to executives of the Company. If the Company terminates Mr. Werblowsky’s employment without cause or he resigns with Good Reason (as defined in the Werblowsky Agreement), the Werblowsky Agreement provides that he will be entitled to receive his base salary through the six( 6 ) months following such termination (the "Severance Period") as well as any incentive bonus that has been declared or awarded to him for a prior fiscal year but has not yet been paid. If Mr. Werblowsky resigns for good reason, he will also be entitled to have the Company continue to pay its portion of healthcare premiums for plans in which he is participating immediately prior to the termination through the Severance Period. Commitment Letter On March 13, 2018 , the Company received a commitment letter from PJC Investments, LLC for an investment of up to $2.0 million under certain circumstances through March 15, 2019 .

SUMMARY OF SIGNIFICANT ACCOUN29

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company, all of its wholly-owned subsidiary companies and its special purpose entities, with the exception of Imperial Settlements Financing 2010, LLC ("ISF 2010"), an unconsolidated special purpose entity which is accounted for using the cost method of accounting. The special purpose entity has been created to fulfill specific objectives. All significant intercompany balances and transactions have been eliminated in consolidation, including income from services performed by subsidiary companies in connection with the White Eagle Revolving Credit Facility.
Ownership of Life Insurance Policies	Ownership of Life Insurance Policies In the ordinary course of our legacy premium finance business, a large portion of our borrowers defaulted by not paying off their loans and relinquished ownership of their life insurance policies to us in exchange for our release of the obligation to pay amounts due. We also buy life insurance policies in the secondary and tertiary markets. We account for life insurance policies that we own as life settlements (life insurance policies) in accordance with ASC 325-30, Investments in Insurance Contracts , which requires us to either elect the investment method or the fair value method. The election is made on an instrument-by-instrument basis and is irrevocable. We have elected to account for these life insurance policies as investments using the fair value method. We initially record life settlements at the transaction price. For policies acquired upon relinquishment by our borrowers, we determined the transaction price based on fair value of the acquired policies at the date of relinquishment. The difference between the net carrying value of the loan and the transaction price is recorded as a gain (loss) on loan payoffs and settlement. For policies acquired for cash, the transaction price is the amount paid.
Valuation of Insurance Policies	Valuation of Insurance Policies Our valuation of insurance policies is a critical component of our estimate of the fair value of our life settlements (life insurance policies). We currently use a probabilistic method of valuing life insurance policies, which we believe to be the preferred valuation method in the industry. The most significant assumptions are the Company’s estimate of the life expectancy of the insured and the discount rate.
Fair Value Measurement Guidance	Fair Value Measurement Guidance We follow ASC 820, Fair Value Measurements and Disclosures , which defines fair value as an exit price representing the amount that would be received if an asset were sold or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. Level 1 relates to quoted prices in active markets for identical assets or liabilities. Level 2 relates to observable inputs other than quoted prices included in Level 1. Level 3 relates to unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Our investments in life insurance policies and debt under the Revolving Credit Facilities are considered Level 3 as there is currently no active market where we are able to observe quoted prices for identical assets/liabilities and our valuation model incorporates significant inputs that are not observable.
Fair Value Option	Fair Value Option We have elected to account for life settlements using the fair value method. The fair value of the asset is the estimated amount that would be received to sell an asset in an orderly transaction between market participants at the measurement date. We calculate the fair value of the asset using a present value technique to estimate the fair value of the life settlements. The Company currently uses a probabilistic method of valuing life insurance policies, which the Company believes to be the preferred valuation method in the industry. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. See Note 7, "Life Settlements (Life Insurance Policies)" and Note 15, "Fair Value Measurements" of the accompanying consolidated financial statements. We have elected to account for the debt under the White Eagle Revolving Credit Facility, which includes the interests in policy proceeds to the lender, using the fair value method. The fair value of the debt is the estimated amount that would have to be paid to transfer the debt to a market participant in an orderly transaction. We calculated the fair value of the debt using a discounted cash flow model taking into account the stated interest rate of the credit facility and probabilistic cash flows from the pledged policies. Considerable judgment is required in interpreting market data to develop the estimates of fair value. Accordingly, our estimates are not necessarily indicative of the amounts that we, or holders of the instruments, could realize in a current market exchange. The most significant assumptions are the estimates of life expectancy of the insured and the discount rate. The use of assumptions and/or estimation methodologies could have a material effect on estimated fair values.
Income Recognition from Continuing Operations	Income Recognition from Continuing Operations Our primary sources of income from continuing operations are in the form of changes in fair value and gains on life settlements, net. Our income recognition policies for these sources of income are as follows: • Changes in Fair Value of Life Settlements —When the Company acquires certain life insurance policies, we initially record these investments at the transaction price, which is the fair value of the policy for those acquired upon relinquishment or the amount paid for policies acquired for cash. The fair value of the investment in insurance policies is evaluated at the end of each reporting period. Changes in the fair value of the investment are recorded as changes in fair value of life settlements in our consolidated statement of operations. The fair value is determined on a discounted cash flow basis that incorporates current life expectancy assumptions. The discount rate incorporates current information about market interest rates, the credit exposure to the insurance company that issued the life insurance policy and our estimate of the risk premium an investor in the policy would require. The Company recognizes income from life settlement maturities on the date we are in receipt of death notice or verified obituary of the insured. This income is the difference between the death benefit and fair value of the policy at the time of maturity. • Loss on Life Settlements, Net —The Company recognizes gains or losses from the sale of life settlement contracts that the Company owns upon the signed sale agreement and/or filing of ownership forms and funds transferred to escrow.
Income Taxes	Income Taxes In July 2013, the FASB issued ASU No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists ("ASU 2013-11"). ASU 2013-11 requires, unless certain conditions exists, an unrecognized tax benefit, or a portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, similar tax loss, or a tax credit carryforward. The Company adopted ASU 2013-11 effective January 1, 2014 , which required the Company to reclassify a $6.3 million current liability for unrecognized tax benefits to deferred taxes. As of December 31, 2017 , the Company has determined that the deferred tax assets that gave rise to this reclassification are worthless due to effects of the ownership change and should be written off. As such, the $6.3 million deferred tax liability for unrecognized tax benefits has also been reversed during the current year. In November 2015, the FASB issued ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes, which requires that all deferred tax assets and liabilities, along with any related valuation allowances be classified as a net noncurrent asset or liability in the balance sheet based on a jurisdictional basis. The new guidance became effective for public business entities in fiscal years beginning after December 15, 2016, including interim periods within those years. The adoption of this guidance only affects the presentation of deferred taxes in the Company’s consolidated balance sheets. In March 2016, the FASB issued ASU No. 2016-09, "Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" as part of its Simplification Initiative. The guidance simplifies several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public business entities, these amendments became effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption was permitted including adoption in an interim period, as long as any adjustment is reflected as of the beginning of the fiscal year that includes the interim period. The Company adopted this guidance during the year ended December 31, 2017. The adoption of this ASU did not impact the consolidated financial statements or related disclosures. In October 2016, the FASB issued ASU No. 2016-16 Income Taxes (Topic 740): Intra-entity transfers of assets other than inventory ("ASU 2016-16"). Current GAAP prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. This prohibition on recognition is an exception to the principle of comprehensive recognition of current and deferred income taxes in GAAP. The Board decided that an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Consequently, the amendments in this Update eliminate the exception for an intra-entity transfer of an asset other than inventory. For public business entities, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2017, including interim reporting periods within those annual reporting periods. We are currently evaluating whether the adoption of this new guidance will have a significant impact on our consolidated financial statements and related disclosures.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include cash on hand and all highly liquid instruments with an original maturity of three months or less, when purchased. The Company maintains the majority of its cash in several operating accounts with two commercial banks. Balances on deposit are insured by the Federal Deposit Insurance Corporation ("FDIC"). However, from time to time, the Company’s balances may exceed the FDIC insurable amount at its banks.
Deferred Debt Costs	Deferred Debt Costs Deferred debt costs include costs incurred in connection with acquiring and maintaining debt arrangements. These costs are directly deducted from the carrying amount of the liability in the consolidated balance sheets, are amortized over the life of the related debt using the effective interest method and are classified as interest expense in the accompanying consolidated statements of operations. These deferred costs are related to the Company's 8.5% Convertible Notes, 5% Convertible Notes and 8.5% Senior Secured Notes. The Company did not recognize any deferred debt costs on the White Eagle Revolving Credit Facility given all costs were expensed due to electing the fair value option in valuing the White Eagle Revolving Credit Facility.
Treasury stock	Treasury Stock The Company accounts for its treasury stock using the treasury stock method as set forth in ASC 505-30, Treasury Stock . Under the treasury stock method, the total amount paid to acquire the stock is recorded and no gain or loss is recognized at the time of purchase. Gains and losses are recognized at the time the treasury stock is reinstated or retired and are recorded in additional paid in capital or retained earnings.
Stock-Based Compensation	Stock-Based Compensation We have adopted ASC 718, Compensation—Stock Compensation. ASC 718 addresses accounting for share-based awards, including stock options, restricted stock, performance shares and warrants, with compensation expense measured using fair value and recorded over the requisite service or performance period of the award. The fair value of equity instruments awarded will be determined based on a valuation using an option pricing model that takes into account various assumptions that are subjective. Key assumptions used in the valuation will include the expected term of the equity award taking into account both the contractual term of the award, the effects of expected exercise and post-vesting termination behavior, expected volatility, expected dividends and the risk-free interest rate for the expected term of the award. Compensation expense associated with performance shares is only recognized to the extent that it is probable the performance measurement will be met.
Earnings Per Share	Earnings Per Share The Company computes net income per share in accordance with ASC 260, Earnings Per Share . Under the provisions of ASC 260, basic net income per share is computed by dividing the net income available to common shareholders by the weighted average common shares outstanding during the period. Diluted net income per share adjusts basic net income per share for the effects of stock options, warrants, convertible notes and restricted stock awards only in periods in which such effect is dilutive. ASC 260 also requires the Company to present basic and diluted earnings per share information separately for each class of equity instruments that participate in any income distribution with primary equity instruments.
Held-for-sale and discontinued operations	Held-for-sale and discontinued operations We report a business as held-for-sale when management has approved or received approval to sell the business and is committed to a formal plan, the business is available for immediate sale, the business is being actively marketed, the sale is anticipated to occur during the ensuing year and certain other specified criteria are met. A business classified as held-for-sale is recorded at the lower of its carrying amount or estimated fair value less cost to sell. If the carrying amount of the business exceeds its estimated fair value, a loss is recognized. Depreciation is not recorded on assets of a business classified as held-for-sale. Assets and liabilities related to a business classified as held-for-sale are segregated in the Consolidated Balance Sheet and major classes are separately disclosed in the notes to the Consolidated Financial Statements commencing in the period in which the business is classified as held-for-sale. We report the results of operations of a business as discontinued operations if the business is classified as held-for-sale, the operations and cash flows of the business have been or will be eliminated from the ongoing operations of the Company as a result of a disposal transaction and we will not have any significant continuing involvement in the operations of the business after the disposal transaction. The results of discontinued operations are reported in Discontinued Operations in the Consolidated Statement of Operations for current and prior periods commencing in the period in which the business meets the criteria of a discontinued operation, and include any gain or loss recognized on closing or adjustment of the carrying amount to fair value less cost to sell. During the fourth quarter of 2013, we sold substantially all of our structured settlements business. As a result, we have classified our structured settlement operating results as discontinued operations.
Foreign Currency	Foreign Currency We own certain foreign subsidiary companies formed under the laws of Ireland, Bahamas and Bermuda. These foreign subsidiary companies utilize the U.S. dollar as their functional currency. The foreign subsidiary companies' financial statements are denominated in U.S. dollars and therefore, there are no translation gains and losses resulting from converting the financial statements at exchange rates other than the functional currency. Any gains and losses resulting from foreign currency transactions (transactions denominated in a currency other than the subsidiary companies functional currency) are included in income. These gains and losses are immaterial to our financial statements.
Use of Estimates	Use of Estimates The preparation of these consolidated financial statements, in conformity with generally accepted accounting principles in the United States of America ("GAAP"), requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results could differ from these estimates and such differences could be material. Significant estimates made by management include income taxes, the valuation of life settlements, the valuation of the debt owing under the White Eagle Revolving Credit Facility and the valuation of equity awards.
Risks and Uncertainties	Risks and Uncertainties In the normal course of business, the Company encounters economic, legal and longevity risk. There are two main components of economic risk that could potentially impact the Company: market risk and concentration of credit risk. Market risk for the Company includes interest rate risk. Market risk also reflects the risk of declines in valuation of the Company’s life settlements, including declines caused by the selection of increased discount rates associated with the Company’s fair value model for life settlements. It is reasonably possible that future changes to estimates involved in valuing life settlements could change and result in material effects to the future financial statements. Concentration of credit risk includes the risk that an insurance carrier who has issued life insurance policies held by the Company in its portfolio, does not remit the amount due under those policies due to the deteriorating financial condition of the carrier or otherwise. Legal risk includes the risk that statutes define or courts interpret insurable interest in a manner adverse to the Company’s ownership rights in its portfolio of life insurance policies and the risk that courts allow insurance carriers to retain premiums paid by the Company in respect of insurance policies that have been successfully rescinded or contested. Longevity risk refers to the risk that the Company does not experience the mortalities of insureds in its portfolio of life insurance policies that are anticipated to occur on an actuarial basis in a timely manner, which would result in the Company expending additional amounts for the payment of premiums.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09, "Revenue from Contracts with Customers," which converges the FASB and the International Accounting Standards Board ("IASB") standard on revenue recognition. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. In April 2015, the FASB voted to defer the effective date of the new revenue recognition standard by one year. As a result, the provisions of this ASU are now effective for interim and annual periods beginning after December 15, 2017. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In February 2016, the FASB issued ASU No. 2016-02, "Leases" (Topic 842). The new guidance establishes the principles to report transparent and economically neutral information about the assets and liabilities that arise from leases. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. All leases create an asset and a liability for the lessee in accordance with FASB Concepts Statement No. 6, Elements of Financial Statements , and, therefore, recognition of those lease assets and lease liabilities represents an improvement over previous GAAP, which did not require lease assets and lease liabilities to be recognized for most leases. This ASU is effective for annual periods beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In March 2016, the FASB issued ASU No. 2016-06, "Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments." Topic 815 requires that embedded derivatives be separated from the host contract and accounted for separately as derivatives if certain criteria are met. One of those criteria is that the economic characteristics and risks of the embedded derivatives are not clearly and closely related to the economic characteristics and risks of the host contract (the "clearly and closely related" criterion). The guidance in this ASU intends to resolve the diversity in practice resulting from the application of the existing four-step decision sequence defined in ASC 815-15-25-42 to call (put) options that can accelerate the repayment of principal on a debt instrument if they meet the clearly and closely related criterion by clarifying that an entity is required to perform only the four-step decision sequence. The entity does not have to separately assess whether the event that triggers its ability to exercise the contingent option is itself indexed only to interest rates or credit risk. This ASU is effective for annual periods beginning after December 15, 2017, and interim periods beginning after December 15, 2018. Early adoption is permitted including adoption in an interim period, as long as any adjustment is reflected as of the beginning of the fiscal year that includes the interim period. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In August 2016, the FASB issued ASU No. 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments." This ASU provides specific guidance on eight cash flow classification issues that are either unclear or not included in current GAAP. These cash flow classification issues include debt prepayment or debt extinguishment costs, settlement of zero-coupon debt instruments, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, proceeds from the settlement of corporate-owned life insurance policies, distributions received from equity method investees, beneficial interests in securitization transactions, and separately identifiable cash flows and application of the predominance principle. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. An entity that elects early adoption must adopt all of the amendments in the same period. The Company does not expect that this guidance will have a material impact on its financial position, results of operations or cash flows. In January 2017, the FASB issued ASU 2017-01, "Business Combinations (Topic 805)," to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses by clarifying the definition of a business. The definition of a business affects many areas of accounting including acquisition, disposals, goodwill and consolidation. This amendment covers Phase 1 of a three phase project. The update is effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The amendments in this update should be applied prospectively on or after the effective date. We are currently evaluating the impact that the adoption of this ASU will have on our consolidated financial statements. In May 2017, the FASB issued ASU 2017-09, "Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting" to clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under this new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. The guidance is effective prospectively for annual periods beginning on or after December 15, 2017. Early adoption was permitted. We do not anticipate the adoption of this guidance will have a material impact on our consolidated financial statements. In August 2017, the FASB issued Accounting Standards Update (ASU) No. 2017-12, "Derivatives and Hedging (Topic 815)," which simplifies and clarifies the accounting and disclosure for hedging activities by more closely aligning the results of cash flow and fair value hedge accounting with the risk management activities of an entity. The amendments in this update are effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2018, with early adoption permitted. We do not expect this standard to have an impact on our consolidated financial position, results of operations or cash flows. Adopted Accounting Pronouncements In August 2014, the FASB issued ASU No. 2014-15, "Disclosures of Uncertainties About an Entity’s Ability to Continue as a Going Concern." The standard provides guidance around management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. The Company adopted this guidance during the year ended December 31, 2017 . Management has performed a going concern analysis of the Company's liquidity needs and the appropriate disclosures have been incorporated in the accompanying consolidated financial statements for the year ended December 31, 2017 . In November 2015, the FASB issued ASU No. 2015-17, "Income Taxes (Topic 740): Balance Sheet Classifications of Deferred Taxes," which aligns the FASB and the IASB standard for financial statement presentation of deferred income taxes. To simplify the presentation of deferred income taxes, this standard requires that deferred tax assets and liabilities be presented as noncurrent on the balance sheet. This ASU is effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption was permitted, including adoption in an interim period. The Company adopted this guidance during the year ended December 31, 2017 and it did not have any material impact on our financial position, results of operations or cash flows. In March 2016, the FASB issued ASU No. 2016-09, "Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" as part of its Simplification Initiative. The guidance simplifies several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. For public business entities, these amendments are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early adoption was permitted including adoption in an interim period, as long as any adjustment is reflected as of the beginning of the fiscal year that includes the interim period. The adoption of this ASU did not impact the consolidated financial statements or related disclosures.

CONSOLIDATION OF VARIABLE INT30

CONSOLIDATION OF VARIABLE INTEREST ENTITIES (Tables)	12 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Consolidated Assets and Consolidated Liabilities of VIEs	The following table presents the consolidated assets and consolidated liabilities of VIEs for which the Company has concluded that it is the primary beneficiary and which are consolidated in the Company’s financial statements as of December 31, 2017 and 2016 , as well as non-consolidated VIEs for which the Company has determined it is not the primary beneficiary (in thousands): Primary Beneficiary Not Primary Beneficiary Consolidated VIEs Non-consolidated VIEs Assets Liabilities Total Assets Maximum Exposure To Loss December 31, 2017 $ 609,976 $ 329,993 $ 2,384 $ 2,384 December 31, 2016 $ 511,792 $ 257,678 $ 2,384 $ 2,384

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2017
Earnings Per Share [Abstract]
Schedule of Reconciliation of Actual Basic and Diluted Loss Per Share	The following tables reconcile actual basic and diluted earnings per share for the years ended December 31, 2017 , 2016 and 2015 (in thousands except per share data). 2017 2016 2015 (1) (2) (3) Loss per share: Numerator: Net (loss) income from continuing operations $ (3,238 ) $ (49,429 ) $ (30,380 ) Net (loss) income from discontinued operations (271 ) (260 ) (644 ) Net (loss) income $ (3,509 ) $ (49,689 ) $ (31,024 ) Basic and diluted (loss) income per common share: Basic and diluted (loss) income per share from continuing operations $ (0.04 ) $ (1.79 ) $ (1.22 ) Basic and diluted (loss) income per share from discontinued operations $ — $ (0.01 ) $ (0.03 ) Basic and diluted (loss) income per share available to common shareholders $ (0.04 ) $ (1.80 ) $ (1.25 ) Denominator: Basic and diluted 82,323,050 27,660,711 24,851,178 (1) The computation of diluted EPS does not include 542,102 options, 48,740,521 warrants, 2,102,522 shares of restricted stock, and up to 37,918,483 shares of underlying common stock issuable upon conversion of the 5% Convertible Notes (as defined below) and up to 181,249 shares of underlying common stock issuable upon conversion of the 8.5% Convertible Notes (as defined below) for the year ended December 31, 2017 , as the effect of their inclusion would have been anti-dilutive. (2) The computation of diluted EPS did not include 763,594 options, 6,240,521 warrants, 265,212 shares of restricted stock and up to 10,738,165 shares of underlying common stock issuable upon conversion of the Convertible Notes for the year ended December 31, 2016 , as the effect of their inclusion would have been anti-dilutive. (3) The computation of diluted EPS did not include 774,394 options and 6,240,521 warrants, 41,259 shares of restricted stock, up to 10,738,165 shares of underlying common stock issuable upon conversion of the Convertible Notes, and 319,500 performance shares for the year ended December 31, 2015 , as the effect of their inclusion would have been anti-dilutive.

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Common Stock Option Activity	The following table presents the activity of the Company’s outstanding stock options of common stock for the year ended December 31, 2017 : Common Stock Options Number of Shares Weighted Average Price per Share Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Options outstanding, January 1, 2017 763,594 $ 8.52 2.47 $ — Options granted — — — Options exercised — — — Options forfeited (221,492 ) 9.01 — Options expired — — — Options outstanding, December 31, 2017 542,102 $ 8.75 1.33 $ — Exercisable at December 31, 2017 542,102 8.75 1.33 Unvested at December 31, 2017 — $ — — $ —
Schedule of Activity of Unvested Restricted Stock Common Shares	The following table presents the activity of the Company’s unvested restricted stock for the year ended December 31, 2017 : Common Unvested Shares Number of Shares Outstanding January 1, 2017 265,212 Granted 2,051,132 Vested (153,822 ) Forfeited (60,000 ) Outstanding December 31, 2017 2,102,522

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Operating Results of Discontinued Structured Settlement Business	Operating results related to the Company’s discontinued structured settlement business are as follows: Year Ended December 31, 2017 2016 2015 (in thousands) Total income $ 33 $ 12 $ 81 Total expenses 304 272 725 Income (loss) before income taxes (271 ) (260 ) (644 ) Income tax benefit — — — Income (loss) from discontinued operations, net of income taxes $ (271 ) $ (260 ) $ (644 )

LIFE SETTLEMENTS (LIFE INSURA34

LIFE SETTLEMENTS (LIFE INSURANCE POLICIES) (Tables)	12 Months Ended
	Dec. 31, 2017
Investments, All Other Investments [Abstract]
Schedule of Investments in Life Settlements	The following table describes the Company’s life settlements as of December 31, 2016 (dollars in thousands) Remaining Life Expectancy (In Years)* Number of Life Settlement Contracts Fair Value Face Value 0-1 4 $ 16,280 $ 19,497 1-2 14 35,019 52,093 2-3 14 31,300 57,274 3-4 31 44,096 114,449 4-5 40 57,792 172,157 Thereafter 518 313,913 2,531,041 Total 621 $ 498,400 $ 2,946,511 *Based on remaining life expectancy at December 31, 2016 , as derived from reports of third party life expectancy providers, and does not indicate the timing of expected death benefits. See "Life Settlements," in Note 15, "Fair Value Measurements," of the accompanying consolidated financial statements. The following table describes the Company’s life settlements as of December 31, 2017 (dollars in thousands): Remaining Life Expectancy (In Years)* Number of Life Settlement Contracts Fair Value Face Value 0-1 9 $ 29,520 $ 36,474 1-2 13 30,362 42,718 2-3 25 46,609 92,780 3-4 32 68,439 168,946 4-5 60 98,516 281,865 Thereafter 469 294,046 2,257,704 Total 608 $ 567,492 $ 2,880,487 *Based on remaining life expectancy at December 31, 2017 , as derived from reports of third party life expectancy providers, and does not indicate the timing of expected death benefits. See "Life Settlements," in Note 15, "Fair Value Measurements," of the accompanying consolidated financial statements.
Schedule of Future Estimated Premiums To Be Paid	Estimated premiums to be paid for each of the five succeeding fiscal years and thereafter to keep the life insurance policies in force as of December 31, 2017 , are as follows (in thousands): 2018 $ 89,963 2019 97,420 2020 100,343 2021 100,015 2022 96,541 Thereafter 784,442 $ 1,268,724

WHITE EAGLE REVOLVING CREDIT 35

WHITE EAGLE REVOLVING CREDIT FACILITY (Tables) - White Eagle Revolving Credit Facility - White Eagle	12 Months Ended
	Dec. 31, 2017
Debt Instrument [Line Items]
Schedule of Long-term Debt Instruments	After distributions for premium payments, fees to service providers and payments of interest, a percentage of the collections from policy proceeds are to be paid to the Company, which will vary depending on the then LTV ratio as illustrated below where the valuation is determined by the lenders: LTV Premiums, Interest & Other Fees Principal Distribution to White Eagle - 55% Lender Participation - 45% N/A 100% —% —% —% >65% N/A 100% —% —% 50-65% N/A 70% 16.5% 13.5% 35-50% N/A 55% 24.8% 20.3% 0-35% N/A 45% 30.3% 24.8%
Schedule of Proceeds Distributed	For the year ended December 31, 2017 , approximately $37.1 million of proceeds received from the maturity of policies pledged under the White Eagle Revolving Credit Facility, were distributed through the waterfall in the following stages of priority (in thousands): December 31, 2017 December 31, 2016 Clause Amount Use of Proceeds First: $ 313 $ 239 Custodian and Securities Intermediary Second: — — White Eagle - Ongoing Maintenance Cost Reimbursable Third: — — Administrative Agent - Protective Advances Fourth: 39 53 Administrative Agent - Administrative Agent Fee and Legal Expense Reimbursement Fifth: 16,037 10,932 Administrative Agent - Accrued and Unpaid Interest Sixth: 19,633 34,799 Administrative Agent - Required Amortization Seventh: — — Administrative Agent - Amortization Shortfall Eighth: 467 — Administrative Agent - Participation Interest Ninth: — — Reserved Tenth: — — Administrative Agent Aggregate Unpaid Participation Interest Eleventh: — — Administrative Agent - Remaining Available Amount After Clause First to Tenth Twelfth: — — Wilmington Trust - Custodian and Securities Intermediary - Unpaid Fees Thirteenth: 570 — Borrower - Any Remaining Available Amount After Clause First to Twelfth Total Distributions $ 37,059 $ 46,023
Schedule of Reconciliation of Proceeds Distributed	The below is a reconciliation of proceeds collected by the White Eagle Revolving Credit Facility and distributed through the waterfall as shown above (in thousands): Face value collected in 2016 and distributed in 2017 $ 2,480 Face value collected in 2017 and distributed in 2017 34,372 Face value collected in 2017 and distributed in 2018 7,759 Other collections* 247 Total collection in 2017 44,858 Less: Total waterfall distribution in 2017 (37,059 ) Total to be distributed in 2018 $ 7,799 *Includes refund of premiums and interest earned on maturity proceeds
Schedule of Amounts Drawn for Premium Payments	During the years ended December 31, 2017 and 2016 , advances for premium payments and fees to service providers amounted to (in thousands): December 31, 2017 2016 Amount drawn for premium payments $ 84,889 $ 51,342 Amount drawn in fees to service providers 2,398 1,721 Amount drawn for Red Falcon policies purchase — 71,079 Total amount drawn $ 87,287 $ 124,142
Schedule of Interest Expense on Facility	The below table shows the composition of interest for the year ended December 31, 2017 and December 31, 2016 (in thousands): December 31, 2017 2016 Interest paid through waterfall $ 16,037 $ 10,932 Interest paid by White Eagle 782 103 Debt issuance cost — 388 Participation interest paid through waterfall 467 — Total interest expense $ 17,286 $ 11,423

RED FALCON REVOLVING CREDIT F36

RED FALCON REVOLVING CREDIT FACILITY (Tables)	12 Months Ended
	Dec. 31, 2017
Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Schedule of Proceeds Distributed	Assuming no event of default, funds on account from policy proceeds shall be distributed in specified stages of priority. For the year ended December 31, 2016 , approximately $7.6 million of proceeds received from the maturity of policies which were pledged under the Red Falcon Revolving Credit Facility were distributed through the waterfall in the following stages of priority (in thousands): Clause Amount Distribution of Proceeds First: $ 378 Administrative Agent - 5% Contingent Interest Second: 37 Servicer, Custodian and Securities Intermediary Fees Third: 15 Portfolio Manager Fees Fourth: — Administrative Agent - Protective Advances Fifth: 47 Administrative Agent Fees Sixth: 537 Accrued and Unpaid Interest Seventh: 756 Lender - Repayment of Principal - 0.5% of Proceeds Eighth: 5,787 Lender - Repayment of Principal - LTV over 50% Ninth: — Unpaid Servicer, Custodian and Securities Fees Tenth: — Red Falcon Total Distributions $ 7,557

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2017
Schedule of Assets And Liabilities Measured at Fair Value on Recurring Basis	The balances of the Company’s assets measured at fair value on a recurring basis as of December 31, 2017 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Assets: Investment in life settlements $ — $ — $ 567,492 $ 567,492 $ — $ — $ 567,492 $ 567,492 The balances of the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2017 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Liabilities: White Eagle Revolving Credit Facility $ — $ — $ 329,240 $ 329,240 $ — $ — $ 329,240 $ 329,240 The balances of the Company’s assets measured at fair value on a recurring basis as of December 31, 2016 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Assets: Investment in life settlements $ — $ — $ 498,400 $ 498,400 $ — $ — $ 498,400 $ 498,400 The balances of the Company’s liabilities measured at fair value on a recurring basis as of December 31, 2016 , are as follows (in thousands): Level 1 Level 2 Level 3 Total Fair Value Liabilities: White Eagle Revolving Credit Facility $ — $ — $ 257,085 $ 257,085 $ — $ — $ 257,085 $ 257,085
Schedule of Quantitative Information about Level 3 Fair Value Measurements	($ in thousands) Quantitative Information about Level 3 Fair Value Measurements Fair Value at 12/31/17 Aggregate death benefit 12/31/2017 Valuation Technique Unobservable Input Range (Weighted Average) Non-premium financed $ 101,591 $ 305,963 Discounted cash flow Discount rate 14.50% - 17.50% Life expectancy evaluation 5.3 years Premium financed $ 465,901 $ 2,574,524 Discounted cash flow Discount rate 15.50% - 21.00% Life expectancy evaluation 8.6 years Life settlements $ 567,492 $ 2,880,487 Discounted cash flow Discount rate 15.95% Life expectancy evaluation 8.3 years White Eagle Revolving Credit Facility $ 329,240 $ 2,868,487 Discounted cash flow Discount rate 18.57% Life expectancy evaluation 8.3 years
Schedule of Changes in Estimated Fair Value, If All of Insured Lives in Company's Life Settlement Portfolio Live Six Months Shorter or Longer Than Life Expectancies Provided by Third Parties	If all of the insured lives in the Company’s life settlement portfolio lived six months shorter or longer than the life expectancies provided by these third parties, the change in estimated fair value would be as follows (dollars in thousands): Life Expectancy Months Adjustment Value Change in Value +6 $ 479,016 $ (88,476 ) - $ 567,492 — -6 $ 660,720 $ 93,228
Schedule of Life Insurance Issuer concentrations	The following table provides information about the life insurance issuer concentrations that exceed 10% of total death benefit and 10% of total fair value of the Company's life settlements as of December 31, 2017 : Carrier Percentage of Total Fair Value Percentage of Total Death Benefit Moody’s Rating S&P Rating Lincoln National Life Insurance Company 22.4 % 19.5 % A1 AA- Transamerica Life Insurance Company 18.4 % 20.8 % A1 AA-
Schedule of Fair Value Measurements Sensitivity Analysis Market Interest Rate	If the weighted average discount rate was increased or decreased by 1/2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value would be as follows (dollars in thousands): Market interest rate sensitivity analysis Weighted Average Rate Calculated Based on Death Benefit Rate Adjustment Value Change in Value 15.45% -0.50 % $ 581,538 $ 14,046 15.95% — $ 567,492 $ — 16.45% 0.50 % $ 554,001 $ (13,491 ) If the weighted average discount rate were increased or decreased by 1/2 of 1% and the other assumptions used to estimate fair value remained the same, the change in estimated fair value of the White Eagle Revolving Credit Facility as of December 31, 2017 would be as follows (dollars in thousands): Discount Rate Rate Adjustment Fair Value of White Eagle Revolving Credit Facility Change in Value 18.07% -0.50 % $ 336,708 $ 7,468 18.57% — $ 329,240 $ — 19.07% 0.50 % $ 322,045 $ (7,195 )
Schedule of Changes in Fair Value for All Assets Using Material Level of Unobservable (Level 3) Inputs	The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2016 , for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consists solely of life settlements (in thousands): Life Settlements: Balance, January 1, 2016 $ 461,925 Purchase of policies 16 Retained death benefits acquisitions 1,374 Change in fair value* 864 Matured/lapsed/sold polices (37,460 ) Premiums paid 71,681 Transfers into level 3 — Transfers out of level 3 — Balance, December 31, 2016 $ 498,400 Changes in fair value included in earnings for the period relating to assets held at December 31, 2016 $ (17,442 ) *Change in the mortality curve after adoption of the 2015 VBT resulted in approximately $17.6 million reduction in the fair value of life settlements. The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2017 , for all assets for which the Company determines fair value using a material level of unobservable (Level 3) inputs, which consists solely of life settlements (in thousands): Life Settlements: Balance, January 1, 2017 $ 498,400 Purchase of policies — Change in fair value 51,551 Matured/lapsed/sold polices (67,177 ) Premiums paid 84,718 Transfers into level 3 — Transfers out of level 3 — Balance, December 31, 2017 $ 567,492 Changes in fair value included in earnings for the period relating to assets held at December 31, 2017 $ 12,848
Schedule of Changes in Fair Value for All Liabilities Using Material Level of Unobservable (Level 3) Inputs	The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2017 , for the White Eagle Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands): White Eagle Revolving Credit Facility: Balance, January 1, 2017 $ 257,085 Draws under the White Eagle Revolving Credit Facility 87,287 Payments on White Eagle Revolving Credit Facility (19,633 ) Unrealized change in fair value 4,501 Transfers into level 3 — Transfer out of level 3 — Balance, December 31, 2017 $ 329,240 Changes in fair value included in earnings for the period relating to liabilities at December 31, 2017 $ 4,501 The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2016 , for the White Eagle Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands): White Eagle Revolving Credit Facility: Balance, January 1, 2016 $ 169,131 Draws under the White Eagle Revolving Credit Facility 124,142 Payments on White Eagle Revolving Credit Facility (34,799 ) Unrealized change in fair value (1,389 ) Transfers into level 3 — Transfer out of level 3 — Balance, December 31, 2016 $ 257,085 Changes in fair value included in earnings for the period relating to liabilities at December 31, 2016 $ (1,389 ) The following table provides a roll-forward in the changes in fair value for the year ended December 31, 2016 , for the Red Falcon Revolving Credit Facility for which the Company determines fair value using a material level of unobservable (Level 3) inputs (in thousands): Red Falcon Revolving Credit Facility Balance, January 1, 2016 $ 55,658 Subsequent draws under the Red Falcon Revolving Credit Facility 20,029 Payments on Red Falcon Revolving Credit Facility (75,417 ) Unrealized change in fair value (509 ) Extinguishment 239 Transfers into level 3 — Transfer out of level 3 — Balance, December 31, 2016 $ — Changes in fair value included in earnings for the period relating to liabilities at December 31, 2016 $ —
Red Falcon Revolving Credit Facilty
Schedule of Changes in Fair Value for All Liabilities Using Material Level of Unobservable (Level 3) Inputs	If all of the insured lives in the life settlement portfolio pledged under the White Eagle Revolving Credit Facility live six months shorter or longer than the life expectancies used to calculate the estimated fair value of the White Eagle Revolving Credit Facility debt, the change in estimated fair value would be as follows (dollars in thousands): Life Expectancy Months Adjustment Fair Value of White Eagle Revolving Credit Facility Change in Value +6 $ 270,304 $ (58,936 ) - $ 329,240 — -6 $ 369,499 $ 40,259

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Future Minimum Payments under Operating Leases	Future minimum payments under operating leases for each of the three succeeding years subsequent to December 31, 2017 are as follows (in thousands): December 31, 2018 $ 248 2019 255 2020 196 $ 699

SUMMARY OF QUARTERLY FINANCIA39

SUMMARY OF QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]
Summary of Quarterly Financial Information (Unaudited)	The following tables set forth our unaudited consolidated financial data regarding continuing operations for each quarter of fiscal 2017 and 2016 (in thousands). This information, in the opinion of management, includes all adjustments necessary, consisting only of normal and recurring adjustments, to state fairly the information set forth therein. Certain amounts previously reported have been reclassified to conform to the current presentation. These reclassifications had no net impact on the results of operations (in thousands). Fiscal 2017 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Total income 25,590 3,461 24,488 (1,666 ) (Loss)/income from continuing operations before taxes 1,884 (6,474 ) 4,217 (2,865 ) Net (loss)/income from continuing operations 1,884 (6,474 ) 4,217 (2,865 ) (Loss)/income per share from continuing operations: Basic $ 0.07 $ (0.23 ) $ 0.04 $ (0.02 ) Diluted $ 0.06 $ (0.23 ) $ 0.03 $ (0.02 ) (1) Fiscal 2016 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Total income 8,454 (15,786 ) 4,767 3,680 (Loss)/income from continuing operations before income taxes (7,445 ) (9,775 ) (8,543 ) (23,666 ) Net (loss)/income from continuing operations (7,445 ) (9,775 ) (8,543 ) (23,666 ) (Loss)/income per share from continuing operations: Basic and diluted $ (0.27 ) $ (0.36 ) $ (0.31 ) $ (0.84 ) (1) (1) The sum of the basic and diluted earnings per share amounts for each quarter in fiscal year 2017 and the basic and diluted for 2016 do not equal the amount presented in the statements of operations for the years ended December 31, 2017 and December 31, 2016 due to the Company having a net loss for the years ended December 31, 2017 and December 31, 2016 and therefore all common stock equivalents were antidilutive.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Provision (Benefit) for Income Taxes from Continuing Operations	The provision (benefit) for income taxes from continuing operations consisted of (in thousands): December 31, 2017 December 31, 2016 December 31, 2015 Continuing operations $ — $ — $ (8,719 ) Discontinued operations — — — Provision (benefit) for income taxes $ — $ — $ (8,719 ) Current Federal $ — $ — $ 10 State — — — $ — $ — $ 10 Deferred Federal 14,109 (16,550 ) (9,149 ) State 2,931 (1,292 ) (3,846 ) 17,040 (17,842 ) (12,995 ) Valuation allowance increase (decrease) (17,040 ) 17,842 4,266 $ — $ — $ (8,729 ) Provision (benefit) for income taxes from continuing operations $ — $ — $ (8,729 )
Schedule of U.S. and Foreign Components of Income (Loss) From Continuing Operations before Income Taxes	U.S. and foreign components of income (loss) from continuing operations before income taxes were as follows (in thousands): December 31, 2017 December 31, 2016 December 31, 2015 U.S. $ (19,016 ) $ (23,405 ) $ (51,749 ) Foreign 15,778 (26,024 ) 12,650 $ (3,238 ) $ (49,429 ) $ (39,099 )
Schedule of Actual Provision (Benefit) for Income Taxes from Continuing operations Differ from Federal Expected Income Tax Provision	The Company’s actual provision (benefit) for income taxes from continuing operations differ from the federal expected income tax provision as follows (in thousands): 2017 2016 2015 Amount Rate Amount Rate Amount Rate Tax provision (benefit) at statutory rate $ (1,134 ) 35.00 % $ (17,300 ) 35.00 % $ (13,685 ) 35.00 % Increase (decrease) in taxes resulting from: State tax (net of federal benefit) (679 ) 20.98 (836 ) 1.72 (1,617 ) 4.14 Attribute reduction from ownership change 35,871 (1,107.45 ) — — — — Impact of rate changes — — 253 (0.50 ) 23 (0.06 ) Litigation settlement — — — — 2,275 (5.82 ) Other permanent items 2 (0.07 ) 4 (0.01 ) 18 (0.05 ) Tax Cuts and Job Act Enactment (17,199 ) 530.99 — — — — Prior year true-ups 50 (1.54 ) — — — — Other 129 (3.99 ) 37 (0.07 ) — — Valuation allowance (decrease) increase (17,040 ) 526.08 17,842 (36.14 ) 4,267 (10.91 ) Provision (benefit) for income taxes $ — — % $ — — % $ (8,719 ) 22.30 %
Schedule of Significant Portions of Deferred Tax Assets and Tax Liabilities	The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and tax liabilities were (in thousands): December 31, 2017 December 31, 2016 Deferred tax assets: Federal and state net operating loss carryforward $ 1,537 $ 37,511 Unrealized gains on life settlements 4 — Revolving Credit Facilities — 7,024 Deferred gain 6,178 14,112 Other 1,281 1,930 Total gross deferred tax assets 9,000 60,577 Less valuation allowance (5,522 ) (22,457 ) Total deferred tax assets 3,478 38,120 Deferred tax liabilities: Unrealized gains on life and structured settlements — 20,321 Gain on structured settlements deferred for tax purposes 2,466 3,655 Convertible debt discount 1,012 3,430 Deferred income — 10,714 Total deferred tax liabilities 3,478 38,120 Total net deferred tax asset (liability) $ — $ —
Schedule of Reconciliation of Total Amounts of Unrecognized Benefits	A reconciliation of the total amounts of unrecognized benefits at the beginning and end of the period was as follows (in thousands): December 31, 2017 December 31, 2016 December 31, 2015 Balance as of beginning of period $ 6,295 $ 6,295 $ 6,295 Additions based on tax positions taken in the current year — — — Reductions of tax positions for prior years (6,295 ) — — Balance as of end of period $ — $ 6,295 $ 6,295

ORGANIZATION AND DESCRIPTION 41

ORGANIZATION AND DESCRIPTION OF BUSINESS ACTIVITIES (Details)	Dec. 31, 2017USD ($)contractpolicy	Sep. 30, 2017USD ($)	Dec. 31, 2016USD ($)contract	Dec. 29, 2016contract	Nov. 09, 2015USD ($)	Apr. 29, 2013USD ($)
Organization and Nature of Operations [Line Items]
Number of policies owned | contract	608		621
Investment in life settlements	$ 567,492,000		$ 498,400,000
Life insurance policies with aggregate death benefit	$ 2,880,487,000		$ 2,946,511,000
Number of unencumbered policies | policy	2
White Eagle Revolving Credit Facility | Securities Not Pledged as Collateral
Organization and Nature of Operations [Line Items]
Investment in life settlements	$ 750,000
Life insurance policies with aggregate death benefit		$ 12,000,000
White Eagle Revolving Credit Facility | White Eagle
Organization and Nature of Operations [Line Items]
Portfolio of life insurance	$ 333,200,000				$ 250,000,000	$ 300,000,000
White Eagle Revolving Credit Facility | White Eagle | Securities Pledged as Collateral
Organization and Nature of Operations [Line Items]
Number of policies owned | contract	606			190
Investment in life settlements	$ 566,700,000
Life insurance policies with aggregate death benefit	2,900,000,000
Portfolio of life insurance	$ 370,000,000

SUMMARY OF SIGNIFICANT ACCOUN42

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) $ in Thousands	Jan. 01, 2014USD ($)	Dec. 31, 2017USD ($)contractpolicyshares	Dec. 31, 2016USD ($)contractshares	Dec. 31, 2015USD ($)	Dec. 29, 2016contract
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Number of policies owned | contract		608	621
Life insurance policies with aggregate death benefit		$ 2,880,487	$ 2,946,511
Investment in life settlements		567,492	498,400
Negative cash flows from operating activities		34,847	45,555	$ 54,348
Cash and cash equivalents		31,300
Cash and cash equivalents available to pay premiums		$ 19,100
Number of unencumbered policies | policy		2
Cash and cash equivalents		$ 18,131	2,246
Reversed deferred tax liability for unrecognized tax benefits		6,295	0	$ 0
Certificates of deposit		$ 1,010	$ 6,025
Interest rate on certificates of deposit		0.20%
Treasury stock (shares) | shares		608,000	608,000
Accounting Standards Update ASU 2013-11
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Reclassification of current liability for unrecognized tax benefits to deferred taxes	$ 6,300
Primary Beneficiary
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Cash and cash equivalents		$ 13,136	$ 9,072
Securities Pledged as Collateral | White Eagle | White Eagle Revolving Credit Facility
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Number of policies owned | contract		606			190
Life insurance policies with aggregate death benefit		$ 2,900,000
Investment in life settlements		$ 566,700

CONSOLIDATION OF VARIABLE INT43

CONSOLIDATION OF VARIABLE INTEREST ENTITIES - Consolidated Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Primary Beneficiary
Variable Interest Entity [Line Items]
Consolidated VIEs, Assets	$ 609,976	$ 511,792
Consolidated VIEs, Liabilities	329,993	257,678
Not Primary Beneficiary
Variable Interest Entity [Line Items]
Non-consolidated VIEs, Assets	2,384	2,384
Non-consolidated VIEs, Maximum Exposure to Loss	$ 2,384	$ 2,384

CONSOLIDATION OF VARIABLE INT44

CONSOLIDATION OF VARIABLE INTEREST ENTITIES - Narrative (Details) $ in Thousands	Dec. 31, 2017USD ($)contract	Dec. 31, 2016USD ($)contract	Dec. 29, 2016contract
Variable Interest Entity [Line Items]
Number of policies owned | contract	608	621
Life insurance policies with aggregate death benefit	$ 2,880,487	$ 2,946,511
Investment in life settlements	567,492	498,400
Affiliated Entity | Imperial Settlements Financing 2010, LLC [Member]
Variable Interest Entity [Line Items]
Investment in affiliates (VIE)	$ 2,400	$ 2,400
White Eagle | White Eagle Revolving Credit Facility | Securities Pledged as Collateral
Variable Interest Entity [Line Items]
Number of policies owned | contract	606		190
Life insurance policies with aggregate death benefit	$ 2,900,000
Investment in life settlements	$ 566,700

EARNINGS PER SHARE - Narrative

EARNINGS PER SHARE - Narrative (Details) - shares	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Common stock, shares issued (shares)	158,495,399	29,021,844	28,130,508
Common stock, shares outstanding (shares)	157,887,399	28,413,844	27,522,508
Treasury Stock
Treasury shares outstanding (shares)	608,000	608,000	608,000	0

EARNINGS PER SHARE - Reconcilia

EARNINGS PER SHARE - Reconciliation of Actual Basic and Dilutive Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Numerator:
Net (loss) income from continuing operations									$ (3,238)	$ (49,429)	$ (30,380)
Net (loss) income from discontinued operations									(271)	(260)	(644)
Net (loss) income	$ (2,865)	$ 4,217	$ (6,474)	$ 1,884	$ (23,666)	$ (8,543)	$ (9,775)	$ (7,445)	$ (3,509)	$ (49,689)	$ (31,024)
Basic and diluted (loss) income per common share:
Basic and diluted (loss) earning per common share, continuing operations (usd per share)									$ (0.04)	$ (1.79)	$ (1.22)
Basic and diluted (loss) earning per common share, discontinued operations (usd per share)									0	(0.01)	(0.03)
Net (loss) income (usd per share)					$ (0.84)	$ (0.31)	$ (0.36)	$ (0.27)	$ (0.04)	$ (1.80)	$ (1.25)
Denominator:
Basic and diluted (in shares)									82,323,050	27,660,711	24,851,178

EARNINGS PER SHARE - Additional

EARNINGS PER SHARE - Additional Information (Details) - shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Stock Option
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	542,102	763,594	774,394
Warrant
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	48,740,521	6,240,521	6,240,521
Restricted Stock
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	2,102,522	265,212	41,259
Convertible Debt Securities | Maximum
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)		10,738,165	10,738,165
Convertible Debt Securities | 5.0% Senior Unsecured Convertible Notes Due 2023 | Maximum
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	37,918,483
Convertible Debt Securities | 8.50% Senior Unsecured Convertible Notes Due 2019 | Maximum
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)	181,249
Performance Shares
Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]
Antidilutive securities excluded from computation of diluted earnings per share (shares)			319,500

STOCK-BASED COMPENSATION - Narr

STOCK-BASED COMPENSATION - Narrative (Details)	Jul. 28, 2017$ / sharesshares	Jun. 27, 2017shares	Feb. 11, 2011shareholder$ / sharesshares	Oct. 31, 2014$ / shares	Apr. 30, 2014USD ($)shares	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)	Dec. 31, 2014shares	Jun. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding (shares)						542,102	763,594
Options outstanding, weighted average price (usd per share) | $ / shares						$ 8.75	$ 8.52
Remaining unamortized amounts to be recognized on options | $						$ 0
Weighted average life of options						1 year 4 months	2 years 5 months 18 days
Exercise price of warrants (usd per share) | $ / shares			$ 14.51
Number of warrants exercisable and fully vested (in shares)						4,240,521
Warrant expiration period			7 years
Warrant Investors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of warrants (usd per share) | $ / shares	$ 0.2
Warrants issued (in shares)	42,500,000
Convertible Notes | Immediately Upon Issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants issued (in shares)	17,500,000
Convertible Notes | At a Later Time Upon Conversion of Notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term of warrants	8 years
Warrants issued (in shares)	25,000,000
USAO Investigation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price of warrants (usd per share) | $ / shares				$ 10.75
Litigation settlement, shares to escrow (shares)					2,000,000
Estimated fair value of warrants | $					$ 5,400,000
Term of warrants				5 years
Minimum | USAO Investigation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average daily trading closing price (usd per share) | $ / shares				$ 8.50
Average daily trading closing price, period				45 days
Over-Allotment Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shareholders | shareholder			3
Including Overallotment Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of warrants outstanding (in shares)						4,240,521
Warrants issued (in shares)			4,240,521
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stocks vested (shares)						153,822
Unvested restricted stock outstanding (shares)						2,102,522	265,212
Restricted stocks forfeited (shares)						60,000
Restricted stocks granted (shares)						2,051,132
Restricted Stock | Directors and Certain Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense | $						$ 388,000	$ 411,000	$ 252,000
Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares authorized for issuance (shares)		9,900,000
Options outstanding (shares)						542,102
Options outstanding, weighted average price (usd per share) | $ / shares						$ 8.75
Omnibus Plan | Employee Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock reserved for future grant (shares)		12,600,000
Share-based compensation expense | $						$ 0	0	238,000
Omnibus Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted stock outstanding (shares)						2,102,522
Stock based compensation that remained unrecognized at end of the year | $						$ 783,000
Omnibus Plan | Restricted Stock | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stocks granted (shares)						233,215
Omnibus Plan | Restricted Stock | Directors | Grant 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense | $						$ 0	$ 103,000	$ 144,000
Restricted stocks vested (shares)							41,259
Restricted stocks forfeited (shares)							41,259
Fair value of restricted stocks granted fair value | $							$ 255,000
Omnibus Plan | Restricted Stock | Directors | Grant 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense | $						106,000	141,000
Fair value of restricted stocks granted fair value | $							$ 255,000
Restricted stocks granted (shares)							65,212
Options outstanding and unexercised, vesting period							1 year
Omnibus Plan | Restricted Stock | Directors | Grant 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense | $						$ 17,000
Restricted stocks vested (shares)						42,610
Unvested restricted stock outstanding (shares)						8,522
Fair value of restricted stocks granted fair value | $						$ 17,000
Restricted stocks granted (shares)						51,132
Options outstanding and unexercised, vesting period						1 year
Aggregative intrinsic value of options | $						$ 3,000
Weighted average life of options						6 months 26 days
Omnibus Plan | Restricted Stock | Certain Employees | Grant 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense | $						$ 215,000	$ 168,000
Restricted stocks vested (shares)						46,000
Unvested restricted stock outstanding (shares)						94,000
Restricted stocks forfeited (shares)						60,000
Fair value of restricted stocks granted fair value | $							$ 674,000
Restricted stocks granted (shares)							200,000
Options outstanding and unexercised, vesting period							2 years
Aggregative intrinsic value of options | $						$ 28,000
Weighted average life of options						2 months 27 days
Omnibus Plan | Restricted Stock | Certain Employees | Grant 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense | $						$ 51,000
Unvested restricted stock outstanding (shares)						2,000,000
Fair value of restricted stocks granted fair value | $						$ 745,000
Options outstanding and unexercised, vesting period						2 years
Aggregative intrinsic value of options | $						$ 600,000
Weighted average life of options						11 months 1 day
Omnibus Plan | Performance Shares | Directors and Certain Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense | $							$ 0
Restricted stocks granted (shares)									323,500
Stock granted, subject to shareholders' approval of an amendment and restatement (shares)									150,000
Omnibus Plan | Performance Shares | Directors and Certain Employees | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of actual shares to be issued										0.00%
Omnibus Plan | Performance Shares | Directors and Certain Employees | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of actual shares to be issued										150.00%

STOCK-BASED COMPENSATION - Comm

STOCK-BASED COMPENSATION - Common Stock Options Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Number of Shares
Options outstanding, Beginning Balance (shares)	763,594
Options granted (shares)	0
Options exercised (shares)	0
Options forfeited (shares)	(221,492)
Options expired (shares)	0
Options outstanding, Ending Balance (shares)	542,102	763,594
Exercisable at end of period (shares)	542,102
Unvested at end of period (shares)	0
Weighted Average Price per Share
Options outstanding, Beginning Balance (usd per share)	$ 8.52
Options granted (usd per share)	0
Options exercised (usd per share)	0
Options forfeited (usd per share)	9.01
Options expired (usd per share)	0
Options outstanding, Ending Balance (usd per share)	8.75	$ 8.52
Exercisable at end of period (usd per share)	8.75
Unvested at end of period (usd per share)	$ 0
Weighted Average Remaining Contractual Term
Options outstanding	1 year 4 months	2 years 5 months 18 days
Exercisable at end of period	1 year 4 months
Unvested at end of period	0 years
Aggregate Intrinsic Value
Options outstanding, Beginning Balance	$ 0
Options outstanding, Ending Balance	0	$ 0
Unvested at end of period	$ 0

STOCK-BASED COMPENSATION - Acti

STOCK-BASED COMPENSATION - Activity of Unvested Restricted Stock Common Shares (Details) - Restricted Stock	12 Months Ended
	Dec. 31, 2017shares
Number of Shares
Beginning balance (shares)	265,212
Granted (shares)	2,051,132
Vested (shares)	(153,822)
Forfeited (shares)	(60,000)
Ending Balance (shares)	2,102,522

DISCONTINUED OPERATIONS - Narra

DISCONTINUED OPERATIONS - Narrative (Details) $ in Thousands	Aug. 18, 2015USD ($)
Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration received on sale of structured settlement receivables	$ 920

DISCONTINUED OPERATIONS - Opera

DISCONTINUED OPERATIONS - Operating Results of Structured Settlement Business (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income (loss) before income taxes	$ (271)	$ (260)	$ (644)
Income tax benefit	0	0	0
Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total income	33	12	81
Total expenses	304	272	725
Income (loss) before income taxes	(271)	(260)	(644)
Income tax benefit	0	0	0
Income (loss) from discontinued operations, net of income taxes	$ (271)	$ (260)	$ (644)

LIFE SETTLEMENTS (LIFE INSURA53

LIFE SETTLEMENTS (LIFE INSURANCE POLICIES) - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)contract	Dec. 31, 2016USD ($)contract
Investments, All Other Investments [Abstract]
Number of policies owned | contract	608	621
Investment in life settlements	$ 567,492	$ 498,400
Average life expectancy of insured	8 years 3 months 12 days	9 years
Estimated future premium payments	$ 1,268,724

LIFE SETTLEMENTS (LIFE INSURA54

LIFE SETTLEMENTS (LIFE INSURANCE POLICIES) - Investments in Life Settlements (Details) $ in Thousands	Dec. 31, 2017USD ($)contract	Dec. 31, 2016USD ($)contract
Number of Life Settlement Contracts
0-1 | contract	9	4
1-2 | contract	13	14
2-3 | contract	25	14
3-4 | contract	32	31
4-5 | contract	60	40
Thereafter | contract	469	518
Total | contract	608	621
Fair Value
0-1	$ 29,520	$ 16,280
1-2	30,362	35,019
2-3	46,609	31,300
3-4	68,439	44,096
4-5	98,516	57,792
Thereafter	294,046	313,913
Total	567,492	498,400
Face Value
0-1	36,474	19,497
1-2	42,718	52,093
2-3	92,780	57,274
3-4	168,946	114,449
4-5	281,865	172,157
Thereafter	2,257,704	2,531,041
Total	$ 2,880,487	$ 2,946,511

LIFE SETTLEMENTS (LIFE INSURA55

LIFE SETTLEMENTS (LIFE INSURANCE POLICIES) - Future Estimated Premiums (Details) $ in Thousands	Dec. 31, 2017USD ($)
Investments, All Other Investments [Abstract]
2,018	$ 89,963
2,019	97,420
2,020	100,343
2,021	100,015
2,022	96,541
Thereafter	784,442
Estimated future premium payments	$ 1,268,724

WHITE EAGLE REVOLVING CREDIT 56

WHITE EAGLE REVOLVING CREDIT FACILITY - Narrative (Details)

Dec. 29, 2017

Dec. 30, 2016

Dec. 29, 2016USD ($)contract

Nov. 09, 2015USD ($)

Apr. 29, 2013USD ($)

Dec. 31, 2017USD ($)contract

Dec. 31, 2016USD ($)contract

Oct. 04, 2017

Jul. 28, 2017USD ($)

Jul. 26, 2017USD ($)

Jun. 30, 2017USD ($)

Feb. 28, 2014USD ($)

Debt Instrument [Line Items]

Number of policies owned | contract

608

621

Life insurance policies with aggregate death benefit

$ 2,880,487,000

$ 2,946,511,000

Investment in life settlements

567,492,000

498,400,000

8.50% Senior Unsecured Convertible Notes Due 2019

Debt Instrument [Line Items]

Debt instrument issued

$ 70,700,000

8.5% New Senior Secured Notes Due 2021

Debt Instrument [Line Items]

Debt instrument issued

$ 30,000,000

8.5% New Senior Secured Notes Due 2021 | Senior Notes

Debt Instrument [Line Items]

Debt instrument issued

35,000,000

8.50% Senior Unsecured Convertible Notes Due 2019 | Convertible Notes

Debt Instrument [Line Items]

Debt instrument issued

$ 1,200,000

$ 74,200,000

$ 73,000,000

New Convertible Notes Indenture | Convertible Notes

Debt Instrument [Line Items]

Debt instrument issued

$ 75,800,000

White Eagle Revolving Credit Facility | White Eagle Asset Portfolio, LLC

Debt Instrument [Line Items]

Cash interest coverage ratio required

2

2

Percentage of remaining proceeds

50.00%

Cash sweep percentage required

100.00%

White Eagle Revolving Credit Facility | After June 30, 2019 | White Eagle Asset Portfolio, LLC

Debt Instrument [Line Items]

Cash interest coverage ratio required

1.75

Number of consecutive days to maintain cash interest coverage ratio

60 days

White Eagle | White Eagle Revolving Credit Facility

Debt Instrument [Line Items]

Initiation date

Apr. 29, 2013

Revolving credit facility period

15 years

Portfolio of life insurance

$ 250,000,000

$ 300,000,000

$ 333,200,000

Interest rate increase

0.50%

Borrowings from lines of credit

$ 87,287,000

124,142,000

Amount drawn for Red Falcon policies purchase

0

71,079,000

Line of credit facility, maximum borrowing capacity

41,000,000

Line of credit facility, remaining borrowing capacity

$ 4,100,000

Cash interest coverage ratio

3.52

Cash sweep percentage

63.00%

Collateral pledge percentage for distributions to be altered

25.00%

Proceeds from distributions

$ 37,059,000

$ 46,023,000

Amount distributed during current year from maturity proceeds collected in prior year

$ 2,480,000

Base rate

0.50%

Debt instrument effective rate

6.61%

6.19%

Expiration date

Dec. 31, 2031

Line of credit fair value

$ 329,200,000

Revolving Credit Facility debt, outstanding

329,000,000

Restricted cash

$ 7,800,000

White Eagle | White Eagle Revolving Credit Facility | Floor Rate

Debt Instrument [Line Items]

Basis spread on variable rate

2.11%

1.69%

1.50%

White Eagle | White Eagle Revolving Credit Facility | Applicable Margin

Debt Instrument [Line Items]

Basis spread on variable rate

4.00%

White Eagle | White Eagle Revolving Credit Facility | Federal Funds Rate

Debt Instrument [Line Items]

Basis spread on variable rate

0.75%

White Eagle | White Eagle Revolving Credit Facility | Securities Pledged as Collateral

Debt Instrument [Line Items]

Portfolio of life insurance

$ 370,000,000

Number of policies owned | contract

190

606

Borrowings from lines of credit

$ 71,100,000

Life insurance policies with aggregate death benefit

$ 2,900,000,000

Investment in life settlements

$ 566,700,000

White Eagle | White Eagle Revolving Credit Facility | Minimum

Debt Instrument [Line Items]

Line of credit facility covenant terms loan to value ratio

45.00%

White Eagle | White Eagle Revolving Credit Facility | White Eagle Amendment | Applicable Margin

Debt Instrument [Line Items]

Basis spread on variable rate

4.50%

White Eagle | White Eagle Revolving Credit Facility | Maintenance Costs

Debt Instrument [Line Items]

Line of credit borrowing base percentage

100.00%

White Eagle | White Eagle Revolving Credit Facility | Accrued and Unpaid Interest

Debt Instrument [Line Items]

Line of credit borrowing base percentage

100.00%

White Eagle | White Eagle Revolving Credit Facility | Policies pledged as collateral as determined by the lenders

Debt Instrument [Line Items]

Line of credit borrowing base percentage

75.00%

White Eagle | White Eagle Revolving Credit Facility | Fifth

Debt Instrument [Line Items]

Proceeds from distributions

$ 16,037,000

$ 10,932,000

WHITE EAGLE REVOLVING CREDIT 57

WHITE EAGLE REVOLVING CREDIT FACILITY - Payouts based on LTV (Details) - White Eagle Revolving Credit Facility	12 Months Ended
	Dec. 31, 2017
White Eagle Amendment
Debt Instrument [Line Items]
Distribution percentage	45.00%
N/A | White Eagle Amendment
Debt Instrument [Line Items]
Collection of policy proceeds percentage	0.00%
More than 65% | White Eagle Amendment
Debt Instrument [Line Items]
Collection of policy proceeds percentage	0.00%
50-65% | White Eagle Amendment
Debt Instrument [Line Items]
Collection of policy proceeds percentage	13.50%
35-50% | White Eagle Amendment
Debt Instrument [Line Items]
Collection of policy proceeds percentage	20.30%
0-35% | White Eagle Amendment
Debt Instrument [Line Items]
Collection of policy proceeds percentage	24.80%
White Eagle | Minimum
Debt Instrument [Line Items]
Loan to value	45.00%
White Eagle | White Eagle Amendment
Debt Instrument [Line Items]
Distribution percentage	55.00%
White Eagle | N/A | White Eagle Amendment
Debt Instrument [Line Items]
Premiums, Interest & Other Fees	100.00%
Principal	0.00%
Collection of policy proceeds percentage	0.00%
White Eagle | More than 65% | Minimum
Debt Instrument [Line Items]
Loan to value	45.00%
White Eagle | More than 65% | White Eagle Amendment
Debt Instrument [Line Items]
Loan to value	65.00%
Principal	100.00%
Collection of policy proceeds percentage	0.00%
White Eagle | 50-65% | White Eagle Amendment
Debt Instrument [Line Items]
Principal	70.00%
Collection of policy proceeds percentage	16.50%
White Eagle | 50-65% | White Eagle Amendment | Minimum
Debt Instrument [Line Items]
Loan to value	50.00%
White Eagle | 50-65% | White Eagle Amendment | Maximum
Debt Instrument [Line Items]
Loan to value	65.00%
White Eagle | 35-50% | White Eagle Amendment
Debt Instrument [Line Items]
Principal	55.00%
Collection of policy proceeds percentage	24.80%
White Eagle | 35-50% | White Eagle Amendment | Minimum
Debt Instrument [Line Items]
Loan to value	35.00%
White Eagle | 35-50% | White Eagle Amendment | Maximum
Debt Instrument [Line Items]
Loan to value	50.00%
White Eagle | 0-35% | White Eagle Amendment
Debt Instrument [Line Items]
Principal	45.00%
Collection of policy proceeds percentage	30.30%
White Eagle | 0-35% | White Eagle Amendment | Minimum
Debt Instrument [Line Items]
Loan to value	0.00%
White Eagle | 0-35% | White Eagle Amendment | Maximum
Debt Instrument [Line Items]
Loan to value	35.00%

WHITE EAGLE REVOLVING CREDIT 58

WHITE EAGLE REVOLVING CREDIT FACILITY - Distribution of Proceeds (Details) - White Eagle - White Eagle Revolving Credit Facility - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Total Distributions	$ 37,059,000	$ 46,023,000
First:
Debt Instrument [Line Items]
Total Distributions	313,000	239,000
Second:
Debt Instrument [Line Items]
Total Distributions	0	0
Third:
Debt Instrument [Line Items]
Total Distributions	0	0
Fourth:
Debt Instrument [Line Items]
Total Distributions	39,000	53,000
Fifth:
Debt Instrument [Line Items]
Total Distributions	16,037,000	10,932,000
Sixth:
Debt Instrument [Line Items]
Total Distributions	19,633,000	34,799,000
Seventh:
Debt Instrument [Line Items]
Total Distributions	0	0
Eighth:
Debt Instrument [Line Items]
Total Distributions	467,000	0
Ninth:
Debt Instrument [Line Items]
Total Distributions	0	0
Reserve	0	0
Tenth:
Debt Instrument [Line Items]
Total Distributions	0	0
Eleventh:
Debt Instrument [Line Items]
Total Distributions	0	0
Twelfth:
Debt Instrument [Line Items]
Total Distributions	0	0
Thirteenth:
Debt Instrument [Line Items]
Total Distributions	$ 570,000	$ 0

WHITE EAGLE REVOLVING CREDIT 59

WHITE EAGLE REVOLVING CREDIT FACILITY - Reconciliation of Proceeds Distributed (Details) - White Eagle - White Eagle Revolving Credit Facility - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Face value collected in 2016 and distributed in 2017	$ 2,480
Face value collected in 2017 and distributed in 2017	34,372
Face value collected in 2017 and distributed in 2018	7,759
Other collections	247
Total collection in 2017	44,858
Less: Total waterfall distribution in 2017	(37,059)	$ (46,023)
Total to be distributed in 2018	$ 7,799

WHITE EAGLE REVOLVING CREDIT 60

WHITE EAGLE REVOLVING CREDIT FACILITY - Amounts Drawn for Premiums (Details) - White Eagle Revolving Credit Facility - White Eagle - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Amount drawn for premium payments	$ 84,889	$ 51,342
Amount drawn in fees to service providers	2,398	1,721
Amount drawn for Red Falcon policies purchase	0	71,079
Total amount drawn	$ 87,287	$ 124,142

WHITE EAGLE REVOLVING CREDIT 61

WHITE EAGLE REVOLVING CREDIT FACILITY - Interest Expense on Facility (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Interest expense	$ 32,797	$ 29,439	$ 27,286
White Eagle Revolving Credit Facility
Debt Instrument [Line Items]
Interest expense	17,286	11,423
White Eagle Revolving Credit Facility | White Eagle
Debt Instrument [Line Items]
Interest paid through waterfall	16,037	10,932
Interest paid by White Eagle	782	103
Debt issuance cost	0	388
Participation interest paid through waterfall	$ 467	$ 0

RED FALCON REVOLVING CREDIT F62

RED FALCON REVOLVING CREDIT FACILITY - Narrative (Details)	Dec. 29, 2016USD ($)	Jul. 15, 2016USD ($)policy	Jul. 16, 2015USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Sep. 30, 2017
Debt Instrument [Line Items]
Interest expense				$ 32,797,000	$ 29,439,000	$ 27,286,000
Interest paid				21,379,000	24,337,000	13,802,000
Loss on extinguishment of debt				2,018,000	554,000	$ 8,782,000
Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Interest expense				$ 17,286,000	11,423,000
Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Initiation date			Jul. 16, 2015
Repayment of facility	$ 65,100,000
Portfolio of life insurance			$ 110,000,000
Yield maintenance provision			5.00%	5.00%
Line of credit facility amortization percentage			8.00%	8.00%
Proceeds from distributions					7,557,000
Proceeds from lines of credit			$ 54,000,000
Basis spread on variable rate			0.50%
Interest expense					4,300,000
Debt issuance costs not capitalized					297,000
Interest paid					$ 4,000,000
Long term debt				$ 0
Loss on extinguishment of debt	554,000
Debt valuation allowance	239,000
Termination fees	$ 315,000
Applicable Margin | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Basis spread on variable rate			4.50%
Floor Rate | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Basis spread on variable rate			1.00%		1.64%
Federal Funds Rate | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Basis spread on variable rate			0.75%
Less than 50% but greater than or equal to 25% | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Principal percentage of remaining outstanding balance			65.00%
Less than 25% | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Principal percentage of remaining outstanding balance			35.00%
Minimum | Equal to or greater than 50% | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Line of credit facility covenant terms loan to value ratio			50.00%
Minimum | Less than 50% but greater than or equal to 25% | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Line of credit facility covenant terms loan to value ratio			25.00%
Maximum | Less than 50% but greater than or equal to 25% | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Line of credit facility covenant terms loan to value ratio			50.00%
Maximum | Less than 25% | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Line of credit facility covenant terms loan to value ratio			25.00%
Maintenance Costs | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Line of credit borrowing base percentage			100.00%
Policies pledged as collateral as determined by the lenders | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Line of credit borrowing base percentage			60.00%
Policies pledged as collateral excluding certain specified life insurance policies | Red Falcon | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Line of credit borrowing base percentage			45.00%
12.875% Senior Secured Notes Due 2017 | Securities Pledged as Collateral | Indaba Capital Management, L.P.
Debt Instrument [Line Items]
Debt instrument, interest rate							12.875%
Red Falcon | Securities Pledged as Collateral | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Term			5 years
Red Falcon | First Amendment to Revolving Loan and Security Agreement | Securities Pledged as Collateral | Red Falcon Revolving Credit Facilty
Debt Instrument [Line Items]
Number of additional policies | policy		6
Number of additional partially pledged contracts | policy		20
Advanced amount		$ 3,000,000

RED FALCON REVOLVING CREDIT F63

RED FALCON REVOLVING CREDIT FACILITY - Distribution of Proceeds (Details) - Red Falcon - Red Falcon Revolving Credit Facilty - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Total Distributions		$ 7,557
First:
Debt Instrument [Line Items]
Total Distributions		378
Administrative agent cash contingent interest percentage	5.00%
Second:
Debt Instrument [Line Items]
Total Distributions		37
Third:
Debt Instrument [Line Items]
Total Distributions		15
Fourth:
Debt Instrument [Line Items]
Total Distributions		0
Fifth:
Debt Instrument [Line Items]
Total Distributions		47
Sixth:
Debt Instrument [Line Items]
Total Distributions		537
Seventh:
Debt Instrument [Line Items]
Total Distributions		756
Lender repayment of principal percentage of cash proceeds	0.50%
Eighth:
Debt Instrument [Line Items]
Total Distributions		5,787
Lender repayment of principal percentage over LTV	50.00%
Ninth:
Debt Instrument [Line Items]
Total Distributions		0
Tenth:
Debt Instrument [Line Items]
Total Distributions		$ 0

8.50% SENIOR UNSECURED CONVER64

8.50% SENIOR UNSECURED CONVERTIBLE NOTES (Details)	Jul. 28, 2017USD ($)	Jul. 26, 2017USD ($)	Apr. 18, 2017	Mar. 14, 2017USD ($)	Feb. 28, 2014USD ($)d$ / shares	Jun. 30, 2015$ / sharesshares	Jun. 30, 2015$ / shares	Sep. 30, 2017USD ($)	Sep. 30, 2016USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Jun. 30, 2017USD ($)	Feb. 14, 2017
Debt Instrument [Line Items]
Interest paid in kind										$ 6,288,000	$ 0	$ 0
One time debt modification costs										$ 2,537,000	0	$ 0
8.50% Senior Unsecured Convertible Notes Due 2019
Debt Instrument [Line Items]
Debt instrument, interest rate					8.50%
Debt instrument issued					$ 70,700,000
Debt maturity					2,019
Debt issuance date					Feb. 21, 2014
Maturity date										Feb. 15, 2019
Period payments										semi-annually in arrears on August 15 and February 15 of each year
Conversion price (usd per share) | $ / shares					$ 6.76	$ 6.59	$ 6.59
Debt instrument, conversion rate					0.147929		0.1517912
Issuance of common stock (in shares) | shares						6,688,433
Redemption start date										Feb. 15, 2017
Debt instrument, convertible, minimum percentage of common stock price					130.00%
Debt instrument, convertible, threshold trading days | d					20
Debt instrument, redemption price, percentage					100.00%
New Convertible Notes Indenture | Convertible Notes
Debt Instrument [Line Items]
Debt instrument issued	$ 75,800,000
One time debt modification costs	2,500,000
Interest included in interest expense										$ 4,200,000
8.50% Senior Unsecured Convertible Notes Due 2019
Debt Instrument [Line Items]
Convertible notes, net of discount										1,098,000	60,535,000
8.50% Senior Unsecured Convertible Notes Due 2019 | Convertible Notes
Debt Instrument [Line Items]
Debt instrument issued		$ 74,200,000								1,200,000			$ 73,000,000
Debt instrument, convertible, threshold consecutive trading days | d					30
Interest paid in kind		$ 2,800,000						$ 522,000
Debt restructuring, amount reclassified to succeeding debt instrument	7,700,000
Debt restructuring, debt discount reclassified to succeeding instrument	6,700,000
Debt instrument, debt issuance costs reclassified to succeeding debt instrument	1,000,000
Convertible notes, net of discount										1,100,000
Unamortized debt discount										84,000
Debt instrument origination cost										12,000
Interest expense debt										9,200,000	9,700,000
Interest included in interest expense	$ 2,500,000										6,000,000
Amortization of debt discounts								2,100,000	$ 3,200,000
Fees and expenses paid								$ 314,000	$ 480,000
Additional 8.50% Senior Unsecured Convertible Notes | Convertible Notes
Debt Instrument [Line Items]
Debt instrument, interest rate														8.50%
Debt instrument issued				$ 3,477,450
Percentage of aggregate principal amount consenting to accept notes in lieu of cash payment				98.00%
5.0% Senior Unsecured Convertible Notes Due 2023
Debt Instrument [Line Items]
Convertible notes, net of discount										$ 68,654,000	$ 0
5.0% Senior Unsecured Convertible Notes Due 2023 | Convertible Notes
Debt Instrument [Line Items]
Debt instrument, interest rate			5.00%
Percentage of holders tendering exchange offer, minimum		98.00%
Exchange Offers | Existing Note Holders
Debt Instrument [Line Items]
Percentage of holders tendering exchange offer, minimum			98.00%

5.0% SENIOR UNSECURED CONVERT65

5.0% SENIOR UNSECURED CONVERTIBLE NOTES (Details) $ / shares in Units, $ in Thousands	Jul. 28, 2017USD ($)d$ / shares	Jul. 26, 2017	Dec. 31, 2017USD ($)	Apr. 18, 2017	Dec. 31, 2016USD ($)
5.0% Senior Unsecured Convertible Notes Due 2023
Debt Instrument [Line Items]
Convertible notes, net of discount			$ 68,654		$ 0
Convertible Notes | 5.0% Senior Unsecured Convertible Notes Due 2023
Debt Instrument [Line Items]
Percentage of holders tendering exchange offer, minimum		98.00%
Debt instrument, interest rate				5.00%
Convertible Notes | New Convertible Notes Indenture
Debt Instrument [Line Items]
Debt instrument issued	$ 75,800
Debt instrument, required percentage of trustees or holders to declare Notes immediately due and payable	25.00%
Debt instrument, required percentage of principal for each day of default	0.25%
Debt instrument, additional required percentage of principal for each day of restricted transfer default	0.25%
Debt instrument, maximum required percentage of principal restricted transfer default	0.50%
Debt instrument, debt default, special interest percentage of principal	0.50%
Interest included in interest expense			4,200
Convertible Notes | New Convertible Notes
Debt Instrument [Line Items]
Conversion price (usd per share) | $ / shares	$ 2
Debt instrument, conversion rate	0.5
Debt instrument, redemption price, percentage	100.00%
Debt instrument, convertible, minimum percentage of common stock price	120.00%
Debt instrument, convertible, threshold trading days | d	15
Debt instrument, convertible, threshold consecutive trading days | d	30
Convertible notes, net of discount			68,700
Unamortized debt discount			6,300
Debt instrument origination cost			927
Interest expense debt			2,100
Interest included in interest expense			1,600
Amortization of debt discounts			432
Amortization of debt issuance costs			$ 64

15% SENIOR SECURED NOTES (Detai

15% SENIOR SECURED NOTES (Details) - USD ($)	Jul. 28, 2017	Jun. 15, 2017	Apr. 07, 2017	Mar. 11, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jun. 28, 2017	May 15, 2017	Dec. 29, 2016	Mar. 24, 2016
Debt Instrument [Line Items]
Loss on extinguishment of debt					$ 2,018,000	$ 554,000	$ 8,782,000
Participation Agreement | Consenting Note Holders
Debt Instrument [Line Items]
Percentage of senior debt to be purchased, maximum			100.00%
Percentage of senior debt to be paid			5.00%
Participation Agreement | PJC
Debt Instrument [Line Items]
Percentage of senior debt to be purchased, maximum			100.00%
15.0% Senior Secured Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	15.00%
15.0% Senior Secured Notes | Senior Secured Notes Holders
Debt Instrument [Line Items]
Redemption price percentage of principal amount redeemed	5.00%
15.00% Promissory Note | Line of Credit | Bridge Note
Debt Instrument [Line Items]
Debt instrument, interest rate								15.00%
Line of credit facility, maximum borrowing capacity								$ 3,300,000	$ 1,500,000
Senior Notes | 15.0% Senior Secured Notes
Debt Instrument [Line Items]
Debt instrument, face amount										$ 69,600,000
Debt issued				$ 21,200,000							$ 8,800,000
Debt instrument, interest rate			15.00%	15.00%
Debt instrument, redemption price, percentage				100.00%
Basis spread on variable rate				0.50%
Change of control redemption, percentage				107.50%
Debt covenant, percent of equity interests pledged as collateral				65.00%
Delinquent interest payment		$ 1,200,000
Loss on extinguishment of debt	$ 2,000,000
Prepayment penalty fee	1,500,000
Write off origination costs	$ 518,000
Interest expense					2,800,000	4,000,000
Interest included in interest expense					2,600,000	3,700,000
Amortization of debt discounts					$ 184,000	$ 356,000
Senior Notes | 15.0% Senior Secured Notes | Maximum
Debt Instrument [Line Items]
Debt instrument, face amount		$ 30,000,000		$ 30,000,000
Senior Notes | 15.0% Senior Secured Notes | Management
Debt Instrument [Line Items]
Debt bought in private transaction				$ 3,300,000
Senior Notes | 15.0% Senior Secured Notes | Securities Pledged as Collateral
Debt Instrument [Line Items]
Debt instrument, interest rate				15.00%
Senior Notes | New Senior Secured Notes
Debt Instrument [Line Items]
Percentage of senior debt to be purchased, maximum	100.00%		100.00%

8.5% SENIOR SECURED NOTES (Deta

8.5% SENIOR SECURED NOTES (Details) - USD ($)	Aug. 14, 2017	Aug. 11, 2017	Jul. 28, 2017	Apr. 07, 2017	Mar. 11, 2016	Dec. 31, 2017	Dec. 31, 2016	Jan. 10, 2018	Dec. 29, 2016
Stock Purchase Agreement
Debt Instrument [Line Items]
Sale of stock, price per share (in dollars per share)			$ 0.2
Sale of stock, number of shares issued (in shares)			115,000,000
Brennan | Stock Purchase Agreement
Debt Instrument [Line Items]
Securities remaining for future issuance (shares)		12,500,000
Sale of stock, price per share (in dollars per share)		$ 0.40
Sale of stock, aggregate purchase price		$ 5,000,000
Sale of stock, number of shares issued (in shares)	3,750,000	8,750,000
8.5% New Senior Secured Notes Due 2021
Debt Instrument [Line Items]
Debt instrument, interest rate			8.50%
Debt instrument issued			$ 30,000,000
Debt amount repurchased						$ 24,500,000
Senior notes, net						33,927,000	$ 0
15.0% Senior Secured Notes
Debt Instrument [Line Items]
Debt instrument, interest rate			15.00%
Senior notes, net						0	29,297,000
Senior Notes | New Senior Secured Notes
Debt Instrument [Line Items]
Percentage of senior debt to be purchased, maximum			100.00%	100.00%
Senior Notes | 8.5% New Senior Secured Notes Due 2021
Debt Instrument [Line Items]
Debt instrument issued						35,000,000
Senior Notes | 15.0% Senior Secured Notes
Debt Instrument [Line Items]
Debt instrument, interest rate				15.00%	15.00%
Debt instrument issued									$ 69,600,000
Debt instrument, redemption price, percentage					100.00%
Debt covenant, percent of equity interests pledged as collateral					65.00%
Interest expense debt						2,800,000	4,000,000
Interest included in interest expense						2,600,000	3,700,000
Amortization of debt discounts						184,000	$ 356,000
Senior Notes | 15.0% Senior Secured Notes | Change in control
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage			107.50%
Senior Notes | Brennan Notes
Debt Instrument [Line Items]
Debt instrument issued		$ 5,000,000
Debt instrument, repurchased amount	$ 1,500,000	$ 3,500,000
Senior Notes | 5.0% Senior Secured Notes Due 2021
Debt Instrument [Line Items]
Senior notes, net						33,900,000
Debt instrument origination cost						1,100,000
Interest expense debt						1,400,000
Interest included in interest expense						1,300,000
Amortization of debt discounts						98,000
Convertible Notes | New Convertible Notes Indenture
Debt Instrument [Line Items]
Debt instrument issued			$ 75,800,000
Debt instrument, required percentage pledged to equity interest			65.00%
Debt instrument, required percentage of trustees or holders to declare Notes immediately due and payable			25.00%
Interest included in interest expense						$ 4,200,000
Convertible Notes | New Convertible Notes Indenture | Subsequent Event
Debt Instrument [Line Items]
Debt covenant, percent of equity interests pledged as collateral								65.00%

15.0% PROMISSORY NOTE (Details)

15.0% PROMISSORY NOTE (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Jun. 28, 2017	May 15, 2017
Line of Credit Facility [Line Items]
Interest expense		$ 32,797,000	$ 29,439,000	$ 27,286,000
Line of Credit | 15.00% Promissory Note | Bridge Note
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity					$ 3,300,000	$ 1,500,000
Debt instrument, interest rate					15.00%
Line of credit, default interest rate					17.00%
Line of credit, default termination fee						$ 1,500,000
Revolving credit facility debt, outstanding	$ 2,800,000
Interest expense		$ 36,000

FAIR VALUE MEASUREMENTS - Asset

FAIR VALUE MEASUREMENTS - Assets And Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	$ 567,492	$ 498,400
Assets fair value	567,492	498,400
Liabilities fair value	329,240	257,085
White Eagle Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	329,240	257,085
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	0	0
Assets fair value	0	0
Liabilities fair value	0	0
Level 1 | White Eagle Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	0	0
Assets fair value	0	0
Liabilities fair value	0	0
Level 2 | White Eagle Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	567,492	498,400
Assets fair value	567,492	498,400
Liabilities fair value	329,240	257,085
Level 3 | White Eagle Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	$ 329,240	$ 257,085

FAIR VALUE MEASUREMENTS - Quant

FAIR VALUE MEASUREMENTS - Quantitative Information about Level 3 Fair Value Measurements (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements	$ 567,492	$ 498,400
Life insurance policies with aggregate death benefit	$ 2,880,487	$ 2,946,511
Weighted average discount rate	15.95%
Life Finance
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	15.95%	16.37%
Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements	$ 567,492	$ 498,400
Life insurance policies with aggregate death benefit	2,880,487
Level 3 | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements	101,591
Life insurance policies with aggregate death benefit	305,963
Level 3 | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements	465,901
Life insurance policies with aggregate death benefit	$ 2,574,524
Level 3 | Life Finance
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	8 years 4 months
Level 3 | Life Finance | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	5 years 3 months
Level 3 | Life Finance | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	8 years 7 months
Level 3 | Minimum | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	14.50%
Level 3 | Minimum | Life Finance | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Weighted average discount rate	14.50%
Level 3 | Minimum | Life Finance | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	15.50%
Weighted average discount rate	15.50%
Level 3 | Maximum | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	17.50%
Level 3 | Maximum | Life Finance | Non Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Weighted average discount rate	17.50%
Level 3 | Maximum | Life Finance | Premium Financed
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount Rate	21.00%
Weighted average discount rate	21.00%
Level 3 | White Eagle | White Eagle Revolving Credit Facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements	$ 329,240
Life insurance policies with aggregate death benefit	$ 2,868,487
Level 3 | White Eagle | White Eagle Revolving Credit Facility | Life Finance
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation Technique	Discounted cash flow
Weighted average life expectancy valuation period	8 years 3 months
Weighted average discount rate	18.57%

FAIR VALUE MEASUREMENTS - Narra

FAIR VALUE MEASUREMENTS - Narrative (Details) claim in Thousands	Jul. 26, 2017USD ($)	Jul. 16, 2015	Sep. 30, 2017USD ($)	Dec. 31, 2017USD ($)contractpolicycarrierclaim	Dec. 31, 2016USD ($)contract	Dec. 31, 2015USD ($)	Jun. 30, 2017USD ($)	Dec. 29, 2016contract	Feb. 28, 2014USD ($)
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Mortality rate				100.00%
Number of policies owned | contract				608	621
Investment in life settlements				$ 567,492,000	$ 498,400,000
Weighted average discount rate				15.95%
Interest paid in kind				$ 6,288,000	0	$ 0
Noninvestment grade
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of insurance carriers | carrier				3
Life insurance, policies issued | policy				19
Additional basis point risk premium				3.00%
Premium Financed
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of policies owned | contract				530
Non Premium Financed
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of policies owned | contract				78
White Eagle Revolving Credit Facility | Red Falcon
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Yield maintenance provision		5.00%		5.00%
Line of credit facility amortization percentage		8.00%		8.00%
Level 3
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements				$ 567,492,000	498,400,000
Level 3 | Premium Financed
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements				465,901,000
Level 3 | Non Premium Financed
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements				$ 101,591,000
Level 3 | Non Premium Financed | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates				14.50%
Level 3 | Non Premium Financed | Maximum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates				17.50%
8.50% Senior Unsecured Convertible Notes Due 2019
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt instrument, face amount									$ 70,700,000
2015 VBT
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of policies | policy				266,000,000
Number of claims on policies | claim				2,550
Number of insurance carriers | carrier				51
2008 VBT
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of policies | policy				75,000,000
White Eagle Revolving Credit Facility
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit fair value				$ 329,240,000	257,085,000
White Eagle Revolving Credit Facility | Level 3
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit fair value				329,240,000	$ 257,085,000
5.0% Senior Unsecured Convertible Notes Due 2023 | Convertible Notes
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Percentage of holders tendering exchange offer, minimum	98.00%
8.50% Senior Unsecured Convertible Notes Due 2019 | Convertible Notes
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt instrument, face amount	$ 74,200,000			1,200,000			$ 73,000,000
Interest paid in kind	$ 2,800,000		$ 522,000
White Eagle | White Eagle Revolving Credit Facility
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit fair value				329,200,000
Fair value of debt outstanding				$ 329,000,000
White Eagle | White Eagle Revolving Credit Facility | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit facility covenant terms loan to value ratio				45.00%
White Eagle | White Eagle Revolving Credit Facility | Scenario 1 | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Line of credit facility covenant terms loan to value ratio				45.00%
White Eagle | Level 3 | White Eagle Revolving Credit Facility
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investment in life settlements				$ 329,240,000
White Eagle | Securities Pledged as Collateral | White Eagle Revolving Credit Facility
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Number of policies owned | contract				606				190
Investment in life settlements				$ 566,700,000
Life Finance
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates				15.95%	16.37%
Life Finance | Level 3 | Premium Financed | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates				15.50%
Weighted average discount rate				15.50%
Life Finance | Level 3 | Premium Financed | Maximum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rates				21.00%
Weighted average discount rate				21.00%
Life Finance | Level 3 | Non Premium Financed | Minimum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Weighted average discount rate				14.50%
Life Finance | Level 3 | Non Premium Financed | Maximum
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Weighted average discount rate				17.50%
Life Finance | White Eagle | Level 3 | White Eagle Revolving Credit Facility
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Weighted average discount rate				18.57%
Impaired life bearing
Fair Value, Instruments Classified in Shareholders' Equity Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Mortality rate				200.00%

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Changes in Life Expectancy Used to Estimate Fair Value (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	$ 567,492	$ 498,400
Change in Value	0	$ 0	$ (41)
Plus 6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	479,016
Change in Value	(88,476)
No Change in Life Expectancy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	567,492
Change in Value	0
-6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in life settlements	660,720
Change in Value	$ 93,228

FAIR VALUE MEASUREMENTS - Life

FAIR VALUE MEASUREMENTS - Life Insurance Issuer concentrations (Detail) - Credit Concentration Risk - Moody's, A1 Rating - Standard & Poor's, AA- Rating	12 Months Ended
	Dec. 31, 2017
Lincoln National Life Insurance Company | 10% of total fair value of our investments in life settlements
Concentration Risk [Line Items]
Concentrations risk percentage	22.40%
Lincoln National Life Insurance Company | Life insurance issuer concentrations that exceed 10% of total death benefit
Concentration Risk [Line Items]
Concentrations risk percentage	19.50%
Transamerica Life Insurance Company | 10% of total fair value of our investments in life settlements
Concentration Risk [Line Items]
Concentrations risk percentage	18.40%
Transamerica Life Insurance Company | Life insurance issuer concentrations that exceed 10% of total death benefit
Concentration Risk [Line Items]
Concentrations risk percentage	20.80%

FAIR VALUE MEASUREMENTS - Cha74

FAIR VALUE MEASUREMENTS - Changes in Weighted Average Discount Rate Used to Estimate Fair Value (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Rate Calculated Based on Death Benefit	15.95%
Investment in life settlements	$ 567,492	$ 498,400
Change in Value	$ 0	$ 0	$ (41)
.50% Decrease in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Rate Calculated Based on Death Benefit	15.45%
Investment in life settlements	$ 581,538
Change in Value	$ 14,046
No Change in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Rate Calculated Based on Death Benefit	15.95%
Investment in life settlements	$ 567,492
Change in Value	$ 0
.50% Increase in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Weighted Average Rate Calculated Based on Death Benefit	16.45%
Investment in life settlements	$ 554,001
Change in Value	$ (13,491)

FAIR VALUE MEASUREMENTS - Cha75

FAIR VALUE MEASUREMENTS - Changes in Life Expectancy Used to Estimate Fair Value of Revolving Credit Facility (Detail) - White Eagle - White Eagle Revolving Credit Facility $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)
Plus 6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	$ 270,304
Change in Value	(58,936)
No Change in Life Expectancy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	329,240
Change in Value	0
-6 Life Expectancy Months Adjustment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	369,499
Change in Value	$ 40,259

FAIR VALUE MEASUREMENTS - Cha76

FAIR VALUE MEASUREMENTS - Changes in Weighted Average Discount Rate Used to Estimate Fair Value of Revolving Credit Facility (Detail) - White Eagle - White Eagle Revolving Credit Facility $ in Thousands	12 Months Ended
	Dec. 31, 2017USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	18.57%
.50% Decrease in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	18.07%
Line of credit fair value	$ 336,708
Change in Value	7,468
No Change in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Line of credit fair value	329,240
Change in Value	$ 0
.50% Increase in Discount Rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount Rate	19.07%
Line of credit fair value	$ 322,045
Change in Value	$ (7,195)

FAIR VALUE MEASUREMENTS - Cha77

FAIR VALUE MEASUREMENTS - Changes in Fair Value for All Assets and Liabilities Using Material Level of Unobservable (Level 3) Inputs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Life Settlements
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, January 1	$ 498,400	$ 461,925
Purchase of policies	0	16
Retained death benefits acquisitions		1,374
Change in fair value	51,551	864
Matured/lapsed/sold polices	(67,177)	(37,460)
Premiums paid	84,718	71,681
Transfers into level 3	0	0
Transfers out of level 3	0	0
Balance, December 31	567,492	498,400
Change in mortality curve that resulted in reduction of fair value of life settlements		(17,600)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Changes in fair value included in earnings for the period relating to assets held	12,848	(17,442)
White Eagle | White Eagle Revolving Credit Facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, January 1	257,085	169,131
Draws under the revolving credit facility	87,287	124,142
Payments on credit facility	(19,633)	(34,799)
Unrealized change in fair value	4,501
Unrealized change in fair value		(1,389)
Transfers into level 3	0	0
Transfer out of level 3	0	0
Balance, December 31	329,240	257,085
Changes in fair value included in earnings for the period relating to assets held	4,501	(1,389)
Red Falcon | White Eagle Revolving Credit Facility
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, January 1	$ 0	55,658
Subsequent draws under the revolving credit facility		20,029
Payments on credit facility		75,417
Unrealized change in fair value		(509)
Extinguishment		239
Unrealized change in fair value		0
Transfers into level 3		0
Transfer out of level 3		0
Balance, December 31		$ 0

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Narrative (Details) $ in Thousands	Jul. 29, 2013USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Apr. 18, 2013policy
Commitments and Contingencies [Line Items]
Annual base rent		$ 246
Percentage of annual increase of base rent		3.00%
Rent expense under operating lease		$ 407	$ 412	$ 423
Legal fees		$ 3,721	$ 6,427	$ 20,739
Chief Executive Officer
Commitments and Contingencies [Line Items]
Multiplier for sum of base salary		300.00%
Period of annual cash bonuses		3 years
Legal fees		$ 150
Pending Litigation
Commitments and Contingencies [Line Items]
Life insurance, policies issued | policy					28
Minimum compensatory damages sought in addition to an award of punitive damages	$ 30,000

COMMITMENTS AND CONTINGENCIES79

COMMITMENTS AND CONTINGENCIES - Future Payments (Details) $ in Thousands	Dec. 31, 2017USD ($)
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2,018	$ 248
2,019	255
2,020	196
Total	$ 699

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details)

Aug. 14, 2017USD ($)shares

Aug. 11, 2017USD ($)$ / sharesshares

Jul. 28, 2017USD ($)nomineedirectordesignee$ / sharesshares

Sep. 01, 2015USD ($)

Jun. 30, 2015$ / sharesshares

Dec. 31, 2017USD ($)$ / sharesshares

Dec. 31, 2016USD ($)$ / sharesshares

Dec. 31, 2015USD ($)$ / sharesshares

Aug. 25, 2017USD ($)shares

Jul. 17, 2017shares

Jun. 30, 2017shares

Jun. 27, 2017shares

Mar. 14, 2016USD ($)

Apr. 30, 2014shares

Feb. 11, 2011$ / shares

Stockholders Equity [Line Items]

Proceeds from issue of common stock, net | $

$ 19,188,000

$ 1,803,000

$ 0

Exercise price of warrants (usd per share) | $ / shares

$ 14.51

Options outstanding (shares)

542,102

763,594

Stock repurchase program, authorized amount (shares) | $

$ 10,000,000

Stock repurchase program, expiration period

2 years

Treasury stock | $

$ 2,534,000

Treasury stock acquired, average cost per share (usd per share) | $ / shares

$ 4.17

Common stock issued, net | $

$ 26,889,000

$ 1,803,000

Share price (usd per share) | $ / shares

$ 0.01

$ 0.01

Common stock, shares authorized (shares)

415,000,000

80,000,000

415,000,000

80,000,000

Number of board of directors | director

7

Number of shares of common stock registered (in shares)

207,918,483

New Convertible Notes | Senior Notes

Stockholders Equity [Line Items]

Registration payment arrangement, maximum potential consideration | $

$ 75,800,000

Brennan Notes | Senior Notes

Stockholders Equity [Line Items]

Debt instrument issued | $

$ 5,000,000

Debt instrument, repurchased amount | $

$ 1,500,000

$ 3,500,000

PJC Investments, LLC, Triax and Other Affiliates

Stockholders Equity [Line Items]

Warrants issued (in shares)

27,150,000

Sale of stock, number of shares issued (in shares)

39,320,038

Warrant Investors

Stockholders Equity [Line Items]

Warrants issued (in shares)

42,500,000

Exercise price of warrants (usd per share) | $ / shares

$ 0.2

Other Investors Designated by PJC and Triax

Stockholders Equity [Line Items]

Warrants issued (in shares)

13,350,000

Sale of stock, number of shares issued (in shares)

55,000,000

Private Placement

Stockholders Equity [Line Items]

Common stock issued, net | $

$ 23,000,000

Sale of stock, number of shares issued (in shares)

115,000,000

Sale of stock, price per share (in dollars per share) | $ / shares

$ 0.2

Share price (usd per share) | $ / shares

$ 0.01

Private Placement | PJC Investments, LLC, Triax and Other Affiliates

Stockholders Equity [Line Items]

Common stock issued, net | $

$ 15,000,000

Sale of stock, number of shares issued (in shares)

75,000,000

Private Placement | Convertible Notes Holders Investors

Stockholders Equity [Line Items]

Common stock issued, net | $

$ 8,000,000

Sale of stock, number of shares issued (in shares)

40,000,000

Private Placement | PJC Investments, LLC

Stockholders Equity [Line Items]

Sale of stock, number of shares issued (in shares)

19,320,038

Private Placement | Brennan Opportunities Fund I LP

Stockholders Equity [Line Items]

Securities remaining for future issuance (shares)

12,500,000

Sale of stock, number of shares issued (in shares)

3,750,000

8,750,000

Sale of stock, price per share (in dollars per share) | $ / shares

$ 0.40

Sale of stock, aggregate purchase price | $

$ 5,000,000

Evermore Designation Agreement

Stockholders Equity [Line Items]

Number of directors | director

1

Number of nominees | nominee

1

Investor Designation Agreement

Stockholders Equity [Line Items]

Number of directors | director

3

Number of nominees | nominee

3

Opal Sheppard Agreement

Stockholders Equity [Line Items]

Number of directors | director

1

Number of nominees | nominee

1

Board of Directors

Stockholders Equity [Line Items]

Number of directors | director

1

Number of designees | designee

3

Ironside Designation Agreement

Stockholders Equity [Line Items]

Number of directors | director

1

Number of nominees | nominee

1

Nanthalla Designation Agreement

Stockholders Equity [Line Items]

Number of directors | director

1

Number of nominees | nominee

1

Immediately Upon Issuance | Convertible Notes

Stockholders Equity [Line Items]

Warrants issued (in shares)

17,500,000

At a Later Time Upon Conversion of Notes | Convertible Notes

Stockholders Equity [Line Items]

Warrants issued (in shares)

25,000,000

Term of warrants

8 years

Emergent Capital, Inc. | PJC Investments, LLC, Triax and Other Affiliates

Stockholders Equity [Line Items]

Percentage of ownership after transaction

38.90%

Emergent Capital, Inc. | Other Investors Designated by PJC and Triax

Stockholders Equity [Line Items]

Percentage of ownership after transaction

43.60%

Restricted Stock

Stockholders Equity [Line Items]

Restricted stocks granted (shares)

2,051,132

Unvested restricted stock outstanding (shares)

2,102,522

265,212

Omnibus Plan

Stockholders Equity [Line Items]

Options outstanding (shares)

542,102

Securities remaining for future issuance (shares)

9,730,683

Omnibus Plan | Employee Stock Options

Stockholders Equity [Line Items]

Shares of common stock reserved for future grant (shares)

12,600,000

Omnibus Plan | Restricted Stock

Stockholders Equity [Line Items]

Unvested restricted stock outstanding (shares)

2,102,522

Omnibus Plan | Restricted Stock | Directors

Stockholders Equity [Line Items]

Restricted stocks granted (shares)

233,215

Omnibus Plan | Restricted Stock Units (RSUs) | Certain Employees

Stockholders Equity [Line Items]

Restricted stocks granted (shares)

2,094,000

Common Stock

Stockholders Equity [Line Items]

Issuance of common stock (in shares)

6,688,433

127,500,000

628,309

Shares issued (usd per share) | $ / shares

$ 5.75

$ 3

Proceeds from issue of common stock, net | $

$ 1,800,000

Offering price | $

$ 50,000,000

Commission rate (up to)

3.00%

Common stock issued, net | $

$ 1,275,000

6,000

Commissions paid | $

$ 56,600

Warrant

Stockholders Equity [Line Items]

Warrants issued (in shares)

2,000,000

Estimated fair value of warrants | $

$ 5,400,000

Term of warrants

5 years

Exercise price of warrants (usd per share) | $ / shares

$ 10.75

Average daily trading closing price (usd per share) | $ / shares

$ 8.50

Average daily trading closing price, period

45 days

Treasury Stock

Stockholders Equity [Line Items]

Purchase of treasury stock (in shares)

608,000

Treasury stock | $

$ 2,534,000

EMPLOYEE BENEFIT PLAN (Details)

EMPLOYEE BENEFIT PLAN (Details)	12 Months Ended
	Dec. 31, 2017USD ($)yr	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Postemployment Benefits [Abstract]
401(k) plan that covers employees eligible age | yr	18
401(k) plan that covers employees service period for eligible	3 months
Employer contributions | $	$ 0	$ 0	$ 0

SUMMARY OF QUARTERLY FINANCIA82

SUMMARY OF QUARTERLY FINANCIAL DATA (UNAUDITED) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Quarterly Financial Information Disclosure [Abstract]
Total income	$ (1,666)	$ 24,488	$ 3,461	$ 25,590	$ 3,680	$ 4,767	$ (15,786)	$ 8,454	$ 51,873	$ 1,115	$ 46,891
(Loss)/income from continuing operations before taxes	(2,865)	4,217	(6,474)	1,884	(23,666)	(8,543)	(9,775)	(7,445)	(3,238)	(49,429)	(39,099)
Net (loss)/income from continuing operations	$ (2,865)	$ 4,217	$ (6,474)	$ 1,884	$ (23,666)	$ (8,543)	$ (9,775)	$ (7,445)	$ (3,509)	$ (49,689)	$ (31,024)
Basic (usd per share)	$ (0.02)	$ 0.04	$ (0.23)	$ 0.07
Diluted (usd per share)	$ (0.02)	$ 0.03	$ (0.23)	$ 0.06
Basic and diluted (usd per share)					$ (0.84)	$ (0.31)	$ (0.36)	$ (0.27)	$ (0.04)	$ (1.80)	$ (1.25)

INCOME TAXES - Provision (Benef

INCOME TAXES - Provision (Benefit) for Income Taxes from Continuing Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Continuing operations	$ 0	$ 0	$ (8,719)
Discontinued operations	0	0	0
Provision (benefit) for income taxes	0	0	(8,719)
Current
Federal	0	0	10
State	0	0	0
Current income tax expense	0	0	10
Deferred
Federal	14,109	(16,550)	(9,149)
State	2,931	(1,292)	(3,846)
Deferred income tax expense	17,040	(17,842)	(12,995)
Valuation allowance increase (decrease)	(17,040)	17,842	4,266
Provision (benefit) for income taxes	0	0	(8,729)
Provision (benefit) for income taxes from continuing operations	$ 0	$ 0	$ (8,729)

INCOME TAXES - U.S. and Foreign

INCOME TAXES - U.S. and Foreign Components of Income (Loss) From Continuing Operations before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
U.S.									$ (19,016)	$ (23,405)	$ (51,749)
Foreign									15,778	(26,024)	12,650
(Loss) income from continuing operations before income taxes	$ (2,865)	$ 4,217	$ (6,474)	$ 1,884	$ (23,666)	$ (8,543)	$ (9,775)	$ (7,445)	$ (3,238)	$ (49,429)	$ (39,099)

INCOME TAXES - Reconciliation o

INCOME TAXES - Reconciliation of Actual and Expected Provision (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Tax provision (benefit) at statutory rate, Amount	$ (1,134)	$ (17,300)	$ (13,685)
Amount, Increase (decrease) in taxes resulting from:
State tax (net of federal benefit)	(679)	(836)	(1,617)
Attribute reduction from ownership change	35,871	0	0
Impact of rate changes	0	253	23
Litigation settlement	0	0	2,275
Other permanent items	2	4	18
Tax Cuts and Job Act Enactment	(17,199)	0	0
Prior year true-ups	50	0	0
Other	129	37	0
Valuation allowance (decrease) increase	(17,040)	17,842	4,267
Provision (benefit) for income taxes from continuing operations	$ 0	$ 0	$ (8,719)
Tax provision (benefit) at statutory rate, Percent	35.00%	35.00%	35.00%
Percent, Increase (decrease) in taxes resulting from:
State tax (net of federal benefit)	20.98%	1.72%	4.14%
Attribute reduction from ownership change	(1107.45%)	0.00%	0.00%
Impact of rate changes	0.00%	(0.50%)	(0.06%)
Litigation settlement	0.00%	0.00%	(5.82%)
Other permanent items	(0.07%)	(0.01%)	(0.05%)
Tax Cuts and Job Act Enactment	530.99%	0.00%	0.00%
Prior year true-ups	(1.54%)	0.00%	0.00%
Other	(3.99%)	(0.07%)	0.00%
Valuation allowance (decrease) increase	526.08%	(36.14%)	(10.91%)
Provision (benefit) for income taxes	0.00%	0.00%	22.30%

INCOME TAXES - Deferred Tax Ass

INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Deferred tax assets:
Federal and state net operating loss carryforward	$ 1,537	$ 37,511
Unrealized gains on life settlements	4	0
Revolving Credit Facilities	0	7,024
Deferred gain	6,178	14,112
Other	1,281	1,930
Total gross deferred tax assets	9,000	60,577
Less valuation allowance	(5,522)	(22,457)
Total deferred tax assets	3,478	38,120
Deferred tax liabilities:
Unrealized gains on life and structured settlements	0	20,321
Gain on structured settlements deferred for tax purposes	2,466	3,655
Convertible debt discount	1,012	3,430
Deferred income	0	10,714
Total deferred tax liabilities	3,478	38,120
Total net deferred tax asset (liability)	$ 0	$ 0

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Jul. 28, 2017	Dec. 31, 2016	May 16, 2014
Income Taxes [Line Items]
Operating loss carryovers	$ 97,500,000
Reduction in deferred tax assets due to change in tax rate fully offset by valuation allowance	3,300,000
Taxable loss resulting from transition tax for accumulated foreign earnings	1,600,000
Net deferred tax liability reversed pertaining to outside differences in foreign subsidiaries	11,800,000
Deferred tax benefit due to reversal tax liability pertaining to outside differences in foreign subsidiaries	11,800,000
Deferred tax asset due to transfers of assets to foreign subsidiaries	6,178,000		$ 14,112,000
Deferred Tax Assets, Unrealized Gains in AOCI
Income Taxes [Line Items]
Increase in deferred tax asset valuation allowance from continuing operations	56,000
Senior Notes | Lamington | Special Dividend Note
Income Taxes [Line Items]
Debt instrument issued		$ 57,000,000
Debt instrument, interest rate		5.00%
Senior notes, net	57,700,000
Capitalized interest on debt	665,000
Transition tax exclusion benefit	137,800,000
Senior Notes | White Eagle | Lamington | Promissory Note
Income Taxes [Line Items]
Debt instrument issued				$ 59,300,000
Debt instrument, interest rate				8.50%
Senior notes, net	80,100,000
Capitalized interest on debt	20,800,000
Prior Agreement [Member]
Income Taxes [Line Items]
Operating loss carryforwards, subject to Section 382 limitations	11,200,000
Federal
Income Taxes [Line Items]
Operating loss carryovers	113,800,000
State
Income Taxes [Line Items]
Operating loss carryovers	$ 119,100,000

INCOME TAXES - Reconciliation88

INCOME TAXES - Reconciliation of Total Amounts of Unrecognized Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Reconciliation of Unrecognized Tax Benefits
Balance as of beginning of period	$ 6,295	$ 6,295	$ 6,295
Additions based on tax positions taken in the current year	0	0	0
Reductions of tax positions for prior years	(6,295)	0	0
Balance as of end of period	$ 0	$ 6,295	$ 6,295

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)	Mar. 13, 2018USD ($)	Mar. 06, 2018	Jun. 30, 2018shares	Jan. 10, 2018	Jul. 28, 2017USD ($)	Dec. 29, 2016USD ($)	Mar. 11, 2016
Convertible Notes | New Convertible Notes Indenture
Subsequent Event [Line Items]
Debt instrument issued					$ 75,800,000
Senior Notes | 15.0% Senior Secured Notes
Subsequent Event [Line Items]
Debt covenant, percent of equity and certain other assets pledged as collateral							65.00%
Debt instrument issued						$ 69,600,000
Subsequent Event
Subsequent Event [Line Items]
Minimum percentage of common stock outstanding required for a shareholder to nominate or elect a director		1.00%
Minimum period required by shareholders to hold percentage of common stock shares to nominate or elect a director		12 months
Subsequent Event | PJC Investments, LLC
Subsequent Event [Line Items]
Commitment received for investment (maximum)	$ 2,000,000
Subsequent Event | Senior Vice President Chief Investment Officer
Subsequent Event [Line Items]
Employment agreement term	1 year
Employment agreement extension period	1 year
Employment agreement period required to receive written notice to extend	60 days
Employment agreement annual base salary	$ 275,000
Employment agreement months following severance period	6 months
Subsequent Event | Vice President Chief Legal Officer and General Counsel
Subsequent Event [Line Items]
Employment agreement term	1 year
Employment agreement extension period	1 year
Employment agreement period required to receive written notice to extend	60 days
Employment agreement annual base salary	$ 250,000
Employment agreement months following severance period	6 months
Subsequent Event | Convertible Notes | New Convertible Notes Indenture
Subsequent Event [Line Items]
Debt covenant, percent of equity and certain other assets pledged as collateral				65.00%
Subsequent Event | Imperial Finance and Trading, Inc | Serior Vice President and Chief Financial Officer
Subsequent Event [Line Items]
Employment agreement term	1 year
Employment agreement extension period	1 year
Employment agreement period required to receive written notice to extend	60 days
Employment agreement annual base salary	$ 275,000
Employment agreement base salary to be received upon termination during severance period	$ 352,229
Employment agreement months following severance period	12 months
Employment agreement termination or resignation withing period of change in control	2 years
Employment agreement base salary multiplier	2
Employment agreement period for reimbursement of COBRA healthcare costs after termination	12 months
Subsequent Event | Scenario, Forecast | Sherman Clay | SB Holdings | Common Stock
Subsequent Event [Line Items]
Initial purchase price (shares) | shares			18,000,000
Number of shares held back for potential indemnified claims (shares) | shares			2,700,000
Maximum period to held back shares for potential indemnified claims			18 months